1671881	94	109	fenilchetonuria	DISEASEORPHENOTYPICFEATURE	D010661
1671881	154	181	La fenilchetonuria classica	DISEASEORPHENOTYPICFEATURE	D010661
1671881	231	260	malattia autosomica recessiva	DISEASEORPHENOTYPICFEATURE	D030342
1671881	324	367	deficit di fenilalanina idrossilasi epatica	DISEASEORPHENOTYPICFEATURE	OMIM:261600
1671881	400	403	PAH	GENEORGENEPRODUCT	5053
1671881	522	525	PAH	GENEORGENEPRODUCT	5053
1671881	655	669	272gly----stop	SEQUENCEVARIANT	RS62514952
1671881	707	720	273ser----phe	SEQUENCEVARIANT	RS62514953
1671881	1002	1005	PKU	DISEASEORPHENOTYPICFEATURE	D010661
1671881	1120	1131	Carenze IPA	DISEASEORPHENOTYPICFEATURE	 OMIM:261600
6086495	50	90	gene della distrofia muscolare di Becker	GENEORGENEPRODUCT	1756
6086495	245	274	Distrofia muscolare di Becker	DISEASEORPHENOTYPICFEATURE	D020388
6086495	319	322	BMD	DISEASEORPHENOTYPICFEATURE	D020388
6086495	518	521	BMD	GENEORGENEPRODUCT	1756
6086495	640	670	Distrofie di Becker e Duchenne	DISEASEORPHENOTYPICFEATURE	D020388
7811247	43	76	Adrenoleucodistrofia legata all'X	DISEASEORPHENOTYPICFEATURE	D000326
7811247	121	124	ALD	DISEASEORPHENOTYPICFEATURE	D000326
7811247	186	189	ALD	GENEORGENEPRODUCT	215
7811247	313	333	adrenoleucodistrofia	DISEASEORPHENOTYPICFEATURE	D000326
7811247	378	381	ALD	DISEASEORPHENOTYPICFEATURE	D000326
7811247	417	425	paziente	ORGANISMTAXON	9606
7811247	485	488	ALD	DISEASEORPHENOTYPICFEATURE	D000326
7811247	658	661	ALD	GENEORGENEPRODUCT	215
7811247	714	767	trasversione da citosina a guanina al nucleotide 1451	SEQUENCEVARIANT	RS128624214
7811247	855	879	prolina 484 con arginina	SEQUENCEVARIANT	RS128624214
7811247	937	945	paziente	ORGANISMTAXON	9606
7811247	1001	1004	ALD	DISEASEORPHENOTYPICFEATURE	D000326
7811247	1053	1074	adrenomieloneuropatia	DISEASEORPHENOTYPICFEATURE	D000326
7811247	1122	1129	Addison	DISEASEORPHENOTYPICFEATURE	D000224
7811247	1200	1227	acidi grassi a catena lunga	CHEMICALENTITY	D005227
7811247	1375	1379	 ALD	DISEASEORPHENOTYPICFEATURE	D000326
7811247	1407	1415	pazienti	ORGANISMTAXON	9606
8944024	70	75	BRCA1	GENEORGENEPRODUCT	672
8944024	353	361	pazienti	ORGANISMTAXON	9606
8944024	673	709	gene del cancro al seno e alle ovaie	GENEORGENEPRODUCT	672
8944024	740	745	BRCA1	GENEORGENEPRODUCT	672
8944024	973	981	pazienti	ORGANISMTAXON	9606
14510914	43	66	Ipotiroidismo congenito	DISEASEORPHENOTYPICFEATURE	D003409
14510914	135	169	proteina symporter di sodio/ioduro	GENEORGENEPRODUCT	6528
14510914	224	257	Difetto di trasporto dello ioduro	DISEASEORPHENOTYPICFEATURE	C564766
14510914	302	306	ITD 	DISEASEORPHENOTYPICFEATURE	C564766
14510914	393	417	incapacitÃ  della tiroide	DISEASEORPHENOTYPICFEATURE	D050033
14510914	466	486	 gradiente di ioduro	CHEMICALENTITY	D007454
14510914	627	650	ipotiroidismo congenito	DISEASEORPHENOTYPICFEATURE	D003409
14510914	824	850	sportatore di sodio/ioduro	GENEORGENEPRODUCT	6528
14510914	884	887	NIS	GENEORGENEPRODUCT	6528
14510914	917	925	PAZIENTE	ORGANISMTAXON	9606
14510914	970	975	donna	ORGANISMTAXON	9606
14510914	1023	1036	ipotiroidismo	DISEASEORPHENOTYPICFEATURE	D007037
14510914	1128	1131	ITD	DISEASEORPHENOTYPICFEATURE	C564766
14510914	1201	1215	gozzo nodulare	DISEASEORPHENOTYPICFEATURE	D020518
14510914	1284	1290	ioduro	CHEMICALENTITY	D007454
14510914	1392	1398	ioduro	CHEMICALENTITY	D007454
14510914	1469	1482	ipotiroidismo	DISEASEORPHENOTYPICFEATURE	D007037
14510914	1584	1594	L-tiroxina	CHEMICALENTITY	D013974
14510914	1659	1670	radioioduro	CHEMICALENTITY	D007454
14510914	1773	1779	 umano	ORGANISMTAXON	9606
14510914	1811	1814	TSH	GENEORGENEPRODUCT	7200
14510914	1873	1875	I-	CHEMICALENTITY	D007454
14510914	1983	1985	I-	CHEMICALENTITY	D007454
14510914	2088	2096	paziente	ORGANISMTAXON	9606
14510914	2128	2131	NIS	GENEORGENEPRODUCT	6528
14510914	2308	2350	inserimento di 15 nt duplicando i primi 15	SEQUENCEVARIANT	C |DUP||15
14510914	2408	2416	paziente	ORGANISMTAXON	9606
14510914	2906	2909	NIS	GENEORGENEPRODUCT	6528
14510914	2971	2977	ioduro	CHEMICALENTITY	D007454
14510914	3077	3080	ITD	DISEASEORPHENOTYPICFEATURE	C564766
14510914	3118	3126	paziente	ORGANISMTAXON	9606
14510914	3237	3260	ipotiroidismo congenito	DISEASEORPHENOTYPICFEATURE	D003409
14510914	3326	3329	NIS	GENEORGENEPRODUCT	6528
15018851	41	56	citomegalovirus	ORGANISMTAXON	10358
15018851	98	107	paziente 	ORGANISMTAXON	9606
15018851	155	162	linfoma	DISEASEORPHENOTYPICFEATURE	D008223
15018851	260	297	Anti- trattamenti con citomegalovirus	DISEASEORPHENOTYPICFEATURE	D003586
15018851	342	345	CMV	DISEASEORPHENOTYPICFEATURE	D003586
15018851	350	358	pazienti	ORGANISMTAXON	9606
15018851	664	667	CMV	DISEASEORPHENOTYPICFEATURE	D003586
15018851	767	770	CMV	DISEASEORPHENOTYPICFEATURE	D003586
15018851	879	887	paziente	ORGANISMTAXON	9606
15018851	935	957	non Hodgkin 's linfoma	DISEASEORPHENOTYPICFEATURE	D008228
15018851	1038	1041	CMV	DISEASEORPHENOTYPICFEATURE	D003586
15018851	1179	1182	CMV	DISEASEORPHENOTYPICFEATURE	D003586
15018851	1225	1233	paziente	ORGANISMTAXON	9606
15018851	1385	1400	glicoproteina B	GENEORGENEPRODUCT	2813
15018851	1433	1435	gB	GENEORGENEPRODUCT	2813
15018851	1557	1560	CMV	DISEASEORPHENOTYPICFEATURE	D003586
15018851	1603	1611	paziente	ORGANISMTAXON	9606
15018851	1687	1690	CMV	DISEASEORPHENOTYPICFEATURE	D003586
15018851	1777	1788	ganciclovir	CHEMICALENTITY	D015774
15018851	1824	1833	cidofovir	CHEMICALENTITY	D000077404
15018851	1868	1877	foscarnet	CHEMICALENTITY	 D017245
15018851	1978	1998	protein chinasi UL97	GENEORGENEPRODUCT	3077517
15018851	2074	2085	ganciclovir	CHEMICALENTITY	D015774
15018851	2235	2244	foscarnet	CHEMICALENTITY	D017245
15018851	2348	2353	N495K	SEQUENCEVARIANT	P| SUB|N|495|K
15018851	2436	2447	ganciclovir	CHEMICALENTITY	D015774
15018851	2485	2494	cidofovir	CHEMICALENTITY	D000077404
15018851	2562	2567	L501I	SEQUENCEVARIANT	P|SUB|L|501|I
15018851	2637	2640	CMV	DISEASEORPHENOTYPICFEATURE	D003586
15018851	2688	2696	paziente	ORGANISMTAXON	9606
15041272	82	119	malattia di von Willebrand di tipo 2B	DISEASEORPHENOTYPICFEATURE	D056728
15041272	160	166	R1306W	SEQUENCEVARIANT	RS61749384
15041272	247	263	difetto genetico	DISEASEORPHENOTYPICFEATURE	D030342
15041272	337	374	malattia di von Willebrand di tipo 2B	DISEASEORPHENOTYPICFEATURE	D056728
15041272	419	422	VWD	DISEASEORPHENOTYPICFEATURE	D014842
15041272	492	497	donna	ORGANISMTAXON	9606
15041272	657	666	emorragie	DISEASEORPHENOTYPICFEATURE	D006470
15041272	806	815	emorragia	DISEASEORPHENOTYPICFEATURE	D006470
15041272	871	875	VIII	GENEORGENEPRODUCT	2157
15041272	922	944	fattore von Willebrand	GENEORGENEPRODUCT	7450
15041272	987	990	VWF	GENEORGENEPRODUCT	7450
15041272	1033	1054	fattore von Willerand	GENEORGENEPRODUCT	7450
15041272	1087	1098	ristocetina	CHEMICALENTITY	D012310
15041272	1141	1144	VWF	GENEORGENEPRODUCT	7450
15041272	1199	1246	aggregazione piastrinica indotta da ristocetina	DISEASEORPHENOTYPICFEATURE	D001791
15041272	1291	1295	RIPA	DISEASEORPHENOTYPICFEATURE	D001791
15041272	1350	1361	ristocetina	CHEMICALENTITY	D012310
15041272	1459	1470	ristocetina	CHEMICALENTITY	D012310
15041272	1606	1631	fattore di von Willebrand	GENEORGENEPRODUCT	7450
15041272	1664	1667	VWF	GENEORGENEPRODUCT	7450
15041272	1893	1896	VWF	GENEORGENEPRODUCT	7450
15041272	2086	2125	Transizione da C a T al nucleotide 3916	SEQUENCEVARIANT	RS61749384
15041272	2175	2200	Arg 1306 Sostituzione Trp	SEQUENCEVARIANT	RS61749384
15041272	2237	2243	R1306W	SEQUENCEVARIANT	RS61749384
15041272	2313	2329	glicoproteina Ib	GENEORGENEPRODUCT	2811
15041272	2362	2366	GPIb	GENEORGENEPRODUCT	2811
15041272	2451	2454	VWF	GENEORGENEPRODUCT	7450
15041272	2570	2585	trombocitopenia	DISEASEORPHENOTYPICFEATURE	D013921
15041272	2667	2678	tipo 2B VWD	DISEASEORPHENOTYPICFEATURE	D056728
15041272	2758	2764	R1306W	SEQUENCEVARIANT	RS61749384
15041272	2836	2839	VWF	GENEORGENEPRODUCT	7450
15069170	59	66	tiazide	CHEMICALENTITY	D049971
15069170	108	131	 Na-Cl co-trasportatore	GENEORGENEPRODUCT	6559
15069170	178	186	pazienti	ORGANISMTAXON	9606
15069170	234	254	Sindrome di Gitelman	DISEASEORPHENOTYPICFEATURE	D053579
15069170	311	331	Sindrome di Gitelman	DISEASEORPHENOTYPICFEATURE	D053579
15069170	376	378	GS	DISEASEORPHENOTYPICFEATURE	D053579
15069170	430	459	malattia autosomica recessiva	DISEASEORPHENOTYPICFEATURE	D030342
15069170	533	540	tiazide	CHEMICALENTITY	D049971
15069170	588	610	Na-Cl co-trasportatore	GENEORGENEPRODUCT	6559
15069170	643	647	NCCT	GENEORGENEPRODUCT	6559
15069170	868	872	NCCT	GENEORGENEPRODUCT	6559
15069170	926	934	pazienti	ORGANISMTAXON	9606
15069170	982	984	GS	DISEASEORPHENOTYPICFEATURE	D053579
15069170	1089	1097	pazienti	ORGANISMTAXON	9606
15069170	1145	1147	GS	DISEASEORPHENOTYPICFEATURE	D053579
15069170	1264	1268	NCCT	GENEORGENEPRODUCT	6559
15069170	1447	1455	pazienti	ORGANISMTAXON	9606
15069170	1666	1674	c.185C>T	SEQUENCEVARIANT	RS371443644
15069170	1712	1720	Thr60Met	SEQUENCEVARIANT	RS371443644
15069170	1759	1768	c.1712C>T	SEQUENCEVARIANT	RS79351185
15069170	1805	1814	Ala569Val	SEQUENCEVARIANT	RS79351185
15069170	1854	1863	c.1930C>T	SEQUENCEVARIANT	RS200697179
15069170	1901	1910	Arg642Cys	SEQUENCEVARIANT	RS200697179
15069170	1949	1959	c .2552T>A	SEQUENCEVARIANT	RS185927948
15069170	1997	2006	Leu849His	SEQUENCEVARIANT	RS185927948
15069170	2047	2058	 c.1932delC	SEQUENCEVARIANT	C|DEL|1932|C
15069170	2122	2130	pazienti	ORGANISMTAXON	9606
15069170	2185	2188	 GS	DISEASEORPHENOTYPICFEATURE	D053579
15069170	2216	2224	pazienti	ORGANISMTAXON	9606
15069170	2316	2322	c.7A>T	SEQUENCEVARIANT	C|SUB|A|7|T
15069170	2361	2368	Met1Leu	SEQUENCEVARIANT	P|SUB|M |1|L
15069170	2619	2627	paziente	ORGANISMTAXON	9606
15069170	2836	2844	pazienti	ORGANISMTAXON	9606
15069170	2968	2985	96 bp inserimento	SEQUENCEVARIANT	C|INS||96
15069170	3049	3057	pazienti	ORGANISMTAXON	9606
15069170	3235	3239	NCCT	GENEORGENEPRODUCT	6559
15069170	3276	3295	pazienti giapponesi	ORGANISMTAXON	9606
15069170	3343	3345	GS	DISEASEORPHENOTYPICFEATURE	D053579
15069170	3461	3465	NCCT	GENEORGENEPRODUCT	6559
15069170	3523	3525	GS	DISEASEORPHENOTYPICFEATURE	D053579
15069170	3553	3561	pazienti	ORGANISMTAXON	9606
15086325	73	75	F5	GENEORGENEPRODUCT	2153
15086325	131	183	 deficit ereditario del fattore V della coagulazione	DISEASEORPHENOTYPICFEATURE	D005166
15086325	312	347	deficit di fattore V (FV) ereditato	DISEASEORPHENOTYPICFEATURE	D005166
15086325	494	537	deficit di FV ereditario della coagulazione	DISEASEORPHENOTYPICFEATURE	D005166
15086325	608	610	FV	GENEORGENEPRODUCT	2153
15086325	723	725	F5	GENEORGENEPRODUCT	2153
15086325	1126	1129	 F5	GENEORGENEPRODUCT	2153
15086325	1385	1427	 ha introdotto otto amminoacidi aggiuntivi	SEQUENCEVARIANT	P|INS||8
15086325	1468	1470	FV	GENEORGENEPRODUCT	2153
15086325	1582	1584	F5	GENEORGENEPRODUCT	2153
15086325	1750	1756	689 AA	SEQUENCEVARIANT	C|ALLELE|A|689
15086325	1818	1828	G6410 di T	SEQUENCEVARIANT	G|SUB|G|6410|T
15086325	1913	1923	Gly2079Val	SEQUENCEVARIANT	P|SUB|G|2079 |V
15086325	1979	1981	F5	GENEORGENEPRODUCT	2153
15086325	2134	2140	G6410T	SEQUENCEVARIANT	G|SUB|G| 6410|T
15086325	2236	2259	deficit di FV congenito	DISEASEORPHENOTYPICFEATURE	D005166
15096016	162	183	Malattia di Parkinson	DISEASEORPHENOTYPICFEATURE	D010300
15096016	228	230	PD	DISEASEORPHENOTYPICFEATURE	D010300
15096016	441	443	PD	DISEASEORPHENOTYPICFEATURE	D010300
15096016	900	902	PD	DISEASEORPHENOTYPICFEATURE	D010300
15096016	952	962	discinesia	DISEASEORPHENOTYPICFEATURE	D004409
15096016	1039	1047	rigiditÃ 	DISEASEORPHENOTYPICFEATURE	D009127
15096016	1092	1104	bradicinesia	DISEASEORPHENOTYPICFEATURE	D018476
15096016	1204	1216	bradicinesia	DISEASEORPHENOTYPICFEATURE	D018476
15096016	1262	1270	rigiditÃ 	DISEASEORPHENOTYPICFEATURE	D009127
15096016	1384	1392	levodopa	CHEMICALENTITY	D007980
15096016	1443	1453	discinesia	DISEASEORPHENOTYPICFEATURE	D004409
15096016	1560	1579	iper- o discinetici	DISEASEORPHENOTYPICFEATURE	D004409,D006948
15096016	1760	1768	paziente	ORGANISMTAXON	9606
15096016	1863	1871	pazienti	ORGANISMTAXON	9606
15579441	43	50	Ipossia	DISEASEORPHENOTYPICFEATURE	D000860
15579441	97	112	malattia renale	DISEASEORPHENOTYPICFEATURE	D007674
15579441	160	171	proteinuria	DISEASEORPHENOTYPICFEATURE	D011507
15579441	231	243	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
15579441	509	516	ipossia	DISEASEORPHENOTYPICFEATURE	D000860
15579441	592	599	ipossia	DISEASEORPHENOTYPICFEATURE	D000860
15579441	639	680	fattore di crescita endoteliale vascolare	GENEORGENEPRODUCT	83785
15579441	770	777	ipossia	DISEASEORPHENOTYPICFEATURE	D000860
15579441	826	829	rat	ORGANISMTAXON	10116
15579441	959	966	ipossia	DISEASEORPHENOTYPICF EATURE	D000860
15579441	1014	1025	rene malato	DISEASEORPHENOTYPICFEATURE	D007674
15579441	1148	1155	ipossia	DISEASEORPHENOTYPICFEATURE	D000860
15579441	1192	1218	puromicina aminonucleoside	CHEMICALENTITY	D011692
15579441	1270	1288	sindrome nefrosica	DISEASEORPHENOTYPICFEATURE	D009404
15579441	1354	1361	ipossia	DISEASEORPHENOTYPICFEATURE	D000860
15579441	1461	1468	ipossia	DISEASEORPHENOTYPICFEATURE	D000860
15579441	1589	1616	 puromicina aminonucleoside	CHEMICALENTITY	D011692
15579441	1728	1769	fattore di crescita endoteliale vascolare	GENEORGENEPRODUCT	83785
15579441	1910	1917	ipossia	DISEASEORPHENOTYPICFEATURE	D000860
15579441	2003	2030	lesione tubulointerstiziale	DISEASEORPHENOTYPICFEATURE	D007674
15579441	2188	2192	ED-1	GENEORGENEPRODUCT	302424
15579441	2245	2258	 cellule dUTP	CHEMICALENTITY	C027078
15579441	2352	2360	ipossica	DISEASEORPHENOTYPICFEATURE	D000860
15579441	2510	2517	ipossia	DISEASEORPHENOTYPICFEATURE	D000860
15579441	2563	2583	malattie glomerulari	DISEASEORPHENOTYPICFEATURE	D007674
15754732	45	49	MEN1	GENEORGENEPRODUCT	4221
15754732	129	155	primary iperparatiroidismo	DISEASEORPHENOTYPICFEATURE	D049950
15754732	247	274	Iperparatiroidismo primario	DISEASEORPHENOTYPICFEATURE	D049950
15754732	319	323	pHPT	DISEASEORPHENOTYPICFEATURE	D049950
15754732	381	399	malattia endocrina	DISEASEORPHENOTYPICFEATURE	D004700
15754732	519	538	malattie ereditarie	DISEASEORPHENOTYPICFEATURE	D030342
15754732	607	635	neoplasia endocrina multipla	DISEASEORPHENOTYPICFEATURE	D009377
15754732	688	696	MEN1 e 2	DISEASEORPHENOTYPICFEATURE	D018761,D018813
15754732	759	763	MEN1	GENEORGENEPRODUCT	4221
15754732	847	866	tumori paratiroidei	DISEASEORPHENOTYPICFEATURE	D010282
15754732	972	976	MEN1	GENEORGENEPRODUCT	4221
15754732	1023	1031	pazienti	ORGANISMTAXON	9606
15754732	1121	1125	pHPT	DISEASEORPHENOTYPICFEATURE	D049950
15754732	1177	1209	adenoma o iperplasia paratiroide	DISEASEORPHENOTYPICFEATURE	D010282
15754732	1263	1272	carcinoma	DISEASEORPHENOTYPICFEATURE	D002277
15754732	1396	1405	paraffina	CHEMICALENTITY	D010232
15754732	1520	1525	 MEN1	GENEORGENEPRODUCT	4221
15754732	1603	1607	MEN1	GENEORGENEPRODUCT	4221
15754732	1647	1655	pazienti	ORGANISMTAXON	9606
15754732	1704	1732	lesione paratiroidea benigna	DISEASEORPHENOTYPICFEATURE	D010279
15754732	1845	1854	carcinomi	DISEASEORPHENOTYPICFEATURE	D002277
15754732	1920	1924	MEN1	GENEORGENEPRODUCT	4221
15754732	2023	2030	222insT	SEQUENCEVARIANT	C|INS|222|T
15754732	2109	2117	912delTA	SEQUENCEVARIANT	C|DEL|912|TA
15754732	2190	2198	835del18	SEQUENCEVARIANT	C|DEL|835|18
15754732	2274	2279	P291A	SEQUENCEVARIANT	P|SUB|P| 291|A
15754732	2361	2365	L89R	SEQUENCEVARIANT	P|SUB|L|89|R
15754732	2441	2446	Q536X	SEQUENCEVARIANT	P|SUB|Q|536|X
15754732	2613	2618	R171Q	SEQUENCEVARIANT	RS607969
15754732	2668	2674	tumori	DISEASEORPHENOTYPICFEATURE	D009369
15754732	2734	2739	D418D	SEQUENCEVARIANT	RS2071313
15754732	2775	2782	GAC/GAT	SEQUENCEVARIANT	RS2071313
15754732	2853	2859	tumori	DISEASEORPHENOTYPICFEATURE	D009369
15754732	3117	3121	MEN1	GENEORGENEPRODUCT	4221
15754732	3165	3171	tumore	DISEASEORPHENOTYPICFEATURE	D009369
15754732	3280	3299	tumori paratiroidei	DISEASEORPHENOTYPICFEATURE	D010282
15867855	55	93	mucina immunoglobulinica a cellule T 1	GENEORGENEPRODUCT	26762
15867855	260	264	asma	DISEASEORPHENOTYPICFEATURE	D001249
15867855	352	388	mucina immunoglobulinica a cellule T	GENEORGENEPRODUCT	26762,84868
15867855	429	432	TIM	GENEORGENEPRODUCT	26762,84868
15867855	580	599	malattie allergiche	DISEASEORPHENOTYPICFEATURE	D004342
15867855	697	702	TIM-1	GENEORGENEPRODUCT	26762
15867855	737	742	TIM-3	GENEORGENEPRODUCT	84868
15867855	815	819	asma	DISEASEORPHENOTYPICFEATURE	D001249
15867855	1131	1141	TIM -1 e 3	GENEORGENEPRODUCT	26762,84868
15867855	1187	1192	TIM-3	GENEORGENEPRODUCT	84868
15867855	1264	1284	virus dell'epatite A	ORGANISMTAXON	208726
15867855	1433	1442	rs2277025	SEQUENCEVARIANT	RS2277025
15867855	1523	1535	157delMTTTVP	SEQUENCEVARIANT	 P|DEL|157|MTTTVP
15867855	1595	1600	TIM-1	GENEORGENEPRODUCT	26762
15867855	1648	1656	pazienti	ORGANISMTAXON	9606
15867855	1688	1696	pazienti	ORGANISMTAXON	9606
15867855	1744	1749	asma 	DISEASEORPHENOTYPICFEATURE	D001249
15867855	2083	2095	157delMTTTVP	SEQUENCEVARIANT	P|DEL|157 |MTTTVP
15867855	2229	2249	virus dell'epatite A	ORGANISMTAXON	208726
15867855	2347	2352	TIM-3	GENEORGENEPRODUCT	84868
15867855	2442	2446	asma	DISEASEORPHENOTYPICFEATURE	D001249
15867855	2492	2519	fenotipi correlati all'asma	DISEASEORPHENOTYPICFEATURE	D001249
15867855	2628	2633	TIM-1	GENEORGENEPRODUCT	26762
15867855	2676	2681	TIM-3	GENEORGENEPRODUCT	84868
15867855	2768	2772	asma	DISEASEORPHENOTYPICFEATURE	D001249
15951966	85	89	MSH2	GENEORGENEPRODUCT	4436
15951966	124	128	MLH1	GENEORGENEPRODUCT	4292
15951966	209	213	MSH2	GENEORGENEPRODUCT	4436
15951966	247	251	MLH1	GENEORGENEPRODUCT	4292
15951966	358	363	HNPCC	DISEASEORPHENOTYPICFEATURE	D003123
15951966	649	653	MLH1	GENEORGENEPRODUCT	4292
15951966	687	691	MSH2	GENEORGENEPRODUCT	4436
15951966	892	896	MLH1	GENEORGENEPRODUCT	4292
15951966	942	946	MSH2	GENEORGENEPRODUCT	4436
15951966	1213	1218	HNPCC	DISEASEORPHENOTYPICFEATURE	D003123
15951966	1246	1254	pazienti	ORGANISMTAXON	9606
15951966	1394	1402	paziente	ORGANISMTAXON	9606
15951966	1486	1490	MSH2	GENEORGENEPRODUCT	4436
15951966	1760	1764	MLH1	GENEORGENEPRODUCT	4292
15951966	1798	1802	MSH2	GENEORGENEPRODUCT	4436
15951966	1856	1861	HNPCC	DISEASEORPHENOTYPICFEATURE	D003123
15951966	1889	1897	pazienti	ORGANISMTAXON	9606
15991002	31	39	Nicotina	CHEMICALENTITY	D009538
15991002	83	91	caffeina	CHEMICALENTITY	D002110
15991002	131	148	pentilentetrazolo	CHEMICALENTITY	D010433
15991002	200	217	effetto ansiogeno	DISEASEORPHENOTYPICFEATURE	D001008
15991002	250	254	topi	ORGANISMTAXON	10090
15991002	298	306	Nicotina	CHEMICALENTITY	D009538
15991002	340	348	caffeina	CHEMICALENTITY	D002110
15991002	414	432	droghe psicoattive	CHEMICALENTITY	D011619
15991002	751	756	ansia	DISEASEORPHENOTYPICFEATURE	D001008
15991002	844	852	nicotina	CHEMICALENTITY	D009538
15991002	899	904	ansia	DISEASEORPHENOTYPICFEATURE	D001008
15991002	947	955	caffeina	CHEMICALENTITY	D002110
15991002	998	1007	ansiogeno	CHEMICALENTITY	D014151
15991002	1041	1059	pentilenetetrazolo	CHEMICALENTITY	 D010433
15991002	1092	1096	topi	ORGANISMTAXON	10090
15991002	1238	1243	ansia	DISEASEORPHENOTYPICFEATURE	D001008
15991002	1310	1314	topi	ORGANISMTAXON	10090
15991002	1371	1379	nicotina	CHEMICALENTITY	D009538
15991002	1474	1482	caffeina	CHEMICALENTITY	D002110
15991002	1533	1563	iniezioni di pentilentetrazolo	CHEMICALENTITY	D010433
15991002	1632	1636	topi	ORGANISMTAXON	10090
15991002	1921	1929	Nicotina	CHEMICALENTITY	D009538
15991002	2055	2063	caffeina	CHEMICALENTITY	 D002110
15991002	2108	2125	pentilentetrazolo	CHEMICALENTITY	D010433
15991002	2199	2216	effetto ansiogeno	DISEASEORPHENOTYPICFEATURE	D001008
15991002	2318	2326	Nicotina	CHEMICALENTITY	D009538
15991002	2386	2394	caffeina	CHEMICALENTITY	D002110
15991002	2434	2451	pentilentetrazolo	CHEMICALENTITY	D010433
15991002	2506	2511	ansia	DISEASEORPHENOTYPICFEATURE	D001008
15991002	2740	2748	nicotina	CHEMICALENTITY	D009538
15991002	2783	2791	caffeina	CHEMICALENTITY	D002110
15991002	2836	2841	ansia	DISEASEORPHENOTYPICFEATURE	D001008
15991002	2888	2896	caffeina	CHEMICALENTITY	D002110
15991002	3047	3055	nicotina	CHEMICALENTITY	D009538
15991002	3089	3097	caffeina	CHEMICALENTITY	D002110
16000134	52	62	argatroban	CHEMICALENTITY	C031942
16000134	132	145	vena trombosi	DISEASEORPHENOTYPICFEATURE	D020246
16000134	179	187	paziente	ORGANISMTAXON	9606
16000134	235	268	deficit congenito di antitrombina	DISEASEORPHENOTYPICFEATURE	D020152
16000134	301	306	donna	ORGANISMTAXON	9606
16000134	384	431	trombosi della vena mesenterica superiore (SMV)	DISEASEORPHENOTYPICFEATURE	D020246
16000134	534	546	antitrombina	GENEORGENEPRODUCT	462
16000134	654	666	antitrombina	GENEORGENEPRODUCT	462
16000134	843	851	trombina	GENEORGENEPRODUCT	2147
16000134	884	894	argatroban	CHEMICALENTITY	C031942
16000134	960	972	antitrombina	GENEORGENEPRODUCT	462
16000134	1041	1084	deficit di antitrombina congenito di tipo I	DISEASEORPHENOTYPICFEATURE	D025861
16000134	1162	1174	antitrombina	GENEORGENEPRODUCT	462
16000134	1303	1321	Glu 272 da fermare	SEQUENCEVARIANT	P|SUB|E|272|X
16000134	1368	1401	La somministrazione di Argatroban	CHEMICALENTITY	C031942
16000134	1481	1514	deficit congenito di antitrombina	DISEASEORPHENOTYPICFEATURE	D020152
16000134	1562	1574	Trombosi SMV	DISEASEORPHENOTYPICFEATURE	D020246
16018252	60	63	SRY	GENEORGENEPRODUCT	6736
16018252	134	156	inversione sessuale XY	DISEASEORPHENOTYPICFEATURE	OMIM: 400044
16018252	204	207	SRY	GENEORGENEPRODUCT	6736
16018252	378	381	SRY	GENEORGENEPRODUCT	6736
16018252	637	640	SRY	GENEORGENEPRODUCT	6736
16018252	714	737	XY inversione del sesso	DISEASEORPHENOTYPICFEATURE	OMIM:400044
16018252	808	816	pazienti	ORGANISMTAXON	9606
16018252	882	907	46,XY inversione di sesso	DISEASEORPHENOTYPICFEATURE	OMIM :400044
16018252	984	987	SRY	GENEORGENEPRODUCT	6736
16018252	1157	1160	SRY	GENEORGENEPRODUCT	6736
16018252	1568	1576	pazienti	ORGANISMTAXON	9606
16018252	1693	1736	A Ã¨ stata sostituita da una G nel codone 38	SEQUENCEVARIANT	C|SUB|A|CODON38|G
16018252	1822	1825	SRY	GENEORGENEPRODUCT	6736
16018252	1913	1935	glutammato con glicina	SEQUENCEVARIANT	P|SUB|E||G
16018252	1996	2038	T ad A nella posizione del nucleotide +387	SEQUENCEVARIANT	C|SUB|T|387|A
16018252	2095	2127	Tyrosine (Tyr) invece di un Term	SEQUENCEVARIANT	 C|SUB|Y||X
16018252	2358	2363	Human	ORGANISMTAXON	9606
16018252	2566	2569	SRY	GENEORGENEPRODUCT	6736
16018252	2788	2807	inversione sessuale	DISEASEORPHENOTYPICFEATURE	OMIM:400044
16018252	2944	2947	SRY	GENEORGENEPRODUCT	6736
16018252	3056	3064	paziente	ORGANISMTAXON	9606
16018252	3116	3152	46,XY inversione del sesso femminile	DISEASEORPHENOTYPICFEATURE	OMIM:400044
16051693	54	58	PEMT	GENEORGENEPRODUCT	10400
16051693	121	151	 steatosi epatica non alcolica	DISEASEORPHENOTYPICFEATURE	D065626
16051693	196	201	NAFLD	DISEASEORPHENOTYPICFEATURE	D065626
16051693	236	277	Fosfatidiletanolammina N-metiltransferasi	GENEORGENEPRODUCT	10400
16051693	311	315	PEMT	GENEORGENEPRODUCT	10400
16051693	359	386	sintesi di fosfatidilcolina	CHEMICALENTITY	D010713
16051693	420	424	PEMT	GENEORGENEPRODUCT	18618
16051693	462	466	topi	ORGANISMTAXON	10090
16051693	516	530	 fegati grassi	DISEASEORPHENOTYPICFEATURE	D005234
16051693	582	587	umani	ORGANISMTAXON	9606
16051693	632	669	grasso analcolico malattie del fegato	DISEASEORPHENOTYPICFEATURE	D065626
16051693	714	719	NAFLD	DISEASEORPHENOTYPICFEATURE	D065626
16051693	783	787	PEMT	GENEORGENEPRODUCT	10400
16051693	858	863	umani	ORGANISMTAXON	9606
16051693	913	926	fegato grasso	DISEASEORPHENOTYPICFEATURE	D005234
16051693	963	968	umani	ORGANISMTAXON	9606
16051693	1016	1021	NAFLD	DISEASEORPHENOTYPICFEATURE	D065626
16051693	1137	1141	PEMT	GENEORGENEPRODUCT	10400
16051693	1203	1208	V175M	SEQUENCEVARIANT	RS7946
16051693	1241	1246	V175M	SEQUENCEVARIANT	RS7946
16051693	1448	1452	PEMT	GENEORGENEPRODUCT	25511
16051693	1505	1510	V175M	SEQUENCEVARIANT	RS7946
16051693	1551	1573	Met/Met at residuo 175	SEQUENCEVARIANT	RS7946
16051693	1676	1681	NAFLD	DISEASEORPHENOTYPICFEATURE	D065626
16051693	1830	1835	umano	ORGANISMTAXON	9606
16051693	1868	1872	PEMT	GENEORGENEPRODUCT	10400
16051693	1910	1915	V175M	SEQUENCEVARIANT	RS7946
16051693	2025	2030	NAFLD	DISEASEORPHENOTYPICFEATURE	D065626
16152606	71	78	657del5	SEQUENCEVARIANT	C|DEL|657|5
16152606	115	124	gene NBS1	GENEORGENEPRODUCT	4683
16152606	147	155	pazienti	ORGANISMTAXON	9606
16152606	260	289	neoplasie linfoidi sporadiche	DISEASEORPHENOTYPICFEATURE	D008223
16152606	334	363	Sindrome da rottura di Nimega	DISEASEORPHENOTYPICFEATURE	D049932
16152606	408	411	NBS	DISEASEORPHENOTYPICFEATURE	D049932
16152606	447	452	umano	ORGANISMTAXON	9606
16152606	496	525	malattia autosomica recessiva	DISEASEORPHENOTYPICFEATURE	D030342
16152606	621	628	 cancro	DISEASEORPHENOTYPICFEATURE	D009369
16152606	706	713	linfoma	DISEASEORPHENOTYPICFEATURE	D008223
16152606	759	767	leucemia	DISEASEORPHENOTYPICFEATURE	D007938
16152606	898	902	NBS1	GENEORGENEPRODUCT	4683
16152606	950	958	657del5 	SEQUENCEVARIANT	C|DEL|657|5
16152606	1043	1070	maligne linfoidi sporadiche	DISEASEORPHENOTYPICFEATURE	D008223
16152606	1140	1159	linfoma non Hodgkin	DISEASEORPHENOTYPICFEATURE	 D008228
16152606	1204	1207	NHL	DISEASEORPHENOTYPICFEATURE	D008228
16152606	1273	1279	643C>T	SEQUENCEVARIANT	C|SUB|C|643|T
16152606	1320	1325	R215W	SEQUENCEVARIANT	P|SUB|R|215 |W
16152606	1425	1453	leucemia linfoblastica acuta	DISEASEORPHENOTYPICFEATURE	D054198
16152606	1498	1503	TUTTI	DISEASEORPHENOTYPICFEATURE	D054198
16152606	1631	1658	maligne linfoidi sporadiche	DISEASEORPHENOTYPICFEATURE	D008223
16152606	1717	1725	pazienti	ORGANISMTAXON	9606
16152606	1828	1832	NBS1	GENEORGENEPRODUCT	4683
16152606	1869	1876	657del5	SEQUENCEVARIANT	C|DEL|657|5
16152606	1941	1949	pazienti	ORGANISMTAXON	9606
16152606	1997	2002	TUTTI	DISEASEORPHENOTYPICFEATURE	D054198
16152606	2083	2086	NHL	DISEASEORPHENOTYPICFEATURE	D008228
16152606	2155	2163	pazienti	ORGANISMTAXON	9606
16152606	2211	2229	linfoma di Hodgkin	DISEASEORPHENOTYPICFEATURE	D006689
16152606	2274	2276	HL	DISEASEORPHENOTYPICFEATURE	D006689
16152606	2349	2354	R215W	SEQUENCEVARIANT	P|SUB|R|215|W
16152606	2473	2480	657del5	SEQUENCEVARIANT	C|DEL|657|5
16152606	2580	2588	paziente	ORGANISMTAXON	9606
16152606	2732	2749	neoplasie maligne	DISEASEORPHENOTYPICFEATURE	D009369
16152606	2857	2865	 657del5	SEQUENCEVARIANT	C|DEL|657|5
16152606	3126	3134	pazienti	ORGANISMTAXON	9606
16152606	3183	3186	ALL	DISEASEORPHENOTYPICFEATURE	D054198
16152606	3232	3235	NHL	DISEASEORPHENOTYPICFEATURE	D008228
16152606	3289	3293	NBS1	GENEORGENEPRODUCT	4683
16152606	3405	3423	neoplasie linfoidi	DISEASEORPHENOTYPICFEATURE	D008223
16181814	44	48	POLG	GENEORGENEPRODUCT	5428
16181814	167	175	paziente	ORGANISMTAXON	9606
16181814	223	241	Sindrome di Alpers	DISEASEORPHENOTYPICFEATURE	D002549
16181814	286	304	Sindrome di Alpers	DISEASEORPHENOTYPICFEATURE	D002549
16181814	383	415	deplezione del DNA mitocondriale	DISEASEORPHENOTYPICFEATURE	D028361
16181814	567	586	malattia del fegato	DISEASEORPHENOTYPICFEATURE	D008107
16181814	668	672	POLG	GENEORGENEPRODUCT	5428
16181814	763	772	pol gamma	GENEORGENEPRODUCT	5428
16181814	823	831	pazienti	ORGANISMTAXON	9606
16181814	879	897	sindrome di Alpers	DISEASEORPHENOTYPICFEATURE	D002549
16181814	1021	1025	POLG	GENEORGENEPRODUCT	5428
16181814	1058	1062	POLG	GENEORGENEPRODUCT	5428
16181814	1288	1296	paziente	ORGANISMTAXON	9606
16181814	1344	1362	sindrome di Alpers	DISEASEORPHENOTYPICFEATURE	D002549
16181814	1418	1426	E873stop	SEQUENCEVARIANT	RS121918047
16181814	1463	1468	A467T	SEQUENCEVARIANT	RS113994095
16181814	1519	1527	E873stop	SEQUENCEVARIANT	RS121918047
16181814	1632	1637	A467T	SEQUENCEVARIANT	RS113994095
16181814	1709	1728	treonina in alanina	SEQUENCEVARIANT	RS113994095
16181814	1848	1856	E873-TAG	SEQUENCEVARIANT	RS121918047
16181814	1986	1995	pol gamma	GENEORGENEPRODUCT	5428
16181814	2265	2269	POLG	GENEORGENEPRODUCT	5428
16181814	2343	2348	A467T	SEQUENCEVARIANT	RS113994095
16181814	2432	2440	E873stop	SEQUENCEVARIANT	RS121918047
16181814	2539	2543	POLG	GENEORGENEPRODUCT	5428
16181814	2615	2620	A467T	SEQUENCEVARIANT	RS113994095
16181814	2695	2703	paziente	ORGANISMTAXON	9606
16181814	2799	2804	A467T	SEQUENCEVARIANT	RS113994095
16181814	2915	2923	E873stop	SEQUENCEVARIANT	RS121918047
16225977	34	45	Amisulpride	CHEMICALENTITY	D000077582
16225977	172	185	schizofrenico	DISEASEORPHENOTYPICFEATURE	D012559
16225977	230	247	I disturbi da tic	DISEASEORPHENOTYPICFEATURE	D013981
16225977	320	333	antipsicotici	CHEMICALENTITY	D014150
16225977	371	382	risperidone	CHEMICALENTITY	D018967
16225977	418	428	olanzapina	CHEMICALENTITY	D000077152
16225977	462	473	ziprasidone	CHEMICALENTITY	C092292
16225977	698	708	quetiapina	CHEMICALENTITY	D000069348
16225977	742	751	clozapina	CHEMICALENTITY	D003024
16225977	834	847	schizofrenica	DISEASEORPHENOTYPICFEATURE	D012559
16225977	919	964	movimenti involontari di sbattere le palpebre	DISEASEORPHENOTYPICFEATURE	D020820
16225977	1030	1041	amisulpride	CHEMICALENTITY	D000077582
16225977	1213	1224	amisulpride	CHEMICALENTITY	D000077582
16225977	1310	1317	psicosi	DISEASEORPHENOTYPICFEATURE	D011605
16225977	1462	1472	quetiapina	CHEMICALENTITY	D000069348
16225977	1774	1782	paziente	ORGANISMTAXON	9606
16225977	1963	1976	antipsicotici	CHEMICALENTITY	D014150
16225977	2017	2027	quetiapina	CHEMICALENTITY	D000069348
16225977	2060	2069	clozapina	CHEMICALENTITY	D003024
16225977	2106	2117	amisulpride	CHEMICALENTITY	D000077582
16277682	66	71	M404V	SEQUENCEVARIANT	RS771966860
16277682	119	123	p62 	GENEORGENEPRODUCT	8878
16277682	155	169	sequestosoma 1	GENEORGENEPRODUCT	8878
16277682	202	205	p62	GENEORGENEPRODUCT	8878
16277682	238	244	SQSTM1	GENEORGENEPRODUCT	8878
16277682	307	330	Malattia ossea di Paget	DISEASEORPHENOTYPICFEATURE	C538098
16277682	407	410	p62	GENEORGENEPRODUCT	8878
16277682	442	461	gene Sequestosoma 1	GENEORGENEPRODUCT	8878
16277682	495	498	p62	GENEORGENEPRODUCT	8878
16277682	530	536	SQSTM1	GENEORGENEPRODUCT	8878
16277682	631	654	Malattia ossea di Paget	DISEASEORPHENOTYPICFEATURE	C538098
16277682	699	702	PDB	DISEASEORPHENOTYPICFEATURE	C538098
16277682	777	822	metionina-->sostituzione valina al codone 404	SEQUENCEVARIANT	RS771966860
16277682	860	865	M404V	SEQUENCEVARIANT	RS771966860
16277682	972	975	p62	GENEORGENEPRODUCT	8878
16277682	1007	1013	SQSTM1	GENEORGENEPRODUCT	8878
16277682	1069	1072	PDB	DISEASEORPHENOTYPICFEATURE	C538098
16277682	1100	1108	paziente	ORGANISMTAXON	9606
16277682	1174	1182	paziente	ORGANISMTAXON	9606
16277682	1269	1272	PDB	DISEASEORPHENOTYPICFEATURE	C538098
16277682	1427	1432	M404V	SEQUENCEVARIANT	RS771966860
16277682	1506	1509	PDB	DISEASEORPHENOTYPICFEATURE	C538098
16277682	1740	1743	PDB	DISEASEORPHENOTYPICFEATURE	C538098
16277682	1771	1779	pazienti	ORGANISMTAXON	9606
16277682	1952	1957	M404V	SEQUENCEVARIANT	RS771966860
16277682	2039	2043	 PDB	DISEASEORPHENOTYPICFEATURE	C538098
16277682	2083	2091	paziente	ORGANISMTAXON	9606
16277682	2209	2230	malattia poliostotica	DISEASEORPHENOTYPICFEATURE	D005357
16277682	2435	2440	M404V	SEQUENCEVARIANT	RS771966860
16277682	2562	2583	la fosfatasi alcalina	CHEMICALENTITY	D000469
16277682	2781	2786	M404V	SEQUENCEVARIANT	RS771966860
16277682	2834	2837	p62	GENEORGENEPRODUCT	8878
16277682	2869	2875	SQSTM1	GENEORGENEPRODUCT	8878
16277682	2952	2955	PDB	DISEASEORPHENOTYPICFEATURE	C538098
16277682	3051	3054	PDB	DISEASEORPHENOTYPICFEATURE	C538098
16277682	3302	3305	p62	GENEORGENEPRODUCT	8878
16277682	3337	3343	SQSTM1	GENEORGENEPRODUCT	8878
16277682	3434	3437	PDB	DISEASEORPHENOTYPICFEATURE	C538098
16419642	65	70	F826Y	SEQUENCEVARIANT	RS13306592
16419642	108	148	gene del recettore dei mineralcorticoidi	GENEORGENEPRODUCT	4306
16419642	206	217	ipertensivi	DISEASEORPHENOTYPICFEATURE	D006973
16419642	384	389	S810L	SEQUENCEVARIANT	RS41511344
16419642	459	491	 recettore dei mineralcorticoidi	GENEORGENEPRODUCT	4306
16419642	524	526	MR	GENEORGENEPRODUCT	4306
16419642	577	582	NR3C2	GENEORGENEPRODUCT	4306
16419642	669	681	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
16419642	904	916	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
16419642	986	994	pazienti	ORGANISMTAXON	9606
16419642	1053	1065	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
16419642	1109	1114	S810L	SEQUENCEVARIANT	RS41511344
16419642	1173	1175	MR	GENEORGENEPRODUCT	4306
16419642	1250	1255	S810L	SEQUENCEVARIANT	RS41511344
16419642	1324	1335	ipertensiva	DISEASEORPHENOTYPICFEATURE	D006973
16419642	1386	1391	S810L	SEQUENCEVARIANT	RS41511344
16419642	1487	1510	ipertensione essenziale	DISEASEORPHENOTYPICFEATURE	D000075222
16419642	1622	1627	F826Y	SEQUENCEVARIANT	RS13306592
16419642	1663	1671	pazienti	ORGANISMTAXON	9606
16419642	1817	1822	L809L	SEQUENCEVARIANT	RS145670736
16419642	1873	1878	F826Y	SEQUENCEVARIANT	RS13306592
16419642	1953	1955	MR	GENEORGENEPRODUCT	4306
16419642	2051	2056	F826Y	SEQUENCEVARIANT	RS13306592
16419642	2146	2157	ipertensivi	DISEASEORPHENOTYPICFEATURE	D006973
16419642	2325	2330	F826Y	SEQUENCEVARIANT	RS13306592
16419642	2392	2403	ipertensiva	DISEASEORPHENOTYPICFEATURE	D006973
16419642	2469	2480	ipertensivo	DISEASEORPHENOTYPICFEATURE	D006973
16419642	2693	2705	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
16419642	2792	2797	F826Y	SEQUENCEVARIANT	RS13306592
16419642	2862	2893	recettore dei mineralcorticoidi	GENEORGENEPRODUCT	4306
16419642	3048	3050	MR	GENEORGENEPRODUCT	4306
16565833	72	79	monoHER	CHEMICALENTITY	C522803
16565833	114	126	doxorubicina	CHEMICALENTITY	D004317
16565833	199	211	doxorubicina	CHEMICALENTITY	D004317
16565833	266	281	cardiotossicitÃ 	DISEASEORPHENOTYPICFEATURE	D066126
16565833	313	317	topi	ORGANISMTAXON	10090
16565833	392	407	cardiotossicitÃ 	DISEASEORPHENOTYPICFEATURE	D066126
16565833	444	456	antraciclina	CHEMICALENTITY	D018943
16565833	489	501	doxorubicina	CHEMICALENTITY	D004317
16565833	534	537	DOX	CHEMICALENTITY	D004317
16565833	648	651	DOX	CHEMICALENTITY	D004317
16565833	703	717	danno cardiaco	DISEASEORPHENOTYPICFEATURE	D006331
16565833	812	815	DOX	CHEMICALENTITY	D004317
16565833	867	875	ossigeno	CHEMICALENTITY	D010100
16565833	1063	1073	flavonoide	CHEMICALENTITY	D005419
16565833	1105	1128	monoidrossietilrutoside	CHEMICALENTITY	C522803
16565833	1162	1169	monoHER	CHEMICALENTITY	C522803
16565833	1238	1241	DOX	CHEMICALENTITY	D004317
16565833	1296	1311	cardiotossicitÃ 	DISEASEORPHENOTYPICFEATURE	D066126
16565833	1396	1401	ferro	CHEMICALENTITY	D007501
16565833	1485	1492	monoHER	CHEMICALENTITY	C522803
16565833	1582	1589	monoHER	CHEMICALENTITY	C522803
16565833	1623	1626	DOX	CHEMICALENTITY	D004317
16565833	1712	1719	monoHER	CHEMICALENTITY	C522803
16565833	1861	1865	topi	ORGANISMTAXON	10090
16565833	1944	1947	DOX	CHEMICALENTITY	D004317
16565833	1989	1992	DOX	CHEMICALENTITY	D004317
16565833	2052	2059	monoHER	CHEMICALENTITY	C522803
16565833	2241	2245	topi	ORGANISMTAXON	10090
16565833	2398	2420	danno cardiomiocitario	DISEASEORPHENOTYPICFEATURE	D009202
16565833	2594	2597	DOX	CHEMICALENTITY	D004317
16565833	2660	2674	danno cardiaco	DISEASEORPHENOTYPICFEATURE	D006331
16565833	2842	2846	topi	ORGANISMTAXON	10090
16565833	2892	2895	DOX	CHEMICALENTITY	 D004317
16565833	3031	3035	topi	ORGANISMTAXON	10090
16565833	3080	3083	DOX	CHEMICALENTITY	D004317
16565833	3129	3136	monoHER	CHEMICALENTITY	C522803
16565833	3177	3181	topi	ORGANISMTAXON	10090
16565833	3344	3351	monoHER	CHEMICALENTITY	C522803
16565833	3392	3395	DOX	CHEMICALENTITY	D004317
16565833	3600	3607	monoHER	CHEMICALENTITY	C522803
16565833	3641	3644	DOX	CHEMICALENTITY	D004317
16565833	3743	3754	ambulatorio	ORGANISMTAXON	9606
16565833	3803	3810	monoHER	CHEMICALENTITY	C522803
16565833	3881	3884	DOX	CHEMICALENTITY	D004317
16611040	62	77	fibrosi cistica	DISEASEORPHENOTYPICFEATURE	D003550
16611040	180	195	Fibrosi cistica	DISEASEORPHENOTYPICFEATURE	D003550
16611040	222	224	CF	DISEASEORPHENOTYPICFEATURE	D003550
16611040	312	330	disturbi ereditari	DISEASEORPHENOTYPICFEATURE	D030342
16611040	553	572	malattie ereditarie	DISEASEORPHENOTYPICFEATURE	D030342
16611040	649	713	regolatore della conduttanza transmembrana della fibrosi cistica	GENEORGENEPRODUCT	1080
16611040	799	801	CF	DISEASEORPHENOTYPICFEATURE	D003550
16611040	818	820	CF	DISEASEORPHENOTYPICFEATURE	D003550
16611040	1191	1209	disturbi ereditari	DISEASEORPHENOTYPICFEATURE	D030342
16611040	1319	1321	CF	DISEASEORPHENOTYPICFEATURE	D003550
16611040	1337	1339	CF	DISEASEORPHENOTYPICFEATURE	D003550
16611040	1595	1597	CF	DISEASEORPHENOTYPICFEATURE	D003550
16611040	1613	1615	CF	DISEASEORPHENOTYPICFEATURE	D003550
16611040	1685	1687	CF	DISEASEORPHENOTYPICFEATURE	D003550
16611040	2404	2412	pazienti	ORGANISMTAXON	9606
16680561	50	65	desipramina HCl	CHEMICALENTITY	D003891
16680561	122	136	cinacalcet HCl	CHEMICALENTITY	C476217
16680561	217	227	cinacalcet	CHEMICALENTITY	C476217
16680561	283	321	isoenzima del citocromo P450 (CYP) 2D6	GENEORGENEPRODUCT	1565
16680561	409	419	cinacalcet	CHEMICALENTITY	C476217
16680561	454	460	CYP2D6	GENEORGENEPRODUCT	1565
16680561	514	525	desipramina	CHEMICALENTITY	D003891
16680561	660	666	CYP2D6	GENEORGENEPRODUCT	1565
16680561	837	848	desipramina	CHEMICALENTITY	D003891
16680561	961	971	cinacalcet	CHEMICALENTITY	C476217
16680561	1207	1218	desipramina	CHEMICALENTITY	D003891
16680561	1281	1292	desipramina	CHEMICALENTITY	D003891
16680561	1390	1400	cinacalcet	CHEMICALENTITY	C476217
16680561	1449	1460	desipramina	CHEMICALENTITY	D003891
16680561	1513	1524	desipramina	CHEMICALENTITY	D003891
16680561	1585	1595	cinacalcet	CHEMICALENTITY	C476217
16680561	1761	1772	desipramina	CHEMICALENTITY	D003891
16680561	1845	1856	desipramina	CHEMICALENTITY	D003891
16680561	1892	1902	cinacalcet	CHEMICALENTITY	C476217
16680561	1991	1997	nausea	DISEASEORPHENOTYPICFEATURE	D009325
16680561	2043	2055	mal di testa	DISEASEORPHENOTYPICFEATURE	D006261
16680561	2109	2117	pazienti	ORGANISMTAXON	9606
16680561	2173	2184	desipramina	CHEMICALENTITY	D003891
16680561	2218	2228	cinacalcet	CHEMICALENTITY	C476217
16680561	2301	2311	cinacalcet	CHEMICALENTITY	C476217
16680561	2367	2373	CYP2D6	GENEORGENEPRODUCT	1565
16680561	2475	2485	cinacalcet	CHEMICALENTITY	C476217
16680561	2654	2660	CYP2D6	GENEORGENEPRODUCT	1565
16838170	76	85	HNF4alpha	GENEORGENEPRODUCT	3172
16838170	165	190	diabete mellito di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
16838170	245	283	Fattore nucleare 4alfa degli epatociti	GENEORGENEPRODUCT	3172
16838170	317	326	HNF4alpha	GENEORGENEPRODUCT	3172
16838170	428	433	umano	ORGANISMTAXON	9606
16838170	559	564	HNF4A	GENEORGENEPRODUCT	3172
16838170	609	618	HNF4alpha	GENEORGENEPRODUCT	3172
16838170	696	727	tolleranza al glucosio alterata	DISEASEORPHENOTYPICFEATURE	D018149
16838170	772	775	IGT	DISEASEORPHENOTYPICFEATURE	D018149
16838170	822	847	diabete mellito di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
16838170	968	976	acarbose	CHEMICALENTITY	D020909
16838170	1061	1086	diabete mellito di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
16838170	1197	1202	HNF4A	GENEORGENEPRODUCT	3172
16838170	1381	1390	rs4810424	SEQUENCEVARIANT	RS4810424
16838170	1426	1435	rs1884614	SEQUENCEVARIANT	RS1884614
16838170	1473	1482	rs2144908	SEQUENCEVARIANT	RS2144908
16838170	1594	1603	rs4810424	SEQUENCEVARIANT	 RS4810424
16838170	1730	1739	rs4810424	SEQUENCEVARIANT	RS4810424
16838170	1896	1903	diabete	DISEASEORPHENOTYPICFEATURE	D003920
16838170	1942	1947	donne	ORGANISMTAXON	9606
16838170	2065	2073	acarbose	CHEMICALENTITY	D020909
16838170	2186	2192	uomini	ORGANISMTAXON	9606
16838170	2269	2278	rs4810424	SEQUENCEVARIANT	RS4810424
16838170	2314	2323	rs2071197	SEQUENCEVARIANT	RS2071197
16838170	2361	2370	rs3818247	SEQUENCEVARIANT	RS3818247
16838170	2538	2563	diabete mellito di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
16838170	2656	2661	donne	ORGANISMTAXON	9606
16838170	2741	2746	HNF4A	GENEORGENEPRODUCT	3172
16838170	2824	2849	diabete mellito di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
16867021	31	52	Profilo antipsicotico	CHEMICALENTITY	D014150
16867021	87	98	tioperamide	CHEMICALENTITY	C052075
16867021	161	173	H3-recettore	GENEORGENEPRODUCT	99296
16867021	205	209	topi	ORGANISMTAXON	10090
16867021	362	374	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
16867021	472	500	recettore H(3) dell'istamina	GENEORGENEPRODUCT	99296
16867021	543	555	neurolettici	CHEMICALENTITY	D014150
16867021	610	620	catalessia	DISEASEORPHENOTYPICFEATURE	D002375
16867021	653	663	apomorfina	CHEMICALENTITY	D001058
16867021	762	772	anfetamine	CHEMICALENTITY	D000661
16867021	805	809	topi	ORGANISMTAXON	10090
16867021	854	864	Catalepsia	DISEASEORPHENOTYPICFEATURE	D002375
16867021	915	926	aloperidolo	CHEMICALENTITY	D006220
16867021	981	991	apomorfina	CHEMICALENTITY	D001058
16867021	1042	1052	anfetamina	CHEMICALENTITY	D000661
16867021	1210	1232	(R)-alfa-metilistamina	CHEMICALENTITY	C069357
16867021	1265	1269	RAMH	CHEMICALENTITY	C069357
16867021	1323	1334	tioperamide	CHEMICALENTITY	C052075
16867021	1367	1370	THP	CHEMICALENTITY	C052075
16867021	1457	1466	catalessi	DISEASEORPHENOTYPICFEATURE	D002375
16867021	1519	1522	THP	CHEMICALENTITY	C052075
16867021	1597	1608	aloperidolo	CHEMICALENTITY	D006220
16867021	1704	1713	catalessi	DISEASEORPHENOTYPICFEATURE	D002375
16867021	1788	1792	RAMH	CHEMICALENTITY	C069357
16867021	1872	1875	THP	CHEMICALENTITY	C052075
16867021	1924	1928	RAMH	CHEMICALENTITY	C069357
16867021	2082	2085	THP	CHEMICALENTITY	C052075
16867021	2194	2204	anfetamina	CHEMICALENTITY	D000661
16867021	2259	2271	iperattivitÃ 	DISEASEORPHENOTYPICFEATURE	D006948
16867021	2305	2308	THP	CHEMICALENTITY	 C052075
16867021	2477	2481	RAMH	CHEMICALENTITY	C069357
16867021	2579	2582	THP	CHEMICALENTITY	C052075
16867021	2676	2686	apomorfina	CHEMICALENTITY	D001058
16867021	2761	2764	THP	CHEMICALENTITY	C052075
16867021	2854	2858	RAMH	CHEMICALENTITY	C069357
16867021	2891	2894	THP	CHEMICALENTITY	C052075
16867021	2958	2971	antipsicotico	CHEMICALENTITY	D014150
16867021	3016	3027	aloperidolo	CHEMICALENTITY	D006220
16867021	3082	3092	catalessia	DISEASEORPHENOTYPICFEATURE	D002375
16867021	3135	3145	anfetamina	CHEMICALENTITY	D000661
16867021	3197	3209	iperattivitÃ 	DISEASEORPHENOTYPICFEATURE	D006948
16867021	3253	3263	apomorfina	CHEMICALENTITY	D001058
16867021	3315	3319	topi	ORGANISMTAXON	10090
16867021	3368	3371	THP	CHEMICALENTITY	C052075
16867021	3427	3431	RAMH	CHEMICALENTITY	C069357
16867021	3496	3524	recettori H(3) dell'istamina	GENEORGENEPRODUCT	99296
16867021	3600	3630	antagonisti del recettore H(3)	CHEMICALENTITY	D054828
16867021	3715	3727	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
16867246	47	51	DRD2	GENEORGENEPRODUCT	1813
16867246	98	111	clorpromazina	CHEMICALENTITY	D002746
16867246	163	187	sindrome extrapiramidale	DISEASEORPHENOTYPICFEATURE	D001480
16867246	241	254	schizofrenico	DISEASEORPHENOTYPICFEATURE	D012559
16867246	283	291	pazienti	ORGANISMTAXON	9606
16867246	347	371	Sindrome extrapiramidale	DISEASEORPHENOTYPICFEATURE	D001480
16867246	416	419	EPS	DISEASEORPHENOTYPICFEATURE	D001480
16867246	493	496	EPS	DISEASEORPHENOTYPICFEATURE	D001480
16867246	529	550	farmaci antipsicotici	CHEMICALENTITY	D014150
16867246	619	631	recettore D2	GENEORGENEPRODUCT	1813
16867246	777	781	DRD2	GENEORGENEPRODUCT	1813
16867246	855	867	schizofrenia	DISEASEORPHENOTYPICFEATURE	 D012559
16867246	895	903	pazienti	ORGANISMTAXON	9606
16867246	1088	1092	DRD2	GENEORGENEPRODUCT	1813
16867246	1127	1140	clorpromazina	CHEMICALENTITY	D002746
16867246	1192	1195	EPS	DISEASEORPHENOTYPICFEATURE	D001480
16867246	1242	1255	schizofrenici	DISEASEORPHENOTYPICFEATURE	D012559
16867246	1283	1292	pazienti 	ORGANISMTAXON	9606
16867246	1409	1421	-141Cins>del	SEQUENCEVARIANT	C|INDEL|0141|C
16867246	1476	1485	Ser311Cys	SEQUENCEVARIANT	C|SUB|S|311|C
16867246	1518	1524	rs6275	SEQUENCEVARIANT	RS6275
16867246	1558	1564	rs6277	SEQUENCEVARIANT	RS6277
16867246	1614	1618	DRD2	GENEORGENEPRODUCT	1813
16867246	1675	1689	schizofrenico 	DISEASEORPHENOTYPICFEATURE	D012559
16867246	1717	1727	ricoverati	ORGANISMTAXON	9606
16867246	1779	1782	EPS	DISEASEORPHENOTYPICFEATURE	D001480
16867246	1837	1840	EPS	DISEASEORPHENOTYPICFEATURE	D001480
16867246	1917	1930	clorpromazina	CHEMICALENTITY	D002746
16867246	2119	2128	Ser311Cys	SEQUENCEVARIANT	C|SUB|S|311|C
16867246	2162	2168	rs6277	SEQUENCEVARIANT	RS6277
16867246	2365	2377	-141Cins>del	SEQUENCEVARIANT	C|INDEL|0141|C
16867246	2418	2424	rs6275	SEQUENCEVARIANT	RS6275
16867246	2511	2517	rs6275	SEQUENCEVARIANT	RS6275
16867246	2715	2719	DRD2	GENEORGENEPRODUCT	1813
16867246	2836	2849	clorpromazina	CHEMICALENTITY	D002746
16867246	2895	2903	pazienti	ORGANISMTAXON	9606
16867246	2951	2963	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
16867246	3074	3078	DRD2	GENEORGENEPRODUCT	1813
16867246	3124	3127	EPS	DISEASEORPHENOTYPICFEATURE	D001480
17033974	67	73	calcio	CHEMICALENTITY	D002118
17033974	113	122	 CACNA2D4	GENEORGENEPRODUCT	93589
17033974	198	214	distrofia conica	DISEASEORPHENOTYPICFEATURE	D000077765
17033974	328	334	calcio	CHEMICALENTITY	D002118
17033974	520	528	Cacna2d4	GENEORGENEPRODUCT	319734
17033974	564	569	mouse	ORGANISMTAXON	10090
17033974	738	746	Cacna2d4	GENEORGENEPRODUCT	319734
17033974	793	868	subunitÃ  ausiliaria del canale del calcio di tipo l del tipo alfa (2) delta	GENEORGENEPRODUCT	781
17033974	918	923	umano	ORGANISMTAXON	9606
17033974	966	974	CACNA2D4	GENEORGENEPRODUCT	93589
17033974	1106	1114	pazienti	ORGANISMTAXON	9606
17033974	1202	1217	cecitÃ  notturna	DISEASEORPHENOTYPICFEATURE	D009755
17033974	1340	1351	c.2406C-->A	SEQUENCEVARIANT	RS71454844
17033974	1389	1397	CACNA2D4	GENEORGENEPRODUCT	93589
17033974	1555	1563	pazienti	ORGANISMTAXON	9606
17033974	1658	1676	distrofia del cono	DISEASEORPHENOTYPICFEATURE	D000077765
17033974	1784	1789	umano	ORGANISMTAXON	9606
17033974	1822	1830	CACNA2D4	GENEORGENEPRODUCT	93589
17033974	1881	1899	distrofia del cono	DISEASEORPHENOTYPICFEATURE	D000077765
17151160	57	67	olanzapina	CHEMICALENTITY	C076029
17151160	110	121	risperidone	CHEMICALENTITY	D018967
17151160	203	215	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
17151160	349	359	olanzapina	CHEMICALENTITY	C076029
17151160	402	413	risperidone	CHEMICALENTITY	D018967
17151160	444	452	pazienti	ORGANISMTAXON	9606
17151160	518	530	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
17151160	691	703	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
17151160	754	779	disturbo schizofreniforme	DISEASEORPHENOTYPICFEATURE	D011618
17151160	831	855	disturbo schizoaffettivo	DISEASEORPHENOTYPICFEATURE	D011618
17151160	948	958	olanzapina	CHEMICALENTITY	C076029
17151160	1008	1019	risperidone	CHEMICALENTITY	D018967
17151160	1138	1148	olanzapina	CHEMICALENTITY	C076029
17151160	1211	1222	risperidone	CHEMICALENTITY	D018967
17151160	1353	1363	olanzapina	CHEMICALENTITY	C076029
17151160	1442	1453	risperidone	CHEMICALENTITY	D018967
17151160	1649	1662	parkinsonismo	DISEASEORPHENOTYPICFEATURE	D010302
17151160	1708	1716	acatisia	DISEASEORPHENOTYPICFEATURE	D017109
17151160	1792	1815	Sintomo extrapiramidale	DISEASEORPHENOTYPICFEATURE	D001480
17151160	1900	1911	risperidone	CHEMICALENTITY	D018967
17151160	1970	1980	olanzapina	CHEMICALENTITY	C076029
17151160	2048	2063	aumento di peso	DISEASEORPHENOTYPICFEATURE	D015430
17151160	2115	2125	olanzapina	CHEMICALENTITY	C076029
17151160	2169	2180	risperidone	CHEMICALENTITY	D018967
17151160	2308	2318	olanzapina	CHEMICALENTITY	C076029
17151160	2382	2393	risperidone	CHEMICALENTITY	D018967
17151160	2536	2546	olanzapina	CHEMICALENTITY	C076029
17151160	2643	2654	risperidone	CHEMICALENTITY	D018967
17151160	2724	2735	risperidone	CHEMICALENTITY	D018967
17151160	2793	2803	olanzapina	CHEMICALENTITY	C076029
17151160	2879	2889	Olanzapina	CHEMICALENTITY	C076029
17151160	2997	3012	aumento di peso	DISEASEORPHENOTYPICFEATURE	D015430
17151160	3057	3072	aumento di peso	DISEASEORPHENOTYPICFEATURE	D015430
17151160	3188	3198	olanzapina	CHEMICALENTITY	C076029
17255138	52	73	Inibitori della COX-2	CHEMICALENTITY	D052246
17255138	123	127	FANS	CHEMICALENTITY	D000894
17255138	309	333	infarto miocardico acuto	DISEASEORPHENOTYPICFEATURE	D009203
17255138	378	381	AMI	DISEASEORPHENOTYPICFEATURE	D009203
17255138	419	444	Gli inibitori della COX-2	CHEMICALENTITY	D052246
17255138	567	607	anti non steroidei -farmaci infiammatori	CHEMICALENTITY	D000894
17255138	640	644	FANS	CHEMICALENTITY	D000894
17255138	744	747	AMI	DISEASEORPHENOTYPICFEATURE	D009203
17255138	793	820	emorragia gastrointestinale	DISEASEORPHENOTYPICFEATURE	D006471
17255138	860	868	pazienti	ORGANISMTAXON	9606
17255138	910	931	inibitori della COX-2	CHEMICALENTITY	D052246
17255138	968	972	FANS	CHEMICALENTITY	D000894
17255138	1006	1019	acetaminofene	CHEMICALENTITY	D000082
17255138	1145	1153	pazienti	ORGANISMTAXON	9606
17255138	1247	1251	FANS	CHEMICALENTITY	D000894
17255138	1285	1298	acetaminofene	CHEMICALENTITY	D000082
17255138	1537	1545	aspirina	CHEMICALENTITY	D001241
17255138	1601	1613	paracetamolo	CHEMICALENTITY	D000082
17255138	1658	1667	rofecoxib	CHEMICALENTITY	C116926
17255138	1711	1720	celecoxib	CHEMICALENTITY	C105934
17255138	1766	1770	FANS	CHEMICALENTITY	D000894
17255138	1827	1835	aspirina	CHEMICALENTITY	D001241
17255138	1887	1896	rofecoxib	CHEMICALENTITY	C116926
17255138	1941	1950	celecoxib	CHEMICALENTITY	C105934
17255138	1997	2001	FANS	CHEMICALENTITY	D000894
17255138	2049	2061	paracetamolo	CHEMICALENTITY	D000082
17255138	2120	2128	aspirina	CHEMICALENTITY	D001241
17255138	2252	2255	AMI	DISEASEORPHENOTYPICFEATURE	D009203
17255138	2293	2305	paracetamolo	CHEMICALENTITY	D000082
17255138	2344	2352	aspirina	CHEMICALENTITY	D001241
17255138	2399	2408	rofecoxib	CHEMICALENTITY	C116926
17255138	2459	2468	celecoxib	CHEMICALENTITY	C105934
17255138	2519	2529	naprossene	CHEMICALENTITY	D009288
17255138	2580	2590	diclofenac	CHEMICALENTITY	D004008
17255138	2642	2652	ibuprofene	CHEMICALENTITY	D007052
17255138	2727	2735	aspirina	CHEMICALENTITY	D001241
17255138	2775	2784	rofecoxib	CHEMICALENTITY	C116926
17255138	2836	2845	celecoxib	CHEMICALENTITY	C105934
17255138	2896	2905	ibuprofen	CHEMICALENTITY	D007052
17255138	2957	2967	diclofenac	CHEMICALENTITY	D004008
17255138	3018	3028	naprossene	CHEMICALENTITY	D009288
17255138	3080	3092	paracetamolo	CHEMICALENTITY	D000082
17255138	3182	3190	aspirina	CHEMICALENTITY	D001241
17255138	3223	3233	naprossene	CHEMICALENTITY	D009288
17255138	3320	3323	AMI	DISEASEORPHENOTYPICFEATURE	D009203
17255138	3367	3394	emorragia gastrointestinale	DISEASEORPHENOTYPICFEATURE	D006471
17255138	3442	3445	AMI	DISEASEORPHENOTYPICFEATURE	D009203
17255138	3489	3501	TossicitÃ  GI	DISEASEORPHENOTYPICFEATURE	D005767
17255138	3537	3546	celecoxib	CHEMICALENTITY	 C105934
17255138	3601	3614	acetaminofene	CHEMICALENTITY	D000082
17255138	3687	3696	rofecoxib	CHEMICALENTITY	C116926
17255138	3733	3737	FANS	CHEMICALENTITY	D000894
17255138	3788	3796	aspirina	CHEMICALENTITY	D001241
17255138	3833	3842	celecoxib	CHEMICALENTITY	C105934
17255138	3877	3887	naprossene	CHEMICALENTITY	D009288
17297207	31	38	Chinino	CHEMICALENTITY	D011803
17297207	90	97	aritmia	DISEASEORPHENOTYPICFEATURE	D001145
17297207	131	139	paziente	ORGANISMTAXON	9606
17297207	187	200	malaria grave	DISEASEORPHENOTYPICFEATURE	D016778
17297207	293	306	malaria grave	DISEASEORPHENOTYPICFEATURE	D016778
17297207	334	342	paziente	ORGANISMTAXON	9606
17297207	390	396	ittero	DISEASEORPHENOTYPICFEATURE	D007565
17297207	457	464	aritmia	DISEASEORPHENOTYPICFEATURE	D001145
17297207	510	544	contrazione ventricolare prematura	DISEASEORPHENOTYPICFEATURE	D018879
17297207	600	607	chinino	CHEMICALENTITY	D011803
17297207	639	643	uomo	ORGANISMTAXON	9606
17297207	732	738	febbre	DISEASEORPHENOTYPICFEATURE	D005334
17297207	784	790	freddo	DISEASEORPHENOTYPICFEATURE	D023341
17297207	835	841	vomito	DISEASEORPHENOTYPICFEATURE	D014839
17297207	887	893	ittero	DISEASEORPHENOTYPICFEATURE	D007565
17297207	925	933	paziente	ORGANISMTAXON	9606
17297207	1117	1138	Plasmodium falciparum	ORGANISMTAXON	5833
17297207	1185	1195	bilirubina	CHEMICALENTITY	D001663
17297207	1249	1259	bilirubina	CHEMICALENTITY	D001663
17297207	1317	1327	bilirubina	CHEMICALENTITY	D001663
17297207	1371	1379	potassio	CHEMICALENTITY	D011188
17297207	1418	1426	Paziente	ORGANISMTAXON	9606
17297207	1497	1510	malaria grave	DISEASEORPHENOTYPICFEATURE	D016778
17297207	1558	1564	ittero	DISEASEORPHENOTYPICFEATURE	D007565
17297207	1608	1615	chinino	CHEMICALENTITY	D011803
17297207	1660	1669	destrosio	CHEMICALENTITY	D005947
17297207	1733	1741	paziente	ORGANISMTAXON	9606
17297207	1791	1797	vomito	DISEASEORPHENOTYPICFEATURE	D014839
17297207	1842	1849	diarrea	DISEASEORPHENOTYPICFEATURE	D003967
17297207	1894	1901	tinnito	DISEASEORPHENOTYPICFEATURE	D014012
17297207	1946	1964	perdita dell'udito	DISEASEORPHENOTYPICFEATURE	D034381
17297207	2025	2032	chinino	CHEMICALENTITY	D011803
17297207	2063	2071	paziente	ORGANISMTAXON	9606
17297207	2127	2139	palpitazioni	DISEASEORPHENOTYPICFEATURE	D006331
17297207	2248	2282	contrazione ventricolare prematura	DISEASEORPHENOTYPICFEATURE	D018879
17297207	2328	2331	PVC	DISEASEORPHENOTYPICFEATURE	D018879
17297207	2416	2434	blocco senoatriale	DISEASEORPHENOTYPICFEATURE	D012848
17297207	2505	2514	lidocaina	CHEMICALENTITY	D008012
17297207	2606	2615	destrosio	CHEMICALENTITY	D005947
17297207	2659	2680	aspartato di potassio	CHEMICALENTITY	D001224
17297207	2723	2745	L'infusione di chinino	CHEMICALENTITY	D011803
17297207	2834	2841	chinino	CHEMICALENTITY	D011803
17297207	2886	2894	paziente	ORGANISMTAXON	9606
17297207	2973	2976	PVC	DISEASEORPHENOTYPICFEATURE	D018879
17297207	3084	3092	potassio	CHEMICALENTITY	D011188
17297207	3193	3200	Chinino	CHEMICALENTITY	D011803
17297207	3238	3247	chinidina	CHEMICALENTITY	D011802
17297207	3364	3372	aritmico	DISEASEORPHENOTYPICFEATURE	D001145
17297207	3440	3447	aritmia	DISEASEORPHENOTYPICFEATURE	D001145
17297207	3513	3520	aritmie	DISEASEORPHENOTYPICFEATURE	D001145
17297207	3574	3582	aritmie 	DISEASEORPHENOTYPICFEATURE	D001145
17297207	3640	3643	PVC	DISEASEORPHENOTYPICFEATURE	D018879
17297207	3700	3707	chinino	CHEMICALENTITY	D011803
17297207	3850	3858	aritmica	DISEASEORPHENOTYPICFEATURE	D001145
17297207	3912	3920	pazienti	ORGANISMTAXON	9606
17297207	3986	4004	malattie cardiache	DISEASEORPHENOTYPICFEATURE	D006331
17297207	4034	4042	pazienti	ORGANISMTAXON	9606
17297207	4090	4112	disturbo elettrolitico	DISEASEORPHENOTYPICFEATURE	D014883
17297207	4158	4169	ipokaliemia	DISEASEORPHENOTYPICFEATURE	 D007008
17297207	4256	4262	vomito	DISEASEORPHENOTYPICFEATURE	D014839
17297207	4309	4316	diarrea	DISEASEORPHENOTYPICFEATURE	D003967
17297207	4369	4376	malaria	DISEASEORPHENOTYPICFEATURE	D008288
17345627	55	59	BMP4	GENEORGENEPRODUCT	652
17345627	92	96	BMP5	GENEORGENEPRODUCT	653
17345627	158	192	malformazioni scheletriche assiali	DISEASEORPHENOTYPICFEATURE	D001848
17345627	238	263	ossificazione eterotopica	DISEASEORPHENOTYPICFEATURE	D009999
17345627	327	356	Proteine morfogenetiche ossee	GENEORGENEPRODUCT	649,650,652,653
17345627	400	403	BMP	GENEORGENEPRODUCT	649,650,652,653
17345627	534	573	cartilagine ectopica e formazione ossea	DISEASEORPHENOTYPICFEATURE	D001847,D002357
17345627	641	671	proteina morfogenetica ossea 4	GENEORGENEPRODUCT	652
17345627	703	707	BMP4	GENEORGENEPRODUCT	652
17345627	763	771	pazienti	ORGANISMTAXON	 9606
17345627	825	863	fibrodisplasia ossificante progressiva	DISEASEORPHENOTYPICFEATURE	D009221
17345627	908	911	FOP	DISEASEORPHENOTYPICFEATURE	D009221
17345627	982	1031	malformazione scheletrica assiale e appendicolare	DISEASEORPHENOTYPICFEATURE	D001848
17345627	1089	1114	ossificazione eterotopica	DISEASEORPHENOTYPICFEATURE	D009999
17345627	1187	1217	proteina morfogenetica ossea 5	GENEORGENEPRODUCT	653
17345627	1249	1253	bmp5	GENEORGENEPRODUCT	653
17345627	1319	1323	BMP5	GENEORGENEPRODUCT	653
17345627	1361	1367	murine	ORGANISMTAXON	10090
17345627	1412	1440	sindrome dell'orecchio corto	DISEASEORPHENOTYPICFEATURE	D004427
17345627	1551	1585	malformazioni scheletriche assiali	DISEASEORPHENOTYPICFEATURE	D001848
17345627	1682	1687	mouse	ORGANISMTAXON	10090
17345627	1733	1736	FOP	DISEASEORPHENOTYPICFEATURE	D009221
17345627	1798	1825	orecchie esterne malformate	DISEASEORPHENOTYPICFEATURE	D004426
17345627	1870	1916	malformazioni multiple dello scheletro assiale	DISEASEORPHENOTYPICFEATURE	D001848
17345627	1975	2000	ossificazione eterotopica	DISEASEORPHENOTYPICFEATURE	D009999
17345627	2088	2091	BMP	GENEORGENEPRODUCT	649,650,652,653
17345627	2287	2291	BMP4	GENEORGENEPRODUCT	652
17345627	2324	2328	BMP5	GENEORGENEPRODUCT	653
17345627	2396	2416	cellule del paziente	ORGANISMTAXON	9606
17345627	2467	2471	BMP2	GENEORGENEPRODUCT	650
17345627	2590	2594	BMP4	GENEORGENEPRODUCT	652
17345627	2627	2631	BMP5	GENEORGENEPRODUCT	653
17345627	2685	2690	umano	ORGANISMTAXON	9606
17345627	2734	2763	anomalie scheletriche assiali	DISEASEORPHENOTYPICFEATURE	D001848
17345627	2819	2824	mouse	ORGANISMTAXON	10090
17345627	2870	2873	FOP	DISEASEORPHENOTYPICFEATURE	D009221
17384765	31	39	Succimer	CHEMICALENTITY	D004113
17384765	159	163	lead	CHEMICALENTITY	D007854
17384765	200	205	ratti	ORGANISMTAXON	10116
17384765	260	284	compromissione cognitiva	DISEASEORPHENOTYPICFEATURE	D003072
17384765	330	334	lead	CHEMICALENTITY	D007854
17384765	494	498	lead	CHEMICALENTITY	D007854
17384765	662	664	Pb	CHEMICALENTITY	D007854
17384765	802	804	Pb	CHEMICALENTITY	D007854
17384765	987	989	Pb	CHEMICALENTITY	D007854
17384765	1052	1061	succimero	CHEMICALENTITY	 D004113
17384765	1169	1188	avvelenamento da Pb	DISEASEORPHENOTYPICFEATURE	D007855
17384765	1232	1234	Pb	CHEMICALENTITY	D007854
17384765	1322	1435	compromissioni nell'apprendimento, nell'attenzione, nel controllo inibitorio e nella regolazione dell'eccitazione	DISEASEORPHENOTYPICFEATURE	D007859,D019958
17384765	1541	1543	Pb	CHEMICALENTITY	D007854
17384765	1576	1584	Succimer	CHEMICALENTITY	D004113
17384765	1632	1634	Pb	CHEMICALENTITY	D007854
17384765	1672	1677	ratti	ORGANISMTAXON	10116
17384765	1870	1872	Pb	CHEMICALENTITY	D007854
17384765	1973	1981	succimer	CHEMICALENTITY	D004113
17384765	2025	2030	ratti	ORGANISMTAXON	10116
17384765	2093	2095	Pb	CHEMICALENTITY	D007854
17384765	2180	2213	disfunzione cognitiva e affettiva	DISEASEORPHENOTYPICFEATURE	D003072,D019964
17384765	2312	2314	Pb	CHEMICALENTITY	D007854
17384765	2509	2526	deficit cognitivi	DISEASEORPHENOTYPICFEATURE	D003072
17384765	2568	2570	Pb	CHEMICALENTITY	D007854
17384765	2717	2725	succimer	CHEMICALENTITY	D004113
17384765	2793	2795	Pb	CHEMICALENTITY	D007854
17384765	2896	2904	succimer	CHEMICALENTITY	D004113
17384765	3033	3036	 Pb	CHEMICALENTITY	D007854
17395743	50	54	PVT1	GENEORGENEPRODUCT	5820
17395743	122	160	 malattia renale allo stadio terminale	DISEASEORPHENOTYPICFEATURE	D007676
17395743	207	224	diabete di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
17395743	444	481	malattia renale allo stadio terminale	DISEASEORPHENOTYPICFEATURE	D007676
17395743	526	530	ESRD	DISEASEORPHENOTYPICFEATURE	D007676
17395743	578	595	diabete di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
17395743	781	785	ESRD	DISEASEORPHENOTYPICFEATURE	D007676
17395743	889	906	diabete di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
17395743	1349	1358	rs2720709	SEQUENCEVARIANT	RS2720709
17395743	1514	1518	PVT1	GENEORGENEPRODUCT	5820
17395743	1630	1634	PVT1	GENEORGENEPRODUCT	5820
17395743	1936	1945	rs2720709	SEQUENCEVARIANT	RS2720709
17395743	2047	2051	ESRD	DISEASEORPHENOTYPICFEATURE	D007676
17395743	2154	2163	rs2648875	SEQUENCEVARIANT	RS2648875
17395743	2265	2269	PVT1	GENEORGENEPRODUCT	5820
17395743	2345	2349	PVT1	GENEORGENEPRODUCT	5820
17395743	2431	2435	ESRD	DISEASEORPHENOTYPICFEATURE	D007676
17395743	2482	2486	ESRD	DISEASEORPHENOTYPICFEATURE	D007676
17395743	2530	2537	diabete	DISEASEORPHENOTYPICFEATURE	D003920
17445520	31	39	Caffeina	CHEMICALENTITY	D002110
17445520	101	119	disturbo di panico	DISEASEORPHENOTYPICFEATURE	D016584
17445520	165	176	depressione	DISEASEORPHENOTYPICFEATURE	D003866
17445520	224	242	attacchi di panico	DISEASEORPHENOTYPICFEATURE	D016584
17445520	304	312	pazienti	ORGANISMTAXON	9606
17445520	360	378	disturbo di panico	DISEASEORPHENOTYPICFEATURE	D016584
17445520	424	426	PD	DISEASEORPHENOTYPICFEATURE	D016584
17445520	457	465	pazienti	ORGANISMTAXON	9606
17445520	513	531	depressione grave 	DISEASEORPHENOTYPICFEATURE	D003865
17445520	579	597	attacchi di panico	DISEASEORPHENOTYPICFEATURE	D016584
17445520	650	653	MDP	DISEASEORPHENOTYPICFEATURE	D003865,D016584
17445520	735	751	Disturbi Mentali	DISEASEORPHENOTYPICFEATURE	D001523
17445520	871	889	attacchi di panico	DISEASEORPHENOTYPICFEATURE	 D016584
17445520	954	962	caffeina	CHEMICALENTITY	D002110
17445520	1026	1034	pazienti	ORGANISMTAXON	9606
17445520	1082	1084	PD	DISEASEORPHENOTYPICFEATURE	D016584
17445520	1145	1148	MDP	DISEASEORPHENOTYPICFEATURE	D003865,D016584
17445520	1200	1217	depressione grave	DISEASEORPHENOTYPICFEATURE	D003865
17445520	1268	1286	attacchi di panico	DISEASEORPHENOTYPICFEATURE	D016584
17445520	1331	1333	MD	DISEASEORPHENOTYPICFEATURE	D003865
17445520	1385	1393	pazienti	ORGANISMTAXON	9606
17445520	1599	1607	caffeina	CHEMICALENTITY	D002110
17445520	1645	1653	caffeina	CHEMICALENTITY	D002110
17445520	1796	1801	ansia	DISEASEORPHENOTYPICFEATURE	D001008
17445520	1885	1893	pazienti	ORGANISMTAXON	9606
17445520	1941	1943	PD	DISEASEORPHENOTYPICFEATURE	D016584
17445520	1991	1999	pazienti	ORGANISMTAXON	9606
17445520	2055	2058	MDP	DISEASEORPHENOTYPICFEATURE	D003865,D016584
17445520	2158	2175	attacco di panico	DISEASEORPHENOTYPICFEATURE	D016584
17445520	2225	2233	caffeina	CHEMICALENTITY	D002110
17445520	2308	2316	pazienti	ORGANISMTAXON	9606
17445520	2364	2366	PD	DISEASEORPHENOTYPICFEATURE	D016584
17445520	2421	2424	MDP	DISEASEORPHENOTYPICFEATURE	D003865 ,D016584
17445520	2476	2484	caffeina	CHEMICALENTITY	D002110
17445520	2523	2531	pazienti	ORGANISMTAXON	9606
17445520	2579	2581	MD	DISEASEORPHENOTYPICFEATURE	D003865
17445520	2665	2682	attacco di panico	DISEASEORPHENOTYPICFEATURE	D016584
17445520	2755	2763	caffeina	CHEMICALENTITY	D002110
17445520	2794	2802	pazienti	ORGANISMTAXON	9606
17445520	2850	2852	MD	DISEASEORPHENOTYPICFEATURE	D003865
17445520	3178	3196	attacchi di panico	DISEASEORPHENOTYPICFEATURE	D016584
17445520	3268	3270	PD	DISEASEORPHENOTYPICFEATURE	D016584
17445520	3324	3327	MDP	DISEASEORPHENOTYPICFEATURE	D003865,D016584
17445520	3382	3390	caffeina	CHEMICALENTITY	D002110
17549393	42	46	IRF6	GENEORGENEPRODUCT	3664
17549393	108	112	Y67X	SEQUENCEVARIANT	P|SUB| Y|67|X
17549393	185	210	Sindrome di Van der Woude	DISEASEORPHENOTYPICFEATURE	C536528
17549393	255	280	Sindrome di Van der Woude	DISEASEORPHENOTYPICFEATURE	C536528
17549393	325	328	VWS	DISEASEORPHENOTYPICFEATURE	C536528
17549393	397	400	VWS	DISEASEORPHENOTYPICFEATURE	C536528
17549393	445	474	schisi orofacciale sindromica	DISEASEORPHENOTYPICFEATURE	D002972
17549393	567	597	labbro leporino e palatoschisi	DISEASEORPHENOTYPICFEATURE	D002971,D002972
17549393	699	718	fossette del labbro	DISEASEORPHENOTYPICFEATURE	C536528
17549393	763	778	labbro leporino	DISEASEORPHENOTYPICFEATURE	D002971
17549393	824	836	palatoschisi	DISEASEORPHENOTYPICFEATURE	D002972
17549393	882	891	ipodontia	DISEASEORPHENOTYPICFEATURE	D000848
17549393	936	939	VWS	DISEASEORPHENOTYPICFEATURE	C536528
17549393	1031	1069	fattore regolatorio dell'interferone 6	GENEORGENEPRODUCT	3664
17549393	1102	1106	IRF6	GENEORGENEPRODUCT	3664
17549393	1284	1288	IRF6	GENEORGENEPRODUCT	3664
17549393	1370	1373	VWS	DISEASEORPHENOTYPICFEATURE	C536528
17549393	1401	1409	pazienti	ORGANISMTAXON	9606
17549393	1564	1568	IRF6	GENEORGENEPRODUCT	3664
17549393	1764	1768	IRF6	GENEORGENEPRODUCT	3664
17549393	1807	1815	pazienti	ORGANISMTAXON	9606
17549393	1901	1909	c.201C-A	SEQUENCEVARIANT	C|SUB|C|201|A
17549393	1967	2020	 alla posizione dell'amminoacido 67 in un codone stop	SEQUENCEVARIANT	P|SUB|Y|67|X
17549393	2059	2065	p.Y67X	SEQUENCEVARIANT	P|SUB|Y|67|X
17549393	2248	2252	Smad	GENEORGENEPRODUCT	4086
17549393	2284	2323	fattore di regolazione dell'interferone	GENEORGENEPRODUCT	3664
17549393	2434	2438	Smad	GENEORGENEPRODUCT	4086
17600377	50	69	maltolil p-cumarato	CHEMICALENTITY	C524754
17600377	123	140	deficit cognitivi	DISEASEORPHENOTYPICFEATURE	 D003072
17600377	236	243	demenza	DISEASEORPHENOTYPICFEATURE	D003704
17600377	427	446	maltolil p-cumarato	CHEMICALENTITY	C524754
17600377	508	515	maltolo	CHEMICALENTITY	C008316
17600377	549	565	acido p-cumarico	CHEMICALENTITY	C495469
17600377	638	658	maltolil p- cumarate	CHEMICALENTITY	C524754
17600377	722	739	declino cognitivo	DISEASEORPHENOTYPICFEATURE	D003072
17600377	774	785	scopolamine	CHEMICALENTITY	D012601
17600377	824	829	ratti	ORGANISMTAXON	10116
17600377	866	893	peptide beta amiloide(1-42)	CHEMICALENTITY	C544092
17600377	931	936	ratti	ORGANISMTAXON	10116
17600377	969	992	P-cumarato di maltolile	CHEMICALENTITY	C524754
17600377	1058	1075	deficit cognitivi	DISEASEORPHENOTYPICFEATURE	D003072
17600377	1117	1120	rat	ORGANISMTAXON	10116
17600377	1278	1306	peptide beta amiloide(1- 42)	CHEMICALENTITY	C544092
17600377	1345	1350	ratti	ORGANISMTAXON	10116
17600377	1438	1457	maltolyl p-cumarato	CHEMICALENTITY	C524754
17600377	1585	1604	maltolil p-cumarato	CHEMICALENTITY	C524754
17600377	1663	1689	amiloide-betapeptide(1-42)	CHEMICALENTITY	C544092
17600377	1722	1732	glutammato	CHEMICALENTITY	D018698
17600377	1766	1770	H2O2	CHEMICALENTITY	D006861
17600377	1824	1843	maltolil p-cumarato	CHEMICALENTITY	C524754
17600377	1945	1975	 specie reattive dell'ossigeno	CHEMICALENTITY	D017382
17600377	2008	2032	rilascio del citocromo c	CHEMICALENTITY	D045304
17600377	2067	2076	caspase 3	GENEORGENEPRODUCT	25402
17600377	2208	2227	maltolyl p-cumarato	CHEMICALENTITY	C524754
17600377	2318	2339	Malattia di Alzheimer	DISEASEORPHENOTYPICFEATURE	 D000544
17600377	2421	2436	morte neuronale	DISEASEORPHENOTYPICFEATURE	D009410
17600377	2494	2527	 declino della funzione cognitiva	DISEASEORPHENOTYPICFEATURE	D003072
17608141	47	60	metanfetamine	CHEMICALENTITY	D008694
17608141	115	128	dopaminergico	CHEMICALENTITY	D004298
17608141	172	186	neurotossicitÃ 	DISEASEORPHENOTYPICFEATURE	D020258
17608141	218	222	topi	ORGANISMTAXON	10090
17608141	258	275	lipopolisaccaride	CHEMICALENTITY	D008070
17608141	391	404	metamfetamina	CHEMICALENTITY	D008694
17608141	456	485	danno terminale dopaminergico	DISEASEORPHENOTYPICFEATURE	D009422
17608141	565	582	lipopolisaccaride	CHEMICALENTITY	D008070
17608141	634	646	infiammatori	DISEASEORPHENOTYPICFEATURE	D007249
17608141	692	713	fattore infiammatorio	DISEASEORPHENOTYPICFEATURE	D007249
17608141	780	793	metamfetamina	CHEMICALENTITY	D008694
17608141	849	857	dopamina	CHEMICALENTITY	D004298
17608141	901	915	neurotossicitÃ 	DISEASEORPHENOTYPICFEATURE	D020258
17608141	948	965	Lipopolisaccaride	CHEMICALENTITY	D008070
17608141	1067	1080	metamfetamina	CHEMICALENTITY	D008694
17608141	1132	1142	ipertermia	DISEASEORPHENOTYPICFEATURE	D005334
17608141	1218	1235	lipopolisaccaride	CHEMICALENTITY	D008070
17608141	1280	1293	metamfetamina	CHEMICALENTITY	D008694
17608141	1336	1344	dopamina	CHEMICALENTITY	D004298
17608141	1378	1409	acido 3,4-diidrossifenilacetico	CHEMICALENTITY	D015102
17608141	1521	1538	lipopolisaccaride	CHEMICALENTITY	D008070
17608141	1634	1647	metamfetamina	CHEMICALENTITY	 D008694
17608141	1699	1712	metamfetamina	CHEMICALENTITY	D008694
17608141	1755	1763	dopamina	CHEMICALENTITY	D004298
17608141	1797	1842	deplezioni di acido 3,4-diidrossifenilacetico	CHEMICALENTITY	D015102
17608141	1936	1953	lipopolisaccaride	CHEMICALENTITY	D008070
17608141	2012	2025	metanfetamina	CHEMICALENTITY	D008694
17608141	2058	2066	dopamina	CHEMICALENTITY	D004298
17608141	2100	2131	acido 3,4-diidrossifenilacetico	CHEMICALENTITY	D015102
17608141	2237	2254	lipopolisaccaride	CHEMICALENTITY	D008070
17608141	2381	2394	metanfetamina	CHEMICALENTITY	D008694
17608141	2507	2524	lipopolisaccaride	CHEMICALENTITY	D008070
17608141	2603	2617	 metanfetamina	CHEMICALENTITY	D008694
17608141	2649	2657	dopamina	CHEMICALENTITY	D004298
17608141	2701	2715	neurotossicitÃ 	DISEASEORPHENOTYPICFEATURE	D020258
17671735	82	90	pazienti	ORGANISMTAXON	9606
17671735	148	152	GJB2	GENEORGENEPRODUCT	2706
17671735	229	264	disturbo dell'udito neurosensoriale	DISEASEORPHENOTYPICFEATURE	D034381
17671735	550	572	compromissione uditiva	DISEASEORPHENOTYPICFEATURE	D034381
17671735	648	652	GJB2	GENEORGENEPRODUCT	2706
17671735	836	840	GJB6	GENEORGENEPRODU CT	10804
17671735	874	878	GJB3	GENEORGENEPRODUCT	2707
17671735	950	954	GJB2	GENEORGENEPRODUCT	2706
17671735	1029	1033	GJB2	GENEORGENEPRODUCT	2706
17671735	1073	1081	pazienti	ORGANISMTAXON	9606
17671735	1241	1245	GJB2	GENEORGENEPRODUCT	2706
17671735	1291	1299	pazienti	ORGANISMTAXON	9606
17671735	1436	1443	p.R127H	SEQUENCEVARIANT	RS111033196
17671735	1499	1503	GJB2	GENEORGENEPRODUCT	2706
17671735	1574	1578	GJB6	GENEORGENEPRODUCT	10804
17671735	1619	1623	GJB6	GENEORGENEPRODUCT	10804
17671735	1718	1722	GJB3	GENEORGENEPRODUCT	2707
17671735	1759	1767	c.357C>T	SEQUENCEVARIANT	RS41310442
17671735	1804	1812	c.798C>T	SEQUENCEVARIANT	RS35983826
17671735	1849	1856	c.94C>T	SEQUENCEVARIANT	RS1805063
17671735	1892	1898	p.R32W	SEQUENCEVARIANT	RS1805063
17671735	2146	2154	c.35delG	SEQUENCEVARIANT	RS80338939
17671735	2186	2194	pazienti	ORGANISMTAXON	9606
17671735	2243	2261	deficit dell'udito	DISEASEORPHENOTYPICFEATURE	D034381
17943461	55	66	Fas ligando	GENEORGENEPRODUCT	356
17943461	126	130	AZT 	CHEMICALENTITY	D015215
17943461	182	196	cardiomiopatia	DISEASEORPHENOTYPICFEATURE	D009202
17943461	252	277	Cardiomiopatia dilatativa	DISEASEORPHENOTYPICFEATURE	D002311
17943461	322	325	DCM	DISEASEORPHENOTYPICFEATURE	D002311
17943461	372	382	miocardite	DISEASEORPHENOTYPICFEATURE	D009205
17943461	450	480	Individui con infezione da HIV	DISEASEORPHENOTYPICFEATURE	D015658
17943461	541	563	insufficienza cardiaca	DISEASEORPHENOTYPICFEATURE	D006333
17943461	607	615	pazienti	ORGANISMTAXON	9606
17943461	772	810	sindrome da immunodeficienza acquisita	DISEASEORPHENOTYPICFEATURE	D000163
17943461	855	859	AIDS	DISEASEORPHENOTYPICFEATURE	D000163
17943461	936	969	miopatie cardiache e scheletriche	DISEASEORPHENOTY PICFEATURE	C538496
17943461	1065	1075	zidovudina	CHEMICALENTITY	D015215
17943461	1108	1138	3'-azido-2', 3'-deossitimidina	CHEMICALENTITY	D015215
17943461	1171	1174	AZT	CHEMICALENTITY	D015215
17943461	1217	1220	Fas	GENEORGENEPRODUCT	355
17943461	1334	1338	muro	ORGANISMTAXON	10090
17943461	1385	1388	DCM	DISEASEORPHENOTYPICFEATURE	D002311
17943461	1460	1471	Fas ligando	GENEORGENEPRODUCT	356
17943461	1519	1524	FasL 	GENEORGENEPRODUCT	14103
17943461	1581	1585	topi	ORGANISMTAXON	10090
17943461	1687	1690	AZT	CHEMICALENTITY	D015215
17943461	1923	1927	FasL	GENEORGENEPRODUCT	14103
17943461	1959	1963	topi	ORGANISMTAXON	10090
17943461	2088	2091	AZT	CHEMICALENTITY	D015215
17943461	2133	2137	FasL	GENEORGENEPRODUCT	14103
17943461	2170	2174	topi	ORGANISMTAXON	10090
17943461	2229	2249	dilatazione cardiaca	DISEASEORPHENOTYPICFEATURE	D002311
17943461	2295	2321	funzione cardiaca depressa	DISEASEORPHENOTYPICFEATURE	D000275
17943461	2407	2419	infiammatori	DISEASEORPHENOTYPICFEATURE	D007249
17943461	2573	2576	Fas	GENEORGENEPRODUCT	355
17943461	2611	2615	FasL	GENEORGENEPRODUCT	14103
17943461	2687	2696	caspase 3	GENEORGENEPRODUCT	12367
17943461	2747	2756	calpain 1	GENEORGENEPRODUCT	12333
17943461	2941	2951	distrofina	GENEORGENEPRODUCT	13405
17943461	2992	3012	troponina cardiaca I	GENEORGENEPRODUCT	21954
17943461	3131	3142	Fas ligando	GENEORGENEPRODUCT	356
17943461	3207	3210	HIV	ORGANISMTAXON	11676
17943461	3247	3255	pazienti	ORGANISMTAXON	9606
17943461	3341	3355	cardiomiopatia	DISEASEORPHENOTYPICFEATURE	D009202
17943461	3488	3522	dilatazione e disfunzione cardiaca	DISEASEORPHENOTYPICFEATURE	D002311,D006331
17962394	85	104	Nistagmo legato a X	DISEASEORPHENOTYPICFEATURE	C580539
17962394	167	174	p.R229G	SEQUENCEVARIANT	RS137852212
17962394	236	241	FRMD7	GENEORGENEPRODUCT	90167
17962394	348	364	difetto genetico	DISEASEORPHENOTYPICFEATURE	D030342
17962394	437	445	X legato	DISEASEORPHENOTYPICFEATURE	C580539
17962394	490	493	NYS	DISEASEORPHENOTYPICFEATURE	C580539
17962394	670	675	FRMD7	GENEORGENEPRODUCT	90167
17962394	945	955	CAG repeat	SEQUENCEVARIANT	C|DUP||CAG|
17962394	995	1020	recettore degli androgeni	GENEORGENEPRODUCT	367
17962394	1136	1139	NYS	DISEASEORPHENOTYPICFEATURE	C580539
17962394	1262	1270	c.686C>G	SEQUENCEVARIANT	RS137852212
17962394	1344	1405	arginina conservata in posizione amminoacidica 229 di glicina	SEQUENCEVARIANT	RS137852212
17962394	1443	1450	p.R229G	SEQUENCEVARIANT	RS137852212
17962394	1501	1507	FRMD7 	GENEORGENEPRODUCT	90167
17962394	1887	1894	p.R229G	SEQUENCEVARIANT	RS137852212
17962394	1936	1941	FRMD7	GENEORGENEPRODUCT	90167
17962394	1996	2008	Fenotipo NYS	DISEASEORPHENOTYPICFEATURE	C580539
17962394	2135	2151	NYS legato all'X	DISEASEORPHENOTYPICFEATURE	C580539
17968299	69	74	IL-10	GENEORGENEPRODUCT	3586
17968299	115	123	pazienti	ORGANISMTAXON	9606
17968299	171	193	parodontite aggressiva	DISEASEORPHENOTYPICFEATURE	D010520
17968299	264	278	La parodontite	DISEASEORPHENOTYPICFEATURE	D010518
17968299	380	402	parodontite aggressiva	DISEASEORPHENOTYPICFEATURE	D010520
17968299	610	621	parodontite	DISEASEORPHENOTYPICFEATURE	D010518
17968299	654	659	IL-10	GENEORGENEPRODUCT	3586
17968299	785	796	parodontite	DISEASEORPHENOTYPICFEATURE	D010518
17968299	850	853	G/A	SEQUENCEVARIANT	C|SUB|G||A
17968299	930	944	IL-10 Il gene 	GENEORGENEPRODUCT	3586
17968299	1052	1057	IL-10	GENEORGENEPRODUCT	3586
17968299	1232	1237	IL-10	GENEORGENEPRODUCT	3586
17968299	1314	1336	parodontite aggressiva	DISEASEORPHENOTYPICFEATURE	D010520
17968299	1505	1527	parodontite aggressiva	DISEASEORPHENOTYPICFEATURE	D010520
17968299	2124	2146	parodontite aggressiva	DISEASEORPHENOTYPICFEATURE	D010520
17968299	2174	2182	pazienti	ORGANISMTAXON	9606
17968299	2274	2282	pazienti	ORGANISMTAXON	9606
17968299	2498	2512	 Il gene IL-10	GENEORGENEPRODUCT	3586
17968299	2574	2596	parodontite aggressiva	DISEASEORPHENOTYPICFEATURE	D010520
18046082	49	66	apolipoproteina E	GENEORGENEPRODUCT	348
18046082	117	137	arginina 150 prolina	SEQUENCEVARIANT	P|SUB| R|150|P
18046082	214	241	glomerulopatia lipoproteica	DISEASEORPHENOTYPICFEATURE	C567089
18046082	308	335	Glomerulopatia lipoproteica	DISEASEORPHENOTYPICFEATURE	C567089
18046082	380	383	LPG	DISEASEORPHENOTYPICFEATURE	C567089
18046082	466	472	trombo	DISEASEORPHENOTYPICFEATURE	D013927
18046082	547	577	capillari glomerulari dilatati	DISEASEORPHENOTYPICFEATURE	D007674
18046082	640	657	apolipoproteina E	GENEORGENEPRODUCT	348
18046082	689	693	apoE	GENEORGENEPRODUCT	348
18046082	788	792	apoE	GENEORGENEPRODUCT	348
18046082	875	878	GPL	DISEASEORPHENOTYPICFEATURE	C567089
18046082	926	929	LPG	DISEASEORPHENOTYPICFEATURE	C567089
18046082	991	995	apoE	GENEORGENEPRODUCT	348
18046082	1052	1060	pazienti	ORGANISMTAXON	9606
18046082	1158	1162	apoE	GENEORGENEPRODUCT	348
18046082	1210	1213	LPG	DISEASEORPHENOTYPICFEATURE	C567089
18046082	1284	1288	apoE	GENEORGENEPRODUCT	348
18046082	1354	1357	LPG	DISEASEORPHENOTYPICFEATURE	C567089
18046082	1386	1394	pazienti	ORGANISMTAXON	9606
18046082	1525	1529	apoE	GENEORGENEPRODUCT	348
18046082	1691	1695	apoE	GENEORGENEPRODUCT	348
18046082	1775	1778	LPG	DISEASEORPHENOTYPICFEATURE	C567089
18046082	1806	1814	pazienti	ORGANISMTAXON	9606
18046082	1934	1987	mutazione puntiforme da G a C nell'esone 4 (base 308)	SEQUENCEVARIANT	C|SUB|G|308|C
18046082	2023	2027	apoE	GENEORGENEPRODUCT	348
18046082	2071	2079	pazienti	ORGANISMTAXON	9606
18046082	2236	2283	 con il residuo di arginina nella posizione 150	SEQUENCEVARIANT	P|SUB|R|150|P
18046082	2318	2322	apoE	GENEORGENEPRODUCT	348
18046082	2356	2364	pazienti	ORGANISMTAXON	9606
18046082	2423	2427	apoE	GENEORGENEPRODUCT	348
18046082	2515	2519	apoE	GENEORGENEPRODUCT	348
18046082	2593	2604	proteinuria	DISEASEORPHENOTYPICFEATURE	D011507
18046082	2695	2699	apoE	GENEORGENEPRODUCT	348
18046082	2739	2760	arginina 150 prolina 	SEQUENCEVARIANT	P|SUB|R|150|P
18046082	2805	2809	apoE	GENEORGENEPRODUCT	348
18046082	2890	2893	LPG	DISEASEORPHENOTYPICFEATURE	C567089
18046082	2942	2946	apoE	GENEORGENEPRODUCT	348
18046082	3054	3058	apoE	GENEORGENEPRODUCT	348
18046082	3139	3145	lipidi	CHEMICALENTITY	D008055
18162529	44	70	recettore della prolattina	GENEORGENEPRODUCT	24684
18162529	113	131	acido ribonucleico	CHEMICALENTITY	D012313
18162529	173	183	prolattina	GENEORGENEPRODUCT	24683
18162529	242	260	iperprolattinemica	DISEASEORPHENOTYPICFEATURE	D006966
18162529	330	350	ormone luteinizzante	CHEMICALENTITY	D007986
18162529	395	405	estradiolo	CHEMICALENTITY	D004958
18162529	451	470	L'iperprolattinemia	DISEASEORPHENOTYPICFEATURE	D006966
18162529	581	591	prolattina	GENEORGENEPRODUCT	24683
18162529	730	747	iperprolattinemia	DISEASEORPHENOTYPICFEATURE	D006966
18162529	865	868	 LH	CHEMICALENTITY	D007986
18162529	913	922	es trogen	CHEMICALENTITY	D004967
18162529	962	964	LH	CHEMICALENTITY	D007986
18162529	1015	1032	iperprolattinemia	DISEASEORPHENOTYPICFEATURE	D006966
18162529	1090	1098	dopamina	CHEMICALENTITY	D004298
18162529	1131	1140	sulpiride	CHEMICALENTITY	D013469
18162529	1205	1207	LH	CHEMICALENTITY	D007986
18162529	1276	1282	 ratti	ORGANISMTAXON	10116
18162529	1363	1373	estradiolo	CHEMICALENTITY	D004958
18162529	1406	1415	Sulpiride	CHEMICALENTITY	D013469
18162529	1481	1489	steroide	CHEMICALENTITY	D013256
18162529	1530	1532	LH	CHEMICALENTITY	D007986
18162529	1630	1642	L'estradiolo	CHEMICALENTITY	D004958
18162529	1733	1759	recettori della prolattina	GENEORGENEPRODUCT	24684
18162529	1794	1799	PRL-R	GENEORGENEPRODUCT	24684
18162529	1878	1888	prolattina	GENEORGENEPRODUCT	24683
18162529	1950	1958	estrogen	CHEMICALENTITY	D004967
18162529	1999	2004	PRL-R	GENEORGENEPRODUCT	24684
18162529	2065	2075	prolattina	GENEORGENEPRODUCT	24683
18162529	2135	2145	estradiolo	CHEMICALENTITY	D004958
18162529	2200	2210	prolattina	GENEORGENEPRODUCT	24683
18162529	2251	2256	STAT5	GENEORGENEPRODUCT	24918
18162529	2327	2332	PRL-R	GENEORGENEPRODUCT	24684
18162529	2380	2426	soppressore della segnalazione delle citochine	GENEORGENEPRODUCT	252971,83681,89829
18162529	2467	2478	SOCS-1 e -3	GENEORGENEPRODUCT	252971,89829
18162529	2513	2516	CIS	GENEORGENEPRODUCT	83681
18162529	2579	2589	prolattina	GENEORGENEPRODUCT	24683
18162529	2654	2663	sulpiride	CHEMICALENTITY	D013469
18162529	2697	2707	estradiolo	CHEMICALENTITY	D004958
18162529	2740	2749	Sulpiride	CHEMICALENTITY	D013469
18162529	2796	2802	SOCS-1	GENEORGENEPRODUCT	252971
18162529	2944	2949	PRL-R	GENEORGENEPRODUCT	24684
18162529	2983	2989	SOCS-3	GENEORGENEPRODUCT	89829
18162529	3024	3027	CIS	GENEORGENEPRODUCT	83681
18162529	3101	3111	Estradiolo	CHEMICALENTITY	D004958
18162529	3176	3182	SOCS-3	GENEORGENEPRODUCT	89829
18162529	3218	3221	CIS	GENEORGENEPRODUCT	83681
18162529	3280	3290	estradiolo	CHEMICALENTITY	D004958
18162529	3340	3345	PRL-R	GENEORGENEPRODUCT	24684
18162529	3380	3386	SOCS-3	GENEORGENEPRODUCT	89829
18162529	3421	3424	CIS	GENEORGENEPRODUCT	83681
18162529	3572	3589	iperprolattinemia	DISEASEORPHENOTYPICFEATURE	D006966
18162529	3627	3635	steroide	CHEMICALENTITY	D013256
18162529	3729	3739	estradiolo	CHEMICALENTITY	D004958
18162529	3822	3827	PRL-R	GENEORGENEPRODUCT	24684
18162529	3902	3912	prolattina	GENEORGENEPRODUCT	24683
18308784	31	46	Ginsenoside Rg1	CHEMICALENTITY	C035054
18308784	104	137	compromissione dell'apprendimento	DISEASEORPHENOTYPICFEATURE	D007859
18308784	211	218	morfina	CHEMICALENTITY	D009020
18308784	250	255	ratti	ORGANISMTAXON	10116
18308784	289	292	Rg1	CHEMICALENTITY	C035054
18308784	330	341	ginsenoside	CHEMICALENTITY	D036145
18308784	382	395	Panax ginseng	ORGANISMTAXON	4054
18308784	463	490	disturbo dell'apprendimento	DISEASEORPHENOTYPICFEATURE	D007859
18308784	561	564	Rg1	CHEMICALENTITY	C035054
18308784	692	700	morfina 	CHEMICALENTITY	D009020
18308784	788	791	Rg1	CHEMICALENTITY	C035054
18308784	838	871	compromissione dell'apprendimento	DISEASEORPHENOTYPICFEATURE	D007859
18308784	935	942	morfina	CHEMICALENTITY	D009020
18308784	1029	1034	ratti	ORGANISMTAXON	10116
18308784	1105	1112	morfina	CHEMICALENTITY	D009020
18308784	1214	1217	Rg1	CHEMICALENTITY	C035054
18308784	1339	1346	morfina	CHEMICALENTITY	D009020
18308784	1526	1531	ratti	ORGANISMTAXON	10116
18308784	1576	1583	morfina	CHEMICALENTITY	D009020
18308784	1616	1619	Rg1	CHEMICALENTITY	C035054
18308784	1890	1893	Rg1	CHEMICALENTITY	C035054
18308784	1990	1997	morfina	CHEMICALENTITY	D009020
18308784	2030	2035	ratti	ORGANISMTAXON	10116
18308784	2171	2174	Rg1	CHEMICALENTITY	C035054
18308784	2238	2243	ratti	ORGANISMTAXON	10116
18308784	2288	2295	morfina	CHEMICALENTITY	D009020
18308784	2401	2408	morfina	CHEMICALENTITY	D009020
18308784	2440	2443	Rg1	CHEMICALENTITY	C035054
18308784	2481	2486	ratti	ORGANISMTAXON	10116
18308784	2565	2601	Recettore N-metil-D-aspartato (NMDA)	GENEORGENEPRODUCT	24408
18308784	2645	2650	MK801	CHEMICALENTITY	D016291
18308784	2699	2702	Rg1	CHEMICALENTITY	C035054
18308784	2821	2828	morfina	CHEMICALENTITY	D009020
18308784	2900	2907	morfina	CHEMICALENTITY	D009020
18308784	2966	2980	recettore NMDA	GENEORGENEPRODUCT	24408
18385794	92	96	SOX2	GENEORGENEPRODUCT	6657
18385794	133	138	CHX10	GENEORGENEPRODUCT	338917
18385794	174	182	pazienti	ORGANISMTAXON	9606
18385794	230	240	anoftalmia	DISEASEORPHENOTYPICFEATURE	D000853
18385794	284	296	microftalmia	DISEASEORPHENOTYPICFEATURE	D008850
18385794	349	353	SOX2	GENEORGENEPRODUCT	6657
18385794	390	395	CHX10	GENEORGENEPRODUCT	338917
18385794	452	460	pazienti	ORGANISMTAXON	9606
18385794	509	519	anoftalmia	DISEASEORPHENOTYPICFEATURE	D000853
18385794	567	579	microftalmia	DISEASEORPHENOTYPICFEATURE	D008850
18385794	662	673	anoftalmico	DISEASEORPHENOTYPICFEATURE	 D000853
18385794	717	730	microftalmico	DISEASEORPHENOTYPICFEATURE	D008850
18385794	758	766	paziente	ORGANISMTAXON	9606
18385794	887	891	SOX2	GENEORGENEPRODUCT	6657
18385794	927	932	CHX10	GENEORGENEPRODUCT	338917
18385794	1066	1070	SOX2	GENEORGENEPRODUCT	6657
18385794	1106	1111	CHX10	GENEORGENEPRODUCT	338917
18385794	1261	1284	I campioni del paziente	ORGANISMTAXON	9606
18385794	1429	1433	SOX2	GENEORGENEPRODUCT	6657
18385794	1469	1474	CHX10	GENEORGENEPRODUCT	338917
18385794	1561	1582	campioni del paziente	ORGANISMTAXON	9606
18385794	1740	1744	SOX2	GENEORGENEPRODUCT	6657
18385794	1794	1803	c.310 G>T	SEQUENCEVARIANT	C|SUB|G|310|T
18385794	1844	1854	p. Glu104X	SEQUENCEVARIANT	P|SUB|E|104| X
18385794	1898	1906	paziente	ORGANISMTAXON	9606
18385794	2068	2104	acido glutammico a un codone di stop	SEQUENCEVARIANT	P|SUB|E||X
18385794	2239	2248	c.549delC	SEQUENCEVARIANT	RS587776776
18385794	2286	2304	p. Pro184ArgfsX19 	SEQUENCEVARIANT	RS587776776
18385794	2631	2640	c.*557G>A	SEQUENCEVARIANT	RS77677339
18385794	2705	2713	paziente	ORGANISMTAXON	 9606
18385794	2878	2889	c. *469 C>A	SEQUENCEVARIANT	RS11915160
18385794	2930	2940	rs11915160	SEQUENCEVARIANT	RS11915160
18385794	3004	3012	pazienti	ORGANISMTAXON	9606
18385794	3063	3068	CHX10	GENEORGENEPRODUCT	338917
18385794	3155	3164	c.471 C>T	SEQUENCEVARIANT	RS35435463
18385794	3201	3212	p.Ser157Ser	SEQUENCEVARIANT	RS35435463
18385794	3249	3259	rs35435463	SEQUENCEVARIANT	RS35435463
18385794	3300	3309	c.579 G>A	SEQUENCEVARIANT	RS182972044
18385794	3347	3359	p. Gln193Gln	SEQUENCEVARIANT	RS182972044
18385794	3452	3461	c.871 G>A	SEQUENCEVARIANT	RS75395981
18385794	3498	3510	p. Asp291Asn	SEQUENCEVARIANT	RS75395981
18385794	3705	3709	SOX2	GENEORGENEPRODUCT	6657
18385794	3791	3795	SOX2	GENEORGENEPRODUCT	6657
18385794	3857	3878	malformazione oculare	DISEASEORPHENOTYPICFEATURE	D005124
18385794	3913	3918	CHX10	GENEORGENEPRODUCT	338917
18385794	3984	3996	microftalmia	DISEASEORPHENOTYPICFEATURE	D008850
18385794	4041	4051	anoftalmia	DISEASEORPHENOTYPICFEATURE	D000853
18385794	4100	4108	pazienti	ORGANISMTAXON	9606
18951540	82	90	levodopa	CHEMICALENTITY	D007980
18951540	142	153	 discinesie	DISEASEORPHENOTYPICFEATURE	D004409
18951540	200	218	Morbo di Parkinson	DISEASEORPHENOTYPICFEATURE	D010300
18951540	482	494	 discinesie 	DISEASEORPHENOTYPICFEATURE	D004409
18951540	525	533	pazienti	ORGANISMTAXON	9606
18951540	581	602	Malattia di Parkinson	DISEASEORPHENOTYPICFEATURE	D010300
18951540	647	649	PD	DISEASEORPHENOTYPICFEATURE	D010300
18951540	685	693	pazienti	ORGANISMTAXON	9606
18951540	741	743	PD	DISEASEORPHENOTYPICFEATURE	D010300
18951540	801	811	discinesie	DISEASEORPHENOTYPICFEATURE	 D004409
18951540	1280	1290	discinesia	DISEASEORPHENOTYPICFEATURE	D004409
18951540	1460	1470	discinesia	DISEASEORPHENOTYPICFEATURE	D004409
18951540	1611	1619	distonia	DISEASEORPHENOTYPICFEATURE	D004421
18951540	1679	1687	paziente	ORGANISMTAXON	9606
18951540	1799	1809	discinesia	DISEASEORPHENOTYPICFEATURE	D004409
18951540	2095	2097	PD	DISEASEORPHENOTYPICFEATURE	D010300
18951540	2296	2306	discinesie	DISEASEORPHENOTYPICFEATURE	D004409
18951540	2353	2356	 PD	DISEASEORPHENOTYPICFEATURE	D010300
19300402	31	75	Antagonisti dei recettori della bradichinina	CHEMICALENTITY	D065168
19300402	125	163	 inibitori dell'ossido nitrico sintasi	CHEMICALENTITY	C080122,C090663,D019335
19300402	198	209	vincristina	CHEMICALENTITY	D014750
19300402	243	258	streptozotocina	CHEMICALENTITY	D013311
19300402	302	313	iperalgesia	DISEASEORPHENOTYPICFEATURE	D006930
19300402	384	404	neuropatia diabetica	DISEASEORPHENOTYPICFEATURE	D003929
19300402	434	439	ratto	ORGANISMTAXON	10116
19300402	533	555	NO sintasi costitutivo	GENEORGENEPRODUCT	24600
19300402	588	595	L-NOArg	CHEMICALENTITY	D019335
19300402	684	705	NO sintasi inducibile	GENEORGENEPRODUCT	24599
19300402	738	744	L-NIL 	CHEMICALENTITY	C090663
19300402	834	854	NO sintasi neuronale	GENEORGENEPRODUCT	24598
19300402	888	892	7-NI	CHEMICALENTITY	C080122
19300402	1004	1021	recettori B2 e B1	GENEORGENEPRODUCT	25245,81509
19300402	1054	1096	D-Arg-[Hyp3,Thi5,D-Tic7,Oic8] bradichinina	CHEMICALENTITY	C065679
19300402	1129	1136	HOE 140	CHEMICALENTITY	C065679
19300402	1186	1203	des Arg10 HOE 140	CHEMICALENTITY	C078665
19300402	1303	1387	neuropatia diabetica (indotta da streptozotocina) e tossica (indotta da vincristina)	DISEASEORPHENOTYPICFEATURE	D003929,D010523
19300402	1484	1490	dolore	DISEASEORPHENOTYPICFEATURE	D010146
19300402	1742	1770	recettori della bradichinina	GENEORGENEPRODUCT	25245,81509
19300402	1805	1826	NO sintasi inducibile	GENEORGENEPRODUCT	24599
19300402	1866	1886	NO sintasi neuronale	GENEORGENEPRODUCT	24598
19300402	1956	1977	iperalgesia diabetica	DISEASEORPHENOTYPICFEATURE	D003920,D006930
19300402	2029	2036	L-NOArg	CHEMICALENTITY	D019335
19300402	2070	2075	L-NIL	CHEMICALENTITY	C090663
19300402	2115	2119	7-NI	CHEMICALENTITY	C080122
19300402	2211	2218	HOE 140	CHEMICALENTITY	C065679
19300402	2253	2270	des Arg10 HOE 140	CHEMICALENTITY	C078665
19300402	2358	2379	NO sintasi inducibile	GENEORGENEPRODUCT	24599
19300402	2414	2434	NO sintasi neuronale	GENEORGENEPRODUCT	24598
19300402	2480	2492	bradichinina	GENEORGENEPRODUCT	3827
19300402	2554	2565	iperalgesia	DISEASEORPHENOTYPICFEATURE	D006930
19300402	2610	2621	vincristina	CHEMICALENTITY	D014750
19300402	2663	2670	L-NOArg	CHEMICALENTITY	D019335
19300402	2704	2708	7-NI	CHEMICALENTITY	C080122
19300402	2748	2753	L-NIL	CHEMICALENTITY	C090663
19300402	2828	2835	HOE 140	CHEMICALENTITY	C065679
19300402	2870	2886	des-Arg10HOE 140	CHEMICALENTITY	C078665
19300402	2933	2951	neuropatia tossica	DISEASEORPHENOTYPICFEATURE	D010523
19300402	3049	3068	I recettori B1 e B2	GENEORGENEPRODUCT	25245,81509
19300402	3190	3220	neuropatia diabetica e tossica	DISEASEORPHENOTYPICFEATURE	D003929 ,D010523
19300402	3256	3271	streptozotocina	CHEMICALENTITY	D013311
19300402	3326	3337	iperalgesia	DISEASEORPHENOTYPICFEATURE	D006930
19300402	3372	3393	NO sintasi inducibile	GENEORGENEPRODUCT	 24599
19300402	3466	3478	bradichinina	GENEORGENEPRODUCT	3827
19300402	3521	3533	 vincristina	CHEMICALENTITY	D014750
19300402	3585	3596	iperalgesia	DISEASEORPHENOTYPICFEATURE	D006930
19300402	3628	3640	bradichinina	GENEORGENEPRODUCT	3827
19300402	3707	3724	Neural NO sintasi	GENEORGENEPRODUCT	24598
19300402	3816	3860	antagonisti del recettore della bradichinina	CHEMICALENTITY	D065168
19300402	3910	3936	NO inibitori della sintasi	CHEMICALENTITY	C080122,C090663,D019335
19300402	4018	4036	dolore neuropatico	DISEASEORPHENOTYPICFEATURE	D009437
19624920	43	69	Mycobacterium tuberculosis	ORGANISMTAXON	1773
19624920	212	218	MDR TB	DISEASEORPHENOTYPICFEATURE	D018088
19624920	404	410	MDR TB	DISEASEORPHENOTYPICFEATURE	D018088
19624920	618	624	MDR TB	DISEASEORPHENOTYPICFEATURE	D018088
19759529	36	59	glicina trasportatore-1	GENEORGENEPRODUCT	14664
19759529	98	108	SSR103800 	CHEMICALENTITY	NOID
19759529	202	206	topi	ORGANISMTAXON	10090
19759529	273	288	La schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
19759529	390	398	dopamina	CHEMICALENTITY	D004298
19759529	481	532	recettore N-metil-D-aspartato (NMDA) del glutammato	GENEORGENEPRODUCT	14810
19759529	586	600	schizofrenico 	DISEASEORPHENOTYPICFEATURE	D012559
19759529	645	650	umani	ORGANISMTAXON	9606
19759529	768	782	Recettore NMDA	GENEORGENEPRODUCT	14810
19759529	1025	1039	recettore NMDA	GENEORGENEPRODUCT	14810
19759529	1092	1121	trasportatore della glicina-1	GENEORGENEPRODUCT	14664
19759529	1155	1160	GlyT1	GENEORGENEPRODUCT	14664
19759529	1199	1204	GlyT1	GENEORGENEPRODUCT	14664
19759529	1315	1329	Recettore NMDA	GENEORGENEPRODUCT	14810
19759529	1385	1392	glicina	CHEMICALENTITY	D005998
19759529	1458	1472	recettore NMDA	GENEORGENEPRODUCT	14810
19759529	1689	1702	 iperattivitÃ 	DISEASEORPHENOTYPICFEATURE	D006948
19759529	1775	1785	anfetamina	CHEMICALENTITY	D000661
19759529	1819	1826	MK-801 	CHEMICALENTITY	D016291
19759529	1870	1874	topi	ORGANISMTAXON	10090
19759529	1913	1921	NMDA Nr1	GENEORGENEPRODUCT	14810
19759529	1964	1967	DAT	GENEORGENEPRODUCT	13162
19759529	2112	2124	iperattivitÃ 	DISEASEORPHENOTYPICFEATURE	D006948
19759529	2198	2212	Recettore NMDA	GENEORGENEPRODUCT	14810
19759529	2245	2251	MK-801	CHEMICALENTITY	D016291
19759529	2330	2342	iperattivitÃ 	DISEASEORPHENOTYPICFEATURE	D006948
19759529	2378	2386	NMDA Nr1	GENEORGENEPRODUCT	14810
19759529	2424	2428	topi	ORGANISMTAXON	10090
19759529	2551	2563	iperattivitÃ 	DISEASEORPHENOTYPICFEATURE	D006948
19759529	2607	2617	anfetamina	CHEMICALENTITY	D000661
19759529	2678	2703	trasportatore di dopamina	GENEORGENEPRODUCT	13162
19759529	2738	2741	DAT	GENEORGENEPRODUCT	13162
19759529	2785	2789	topi	ORGANISMTAXON	10090
19759529	2885	2896	aloperidolo	CHEMICALENTITY	D006220
19759529	2942	2952	olanzapina	CHEMICALENTITY	C076029
19759529	2986	2995	clozapina	CHEMICALENTITY	D003024
19759529	3029	3041	aripiprazolo	CHEMICALENTITY	C094645
19759529	3146	3158	iperattivitÃ 	DISEASEORPHENOTYPICFEATURE	D006948
19759529	3295	3305	catalessia	DISEASEORPHENOTYPICFEATURE	D002375
19759529	3434	3439	GlyT1	GENEORGENEPRODUCT	14664
19759529	3643	3656	dopaminergico	CHEMICALENTITY	D004298
19880293	54	59	FOXP3	GENEORGENEPRODUCT	50943
19880293	117	126	 psoriasi	DISEASEORPHENOTYPICFEATURE	D011565
19880293	154	162	pazienti	ORGANISMTAXON	9606
19880293	219	227	Psoriasi	DISEASEORPHENOTYPICFEATURE	D011565
19880293	283	305	disturbo dermatologico	DISEASEORPHENOTYPICFEATURE	D012871
19880293	392	395	CD4	GENEORGENEPRODUCT	920
19880293	429	433	CD25	GENEORGENEPRODUCT	3559
19880293	577	596	malattie autoimmuni	DISEASEORPHENOTYPICFEATURE	D001327
19880293	709	714	FOXP3	GENEORGENEPRODUCT	50943
19880293	919	924	FOXP3	GENEORGENEPRODUCT	50943
19880293	1013	1034	disordini autoimmuni 	DISEASEORPHENOTYPICFEATURE	D001327
19880293	1103	1108	FOXP3	GENEORGENEPRODUCT	50943
19880293	1161	1169	psoriasi	DISEASEORPHENOTYPICFEATURE	D011565
19880293	1273	1278	FOXP3	GENEORGENEPRODUCT	50943
19880293	1351	1359	psoriasi	DISEASEORPHENOTYPICFEATURE	D011565
19880293	1472	1480	pazienti	ORGANISMTAXON	9606
19880293	1528	1536	psoriasi	DISEASEORPHENOTYPICFEATURE	D011565
19880293	1586	1594	psoriasi	DISEASEORPHENOTYPICFEATURE	D011565
19880293	1731	1736	FOXP3	GENEORGENEPRODUCT	50943
19880293	2014	2024	psoriasica	DISEASEORPHENOTYPICFEATURE	D011565
19880293	2052	2060	pazienti	ORGANISMTAXON	9606
19880293	2156	2166	psoriasico	DISEASEORPHENOTYPICFEATURE	D011565
19880293	2194	2202	pazienti	ORGANISMTAXON	9606
19880293	2576	2584	psoriasi	DISEASEORPHENOTYPICFEATURE	D011565
19880293	2634	2639	FOXP3	GENEORGENEPRODUCT	50943
19880293	2986	2994	psoriasi	DISEASEORPHENOTYPICFEATURE	D011565
19880293	3044	3049	FOXP3	GENEORGENEPRODUCT	50943
19880293	3452	3457	FOXP3	GENEORGENEPRODUCT	50943
19880293	3542	3547	FOXP3	GENEORGENEPRODUCT	50943
19880293	3678	3683	FOXP3	GENEORGENEPRODUCT	50943
19880293	3873	3881	psoriasi	DISEASEORPHENOTYPICFEATURE	D011565
19880293	3910	3918	pazienti	ORGANISMTAXON	9606
19880293	4029	4034	FOXP3	GENEORGENEPRODUCT	50943
19880293	4172	4180	psoriasi	DISEASEORPHENOTYPICFEATURE	D011565
19880293	4208	4216	pazienti	ORGANISMTAXON	9606
19880293	4302	4307	FOXP3	GENEORGENEPRODUCT	50943
19880293	4401	4409	psoriasi	DISEASEORPHENOTYPICFEATURE	D011565
19914299	31	41	Fluoxetina	CHEMICALENTITY	D005473
19914299	97	115	deficit di memoria	DISEASEORPHENOTYPICFEATURE	D008569
19914299	182	197	5-fluorouracile	CHEMICALENTITY	D005472
19914299	242	248	Cancro	DISEASEORPHENOTYPICFEATURE	D009369
19914299	276	284	pazienti	ORGANISMTAXON	9606
19914299	477	492	5-fluorouracile	CHEMICALENTITY	D005472
19914299	525	529	5-FU	CHEMICALENTITY	D005472
19914299	948	952	SSRI	CHEMICALENTITY	D017367
19914299	984	994	fluoxetina	CHEMICALENTITY	D005473
19914299	1118	1122	5-FU	CHEMICALENTITY	D005472
19914299	1177	1187	Fluoxetina	CHEMICALENTITY	D005473
19914299	1261	1265	5-FU	CHEMICALENTITY	D005472
19914299	1339	1344	ratti	ORGANISMTAXON	10116
19914299	1552	1556	5-FU	CHEMICALENTITY	D005472
19914299	1888	1892	5-FU	CHEMICALENTITY	D005472
19914299	2035	2045	Fluoxetina	CHEMICALENTITY	D005473
19914299	2110	2114	5-FU	CHEMICALENTITY	D005472
19914299	2340	2350	fluoxetina	CHEMICALENTITY	D005473
19914299	2411	2415	5-FU	CHEMICALENTITY	D005472
19914299	2448	2461	La fluoxetina	CHEMICALENTITY	D005473
19914299	2621	2625	5-FU	CHEMICALENTITY	D005472
19914299	2870	2880	Fluoxetina	CHEMICALENTITY	D005473
20126413	130	135	umano	ORGANISMTAXON	 9606
20126413	179	185	cancro	DISEASEORPHENOTYPICFEATURE	D009369
20126413	322	340	glioma di grado IV	DISEASEORPHENOTYPICFEATURE	D005909
20126413	596	602	cancer	DISEASEORPHENOTYPICFEATURE	D009369
20126413	1505	1509	PTEN	GENEORGENEPRODUCT	5728
20126413	2109	2115	cancro	DISEASEORPHENOTYPICFEATURE	D009369
20126413	2634	2640	cancro	DISEASEORPHENOTYPICFEATURE	D009369
20143913	83	98	arilsolfatasi B	GENEORGENEPRODUCT	411
20143913	182	209	mucopolisaccaridosi tipo VI	DISEASEORPHENOTYPICFEATURE	D009087
20143913	237	245	paziente	ORGANISMTAXON	9606
20143913	322	329	p.R315X	SEQUENCEVARIANT	P|SUB|R|315|X
20143913	386	402	 arilsolfatasi B	GENEORGENEPRODUCT	411
20143913	434	438	ARSB	GENEORGENEPRODUCT	411
20143913	494	521	mucopolisaccaridosi tipo VI	DISEASEORPHENOTYPICFEATURE	D009087
20143913	549	557	paziente	ORGANISMTAXON	9606
20143913	669	677	Paziente	ORGANISMTAXON	9606
20143913	769	773	ARSB	GENEORGENEPRODUCT	411
20143913	1141	1145	ARSB	GENEORGENEPRODUCT	411
20195852	54	64	nefropatia	DISEASEORPHENOTYPICFEATURE	D007674
20195852	115	141	contrasto non ionico media	CHEMICALENTITY	D003287
20195852	278	296	mezzi di contrasto	CHEMICALENTITY	D003287
20195852	351	361	nefropatia	DISEASEORPHENOTYPICFEATURE	D007674
20195852	407	410	CIN	DISEASEORPHENOTYPICFEATURE	D007674
20195852	415	423	pazienti	ORGANISMTAXON	9606
20195852	481	489	pazienti	ORGANISMTAXON	9606
20195852	817	820	CIN	DISEASEORPHENOTYPICFEATURE	D007674
20195852	860	889	mezzi di contrasto non ionici	CHEMICALENTITY	D003287
20195852	923	925	CM	CHEMICALENTITY	D003287
20195852	959	968	iopromide	CHEMICALENTITY	C038192
20195852	1003	1010	iohexol	CHEMICALENTITY	D007472
20195852	1045	1053	pazienti	ORGANISMTAXON	9606
20195852	1194	1196	CM	CHEMICALENTITY	D003287
20195852	1257	1264	cianosi	DISEASEORPHENOTYPICFEATURE	D003490
20195852	1300	1308	pazienti	ORGANISMTAXON	9606
20195852	1385	1394	iopromide	CHEMICALENTITY	C038192
20195852	1447	1454	ioesolo	CHEMICALENTITY	D007472
20195852	1512	1517	sodio	CHEMICALENTITY	D012964
20195852	1550	1552	Na	CHEMICALENTITY	D012964
20195852	1587	1595	potassio	CHEMICALENTITY	 D011188
20195852	1628	1629	K	CHEMICALENTITY	D011188
20195852	1664	1674	creatinina	CHEMICALENTITY	D003404
20195852	1707	1709	Cr	CHEMICALENTITY	D003404
20195852	1872	1874	CM	CHEMICALENTITY	D003287
20195852	1941	1943	Na	CHEMICALENTITY	D012964
20195852	1977	1979	Cr	CHEMICALENTITY	D003404
20195852	2081	2101	insufficienza renale	DISEASEORPHENOTYPICFEATURE	D051437
20195852	2146	2159	Danno al rene	DISEASEORPHENOTYPICFEATURE	D058186
20195852	2205	2240	Insufficienza della funzione renale	DISEASEORPHENOTYPICFEATURE	D051437
20195852	2285	2314	Perdita della funzione renale	DISEASEORPHENOTYPICFEATURE	D051437
20195852	2378	2390	danno renale	DISEASEORPHENOTYPICFEATURE	D007674
20195852	2485	2488	CIN	DISEASEORPHENOTYPICFEATURE	D007674
20195852	2609	2612	CIN	DISEASEORPHENOTYPICFEATURE	D007674
20195852	2640	2648	pazienti	ORGANISMTAXON	9606
20195852	2695	2703	pazienti	ORGANISMTAXON	9606
20195852	2809	2821	danno renale	DISEASEORPHENOTYPICFEATURE	D058186
20195852	2940	2954	lesione renale	DISEASEORPHENOTYPICFEATURE	D058186
20195852	3013	3021	pazienti	ORGANISMTAXON	9606
20195852	3069	3072	CIN	DISEASEORPHENOTYPICFEATURE	D007674
20195852	3164	3166	CM	CHEMICALENTITY	D003287
20195852	3344	3347	CIN	DISEASEORPHENOTYPICFEATURE	D007674
20195852	3410	3412	CM	CHEMICALENTITY	D003287
20195852	3462	3470	pazienti	ORGANISMTAXON	9606
20195852	3518	3521	CIN	DISEASEORPHENOTYPICFEATURE	D007674
20195852	3594	3622	malattie cardiache congenite	DISEASEORPHENOTYPICFEATURE	D006331
20195852	3715	3723	pazienti	ORGANISMTAXON	9606
20195852	3825	3828	CIN	DISEASEORPHENOTYPICFEATURE	D007674
20195852	3956	3958	CM	CHEMICALENTITY	D003287
20195852	4024	4031	cianosi	DISEASEORPHENOTYPICFEATURE	D003490
20195852	4086	4089	CIN	DISEASEORPHENOTYPICFEATURE	D007674
20540798	74	92	fosfodiesterasi 4D	GENEORGENEPRODUCT	5144
20540798	126	131	PDE4D	GENEORGENEPRODUCT	5144
20540798	179	202	aterosclerosi carotidea	DISEASEORPHENOTYPICFEATURE	D002340
20540798	255	273	fosfodiesterasi 4D	GENEORGENEPRODUCT	5144
20540798	306	311	PDE4D	GENEORGENEPRODUCT	5144
20540798	402	407	ictus	DISEASEORPHENOTYPICFEATURE	D020521
20540798	536	545	aterogeno	DISEASEORPHENOTYPICFEATURE	D050197
20540798	779	792	aterosclerosi	DISEASEORPHENOTYPICFEATURE	D050197
20540798	921	926	ictus	DISEASEORPHENOTYPICFEATURE	D020521
20540798	1040	1046	uomini	ORGANISMTAXON	9606
20540798	1486	1492	uomini	ORGANISMTAXON	9606
20540798	1522	1527	donne	ORGANISMTAXON	9606
20540798	1651	1659	Rs702553	SEQUENCEVARIANT	RS702553
20540798	1699	1704	PDE4D	GENEORGENEPRODUCT	5144
20540798	1810	1815	ictus	DISEASEORPHENOTYPICFEATURE	D020521
20540798	1909	1914	ictus	DISEASEORPHENOTYPICFEATURE	D020521
20540798	2166	2174	rs702553	SEQUENCEVARIANT	RS702553
20540798	2366	2372	uomini	ORGANISMTAXON	9606
20540798	2410	2415	donne	ORGANISMTAXON	9606
20540798	2639	2645	uomini	ORGANISMTAXON	9606
20540798	2816	2821	donne	ORGANISMTAXON	9606
20540798	2905	2913	rs702553	SEQUENCEVARIANT	RS702553
20540798	2970	2978	rs702553	SEQUENCEVARIANT	RS702553
20540798	3057	3062	ictus	DISEASEORPHENOTYPICFEATURE	D020521
20540798	3091	3097	uomini	ORGANISMTAXON	9606
20540798	3157	3162	donne	ORGANISMTAXON	9606
20540798	3282	3287	PDE4D	GENEORGENEPRODUCT	5144
20540798	3358	3363	ictus	DISEASEORPHENOTYPICFEATURE	D020521
20540798	3458	3469	aterogenesi	DISEASEORPHENOTYPICFEATURE	D050197
20621845	46	52	ADAM10	GENEORGENEPRODUCT	29650
20621845	86	92	ADAM17	GENEORGENEPRODUCT	57027
20621845	126	131	MMP-2	GENEORGENEPRODUCT	81686
20621845	166	171	MMP-9	GENEORGENEPRODUCT	81687
20621845	262	267	CaCl2	CHEMICALENTITY	D002122
20621845	319	348	aneurisma dell'aorta toracica	DISEASEORPHENOTYPICFEATURE	D017545
20621845	388	391	rat	ORGANISMTAXON	10116
20621845	494	497	rat	ORGANISMTAXON	10116
20621845	544	573	aneurisma dell'aorta toracica	DISEASEORPHENOTYPICFEATURE	D017545
20621845	618	621	TAA	DISEASEORPHENOTYPICFEATURE	D017545
20621845	657	674	cloruro di calcio	CHEMICALENTITY	D002122
20621845	709	716	CaCl(2)	CHEMICALENTITY	D002122
20621845	772	787	danno arterioso	DISEASEORPHENOTYPICFEATURE	D014652
20621845	863	899	una disintegrina e metalloproteinasi	GENEORGENEPRODUCT	29650,57027
20621845	939	943	ADAM	GENEORGENEPRODUCT	29650,57027
20621845	985	1013	metalloproteinasi di matrice	GENEORGENEPRODUCT	81686,81687
20621845	1053	1056	MMP	GENEORGENEPRODUCT	81686,81687
20621845	1139	1142	TAA	DISEASEORPHENOTYPICFEATURE	D017545
20621845	1235	1240	ratti	ORGANISMTAXON	10116
20621845	1295	1302	CaCl(2)	CHEMICALENTITY	D002122
20621845	1359	1363	NaCl	CHEMICALENTITY	D012965
20621845	1464	1471	CaCl(2)	CHEMICALENTITY	D002122
20621845	1513	1520	CaCl(2)	CHEMICALENTITY	D002122
20621845	1574	1578	NaCl	CHEMICALENTITY	D012965
20621845	1712	1715	MMP	GENEORGENEPRODUCT	81686,81687
20621845	1749	1753	TIMP	GENEORGENEPRODUCT	116510
20621845	1795	1799	ADAM	GENEORGENEPRODUCT	 29650,57027
20621845	2012	2019	CaCl(2)	CHEMICALENTITY	D002122
20621845	2065	2072	CaCl(2)	CHEMICALENTITY	D002122
20621845	2141	2145	NaCl	CHEMICALENTITY	D012965
20621845	2402	2409	CaCl(2)	CHEMICALENTITY	D002122
20621845	2443	2448	MMP-2	GENEORGENEPRODUCT	81686
20621845	2482	2487	MMP-9	GENEORGENEPRODUCT	81687
20621845	2522	2529	ADAM-10	GENEORGENEPRODUCT	29650
20621845	2564	2571	ADAM-17	GENEORGENEPRODUCT	57027
20621845	2646	2675	Segmenti trattati con CaCl(2)	CHEMICALENTITY	 D002122
20621845	2750	2757	CaCl(2)	CHEMICALENTITY	D002122
20621845	2823	2827	NaCl	CHEMICALENTITY	D012965
20621845	2957	2962	MMP-2	GENEORGENEPRODUCT	81686
20621845	2996	3001	MMP-9	GENEORGENEPRODUCT	81687
20621845	3035	3042	ADAM-10	GENEORGENEPRODUCT	29650
20621845	3077	3084	ADAM-17	GENEORGENEPRODUCT	57027
20621845	3178	3185	CaCl(2)	CHEMICALENTITY	D002122
20621845	3220	3224	TIMP	GENEORGENEPRODUCT	116510
20621845	3403	3406	TAA	DISEASEORPHENOTYPICFEATURE	D017545
20621845	3442	3449	CaCl(2)	CHEMICALENTITY	D002122
20621845	3507	3512	ratti	ORGANISMTAXON	10116
20621845	3605	3610	MMP-2	GENEORGENEPRODUCT	81686
20621845	3644	3649	MMP-9	GENEORGENEPRODUCT	81687
20621845	3683	3689	ADAM10	GENEORGENEPRODUCT	29650
20621845	3725	3731	ADAM17	GENEORGENEPRODUCT	57027
20682662	59	91	C-C recettore 5 delle chemochine	GENEORGENEPRODUCT	1234
20682662	127	141	Delezione DD32	SEQUENCEVARIANT	C| DEL||32
20682662	195	213	artrite reumatoide	DISEASEORPHENOTYPICFEATURE	D001172
20682662	258	285	lupus sistemico eritematoso	DISEASEORPHENOTYPICFEATURE	D008180
20682662	330	343	lupus nefrite	DISEASEORPHENOTYPICFEATURE	D008181
20682662	412	446	Il recettore 5 delle chemochine CC	GENEORGENEPRODUCT	1234
20682662	479	483	CCR5	GENEORGENEPRODUCT	1234
20682662	558	571	infiammazione	DISEASEORPHENOTYPICFEATURE	D007249
20682662	609	652	32 eliminazione della coppia di basi (DD32)	SEQUENCEVARIANT	C|DEL||32
20682662	688	692	CCR5	GENEORGENEPRODUCT	1234
20682662	889	908	malattie autoimmuni	DISEASEORPHENOTYPICFEATURE	D001327
20682662	967	981	delezione DD32	SEQUENCEVARIANT	C|DEL||32
20682662	1077	1085	pazienti	ORGANISMTAXON	9606
20682662	1133	1151	artrite reumatoide	DISEASEORPHENOTYPICFEATURE	D001172
20682662	1196	1198	RA	DISEASEORPHENOTYPICFEATURE	D001172
20682662	1244	1271	lupus eritematoso sistemico	DISEASEORPHENOTYPICFEATURE	D008180
20682662	1316	1319	LES	DISEASEORPHENOTYPICFEATURE	D008180
20682662	1366	1382	nefrite da lupus	DISEASEORPHENOTYPICFEATURE	D008181
20682662	1427	1429	LN	DISEASEORPHENOTYPICFEATURE	D008181
20682662	1552	1554	RA	DISEASEORPHENOTYPICFEATURE	D001172
20682662	1582	1590	pazienti	ORGANISMTAXON	9606
20682662	1638	1641	LES	DISEASEORPHENOTYPICFEATURE	D008180
20682662	1669	1677	pazienti	ORGANISMTAXON	9606
20682662	1726	1728	LN	DISEASEORPHENOTYPICFEATURE	D008181
20682662	1756	1764	pazienti	ORGANISMTAXON	9606
20682662	1846	1850	CCR5	GENEORGENEPRODUCT	1234
20682662	1885	1902	Eliminazione DD32	SEQUENCEVARIANT	C|DEL||32
20682662	1996	2004	pazienti	ORGANISMTAXON	9606
20682662	2244	2252	pazienti	ORGANISMTAXON	9606
20682662	2334	2338	CCR5	GENEORGENEPRODUCT	1234
20682662	2374	2378	DD32	SEQUENCEVARIANT	C|DEL||32
20682662	2414	2418	DD32	SEQUENCEVARIANT	C|DEL||32
20682662	2454	2458	DD32	SEQUENCEVARIANT	C|DEL||32
20682662	2503	2505	RA	DISEASEORPHENOTYPICFEATURE	D001172
20682662	2580	2583	LES	DISEASEORPHENOTYPICFEATURE	D008180
20682662	2641	2643	LN	DISEASEORPHENOTYPICFEATURE	D008181
20682662	2784	2788	DD32	SEQUENCEVARIANT	C|DEL||32
20682662	2835	2837	LN	DISEASEORPHENOTYPICFEATURE	D008181
20682662	2865	2873	pazienti	ORGANISMTAXON	9606
20682662	2997	3001	CCR5	GENEORGENEPRODUCT	1234
20682662	3076	3078	RA	DISEASEORPHENOTYPICFEATURE	D001172
20682662	3124	3127	LES	DISEASEORPHENOTYPICFEATURE	D008180
20682662	3173	3175	LN	DISEASEORPHENOTYPICFEATURE	D008181
20682662	3261	3263	LN	DISEASEORPHENOTYPICFEATURE	D008181
20682662	3324	3328	CCR5	GENEORGENEPRODUCT	1234
20682662	3364	3378	Delezione DD32	SEQUENCEVARIANT	C|DEL||32
20682662	3488	3490	RA	DISEASEORPHENOTYPICFEATURE	D001172
20682662	3535	3538	LES	DISEASEORPHENOTYPICFEATURE	D008180
20682662	3584	3586	LN	DISEASEORPHENOTYPICFEATURE	D008181
20682662	3689	3693	DD32	SEQUENCEVARIANT	C|DEL||32
20801540	56	61	ferro	CHEMICALENTITY	D007501
20801540	126	137	deferasirox	CHEMICALENTITY	D000077588
20801540	184	202	aceruloplasminemia	DISEASEORPHENOTYPICFEATURE	C536004
20801540	311	329	Aceruloplasminemia	DISEASEORPHENOTYPICFEATURE	C536004
20801540	384	431	malattia neurodegenerativa autosomica recessiva	DISEASEORPHENOTYPICFEATURE	D020271
20801540	482	487	ferro	CHEMICALENTITY	D007501
20801540	570	592	disturbi del movimento	DISEASEORPHENOTYPICFEATURE	D009069
20801540	638	660	degenerazione retinica	DISEASEORPHENOTYPICFEATURE	D012162
20801540	706	721	diabete mellito	DISEASEORPHENOTYPICFEATURE	D003920
20801540	754	768	Ceruloplasmina	GENEORGENEPRODUCT	1356
20801540	919	924	ferro	CHEMICALENTITY	D007501
20801540	958	963	ferro	CHEMICALENTITY	D007501
20801540	1008	1021	trasferimento	GENEORGENEPRODUCT	7018
20801540	1104	1118	ceruloplasmina	GENEORGENEPRODUCT	1356
20801540	1253	1271	aceruloplasminemia	DISEASEORPHENOTYPICFEATURE	C536004
20801540	1370	1392	disturbi del movimento	DISEASEORPHENOTYPICFEATURE	D009069
20801540	1438	1445	diabete	DISEASEORPHENOTYPICFEATURE	D003920
20801540	1749	1757	pazienti	ORGANISMTAXON	9606
20801540	1860	1878	Aceruloplasminemia	DISEASEORPHENOTYPICFEATURE	C536004
20801540	1966	1987	sovraccarico di ferro	DISEASEORPHENOTYPICFEATURE	D019190
20801540	2064	2069	ferro	CHEMICALENTITY	D007501
20801540	2102	2110	epcidina	GENEORGENEPRODUCT	57817
20801540	2200	2221	sovraccarico di ferro	DISEASEORPHENOTYPICFEATURE	D019190
20801540	2277	2282	ferro	CHEMICALENTITY	D007501
20801540	2346	2351	ferro	CHEMICALENTITY	D007501
20801540	2404	2409	ferro	CHEMICALENTITY	D007501
20801540	2444	2455	deferasirox	CHEMICALENTITY	D000077588
20801540	2539	2547	insulina	GENEORGENEPRODUCT	3630
20801540	2709	2730	sovraccarico di ferro	DISEASEORPHENOTYPICFEATURE	D019190
20801540	2788	2806	Aceruloplasminemia	DISEASEORPHENOTYPICFEATURE	C536004
20801540	2918	2923	ferro	CHEMICALENTITY	D007501
20801540	2991	2996	Ferro	CHEMICALENTITY	D007501
20801540	3052	3070	aceruloplasminemia	DISEASEORPHENOTYPICFEATURE	C536004
20801540	3142	3147	ferro	CHEMICALENTITY	D007501
20801540	3220	3227	epcidin	GENEORGENEPRODUCT	57817
20801540	3302	3323	sovraccarico di ferro	DISEASEORPHENOTYPICFEATURE	D019190
20801540	3356	3361	Ferro	CHEMICALENTITY	D007501
20801540	3411	3422	deferasirox	CHEMICALENTITY	D000077588
20801540	3500	3505	ferro	CHEMICALENTITY	D007501
20801540	3568	3573	ferro	CHEMICALENTITY	D007501
20859899	43	50	Sincope	DISEASEORPHENOTYPICFEATURE	D013575
20859899	105	117	iperkaliemia	DISEASEORPHENOTYPICFEATURE	D006947
20859899	192	246	inibitore dell'enzima di conversione dell'angiotensina	CHEMICALENTITY	D000806
20859899	280	294	spironolattone	CHEMICALENTITY	D013148
20859899	328	333	donna	ORGANISMTAXON	9606
20859899	437	458	infarto del miocardio	DISEASEORPHENOTYPICFEATURE	D009203
20859899	544	564	perdita di coscienza	DISEASEORPHENOTYPICFEATURE	D014474
20859899	625	636	bradicardia	DISEASEORPHENOTYPICFEATURE	D001919
20859899	691	703	iperkaliemia	DISEASEORPHENOTYPICFEATURE	D006947
20859899	765	773	potassio	CHEMICALENTITY	D011188
20859899	895	903	potassio	CHEMICALENTITY	D011188
20859899	968	980	iperkaliemia	DISEASEORPHENOTYPICFEATURE	D006947
20859899	1055	1069	spiranolattone	CHEMICALENTITY	D013148
20859899	1105	1116	aldosterone	CHEMICALENTITY	D000450
20859899	1201	1209	ramipril	CHEMICALENTITY	D017257
20859899	1245	1248	ACE	GENEORGENEPRODUCT	1636
20859899	1467	1479	iperkaliemia	DISEASEORPHENOTYPICFEATURE	D006947
20859899	1525	1533	pazienti	ORGANISMTAXON	9606
20859899	1585	1588	ACE	GENEORGENEPRODUCT	1636
20859899	1620	1623	ARB	CHEMICALENTITY	D057911
20859899	1676	1684	potassio	CHEMICALENTITY	D011188
20859899	1779	1794	disturbi renali	DISEASEORPHENOTYPICFEATURE	D007674
20959502	74	85	daptomicina	CHEMICALENTITY	D017576
20959502	127	148	Staphylococcus aureus	ORGANISMTAXON	 1280
20959502	192	201	meningite	DISEASEORPHENOTYPICFEATURE	D008581
20959502	265	277	meticillina 	CHEMICALENTITY	D008712
20959502	315	336	Staphylococcus aureus	ORGANISMTAXON	1280
20959502	387	398	batteriemia	DISEASEORPHENOTYPICFEATURE	D016470
20959502	460	469	meningite	DISEASEORPHENOTYPICFEATURE	D008581
20959502	514	525	daptomicina	CHEMICALENTITY	D017576
20959502	743	752	debolezza	DISEASEORPHENOTYPICFEATURE	D018908
20959502	815	824	polmonite	DISEASEORPHENOTYPICFEATURE	D011014
20959502	953	964	vancomicina	CHEMICALENTITY	D014640
20959502	997	1010	levofloxacina	CHEMICALENTITY	D064704
20959502	1049	1073	piperacillina/tazobactam	CHEMICALENTITY	D000077725
20959502	1131	1140	S. aureus	ORGANISMTAXON	1280
20959502	1184	1194	oxacillina	CHEMICALENTITY	D010068
20959502	1251	1262	antibiotico	CHEMICALENTITY	D000900
20959502	1312	1322	nafcillina	CHEMICALENTITY	D009254
20959502	1380	1388	paziente	ORGANISMTAXON	9606
20959502	1446	1472	insufficienza renale acuta	DISEASEORPHENOTYPICFEATURE	D058186
20959502	1512	1522	creatinina	CHEMICALENTITY	D003404
20959502	1661	1669	paziente	ORGANISMTAXON	9606
20959502	1723	1727	Coma	DISEASEORPHENOTYPICFEATURE	D003128
20959502	1892	1908	arresto cardiaco	DISEASEORPHENOTYPICFEATURE	D006323
20959502	1953	1961	paziente	ORGANISMTAXON	9606
20959502	2038	2049	batteriemia	DISEASEORPHENOTYPICFEATURE	D016470
20959502	2135	2179	nervoso centrale infezione del sistema (SNC)	DISEASEORPHENOTYPICFEATURE	D002494
20959502	2212	2222	Nafcillina	CHEMICALENTITY	D009254
20959502	2275	2286	daptomicina	CHEMICALENTITY	D017576
20959502	2378	2387	meningite	DISEASEORPHENOTYPICFEATURE	D008581
20959502	2454	2462	paziente	ORGANISMTAXON	9606
20959502	2507	2512	morte	DISEASEORPHENOTYPICFEATURE	D003643
20959502	2558	2597	Le concentrazioni minime di daptomicina	CHEMICALENTITY	D017576
20959502	2859	2886	I livelli di creatinchinasi	GENEORGENEPRODUCT	1152
20959502	2956	2967	daptomicina	CHEMICALENTITY	D017576
20959502	3041	3051	Daptomycin	CHEMICALENTITY	D017576
20959502	3107	3115	paziente	ORGANISMTAXON	9606
20959502	3176	3186	nafcillina	CHEMICALENTITY	D009254
20959502	3244	3265	nefrite interstiziale	DISEASEORPHENOTYPICFEATURE	D009395
20959502	3324	3335	batteriemia	DISEASEORPHENOTYPICFEATURE	D016470
20959502	3536	3547	daptomicina	CHEMICALENTITY	D017576
20959502	3638	3649	batteriemia	DISEASEORPHENOTYPICFEATURE	D016470
20959502	3709	3717	pazienti	ORGANISMTAXON	9606
20959502	3859	3867	pazienti	ORGANISMTAXON	9606
20959502	3915	3924	meningite	DISEASEORPHENOTYPICFEATURE	D008581
21042587	41	70	recettore dei glucocorticoidi	GENEORGENEPRODUCT	2908
21042587	181	201	iperplasia surrenale	DISEASEORPHENOTYPICFEATURE	D000312
21042587	247	285	eccesso apparente di mineralcorticoidi	DISEASEORPHENOTYPICFEATURE	C537422
21042587	338	368	resistenza ai glucocorticoidi 	DISEASEORPHENOTYPICFEATURE	C564221
21042587	417	428	OMIM 138040	DISEASEORPHENOTYPICFEATURE	OMIM:138040
21042587	484	503	malattia ereditaria	DISEASEORPHENOTYPICFEATURE	D030342
21042587	599	614	glucocorticoide	CHEMICALENTITY	D005938
21042587	683	708	glucocorticoide recettore	GENEORGENEPRODUCT	2908
21042587	741	743	GR	GENEORGENEPRODUCT	2908
21042587	800	827	alomi incidentali surrenali	DISEASEORPHENOTYPICFEATURE	C538238
21042587	967	990	resistenza al cortisolo	DISEASEORPHENOTYPICFEATURE	C535280
21042587	1035	1068	iperplasia surrenalica bilaterale	DISEASEORPHENOTYPICFEATURE	D000312
21042587	1123	1136	 ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
21042587	1182	1193	ipokaliemia	DISEASEORPHENOTYPICFEATURE	D007008
21042587	1328	1339	p.R469[R,X]	SEQUENCEVARIANT	P|SUB|R|469|X
21042587	1401	1403	GR	GENEORGENEPRODUCT	2908
21042587	1458	1512	arginina (CGA) con uno stop ( TGA) all'amminoacido 469	SEQUENCEVARIANT	P|SUB|R|469|X
21042587	1652	1654	GR	GENEORGENEPRODUCT	2908
21042587	1986	1988	GR	GENEORGENEPRODUCT	2908
21042587	2085	2087	GR	GENEORGENEPRODUCT	2908
21042587	2174	2176	GR	GENEORGENEPRODUCT	2908
21042587	2272	2287	glucocorticoide	CHEMICALENTITY	D005938
21042587	2344	2349	FKBP5	GENEORGENEPRODUCT	2289
21042587	2448	2463	glucocorticoide	CHEMICALENTITY	D005938
21042587	2535	2537	GR	GENEORGENEPRODUCT	2908
21042587	2637	2639	GR	GENEORGENEPRODUCT	2908
21042587	2775	2783	emetina 	CHEMICALENTITY	D004640
21042587	2851	2853	GR	GENEORGENEPRODUCT	2908
21042587	2923	2935	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
21042587	3006	3037	recettore dei mineralcorticoidi	GENEORGENEPRODUCT	4306
21042587	3075	3084	cortisolo	CHEMICALENTITY	D006854
21042587	3148	3166	mineralocorticoide	CHEMICALENTITY	 D008901
21042587	3234	3263	resistenza ai glucocorticoidi	DISEASEORPHENOTYPICFEATURE	C564221
21042587	3317	3355	apparente eccesso di mineralcorticoidi	DISEASEORPHENOTYPICFEATURE	C537422
21042587	3429	3447	tetraidrocortisone	CHEMICALENTITY	D013761
21042587	3480	3498	tetraidrocortisolo	CHEMICALENTITY	D013760
21042587	3539	3547	pazienti	ORGANISMTAXON	9606
21042587	3608	3623	glucocorticoide	CHEMICALENTITY	D005938
21042587	3694	3733	11b-idrossisteroide deidrogenasi tipo 2	GENEORGENEPRODUCT	3291
21042587	3769	3771	GR	GENEORGENEPRODUCT	2908
21042587	3840	3842	GR	GENEORGENEPRODUCT	2908
21042587	3904	3919	glucocorticoide	CHEMICALENTITY	D005938
21042587	4026	4042	ipercortisolismo	DISEASEORPHENOTYPICFEATURE	D003480
21042587	4112	4145	iperplasia surrenalica bilaterale	DISEASEORPHENOTYPICFEATURE	D000312
21042587	4180	4198	mineralocorticoide	CHEMICALENTITY	D008901
21042587	4255	4267	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
21054465	54	60	CYP2C8	GENEORGENEPRODUCT	1558
21054465	107	118	ipertensivo	DISEASEORPHENOTYPICFEATURE	D006973
21054465	146	154	pazienti	ORGANISMTAXON	9606
21054465	281	287	CYP2C8	GENEORGENEPRODUCT	1558
21054465	337	370	citocromo P450 (CYP) epossigenasi	GENEORGENEPRODUCT	1558
21054465	412	430	Acido arachidonico	CHEMICALENTITY	D016718
21054465	640	652	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
21054465	798	804	CYP2C8	GENEORGENEPRODUCT	1558
21054465	967	978	ipertensivo	DISEASEORPHENOTYPICFEATURE	D006973
21054465	1006	1014	pazienti	ORGANISMTAXON	9606
21054465	1109	1115	CYP2C8	GENEORGENEPRODUCT	1558
21054465	1200	1206	CYP2C8	GENEORGENEPRODUCT	1558
21054465	1257	1265	pazienti	ORGANISMTAXON	9606
21054465	1314	1326	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
21054465	1465	1487	T cancellazione a 5063	SEQUENCEVARIANT	C|DEL|5063|T
21054465	1546	1559	C a T a 33468	SEQUENCEVARIANT	C|SUB|C|33468|T
21054465	1697	1708	ipertensivo	DISEASEORPHENOTYPICFEATURE	D006973
21054465	1737	1745	pazienti	ORGANISMTAXON	9606
21054465	1851	1858	C35322C	SEQUENCEVARIANT	C|SUB|C|35322|C
21054465	1898	1906	pazienti	ORGANISMTAXON	9606
21054465	2023	2030	C35322C	SEQUENCEVARIANT	C|SUB|C|35322|C
21054465	2126	2138	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
21054465	2381	2388	C35322T	SEQUENCEVARIANT	C|SUB|C|35322|T
21054465	2458	2469	ipertensivo	DISEASEORPHENOTYPICFEATURE	D006973
21054465	2497	2505	pazienti	ORGANISMTAXON	9606
21130517	46	50	EGFR	GENEORGENEPRODUCT	1956
21130517	126	145	 cancro del polmone	DISEASEORPHENOTYPICFEATURE	D008175
21130517	173	181	pazienti	ORGANISMTAXON	9606
21130517	293	299	tumore	DISEASEORPHENOTYPICFEATURE	D009369
21130517	331	335	EGFR	GENEORGENEPRODUCT	1956
21130517	386	390	EGFR	GENEORGENEPRODUCT	1956
21130517	457	461	EGFR	GENEORGENEPRODUCT	1956
21130517	543	547	EGFR	GENEORGENEPRODUCT	1956
21130517	594	611	cancro ai polmoni	DISEASEORPHENOTYPICFEATURE	D008175
21130517	689	693	EGFR	GENEORGENEPRODUCT	1956
21130517	777	783	tumore	DISEASEORPHENOTYPICFEATURE	D009369
21130517	1053	1057	EGFR	GENEORGENEPRODUCT	1956
21130517	1110	1118	pazienti	ORGANISMTAXON	9606
21130517	1166	1183	cancro ai polmoni	DISEASEORPHENOTYPICFEATURE	D008175
21130517	1277	1285	pazienti	ORGANISMTAXON	9606
21130517	1356	1360	EGFR	GENEORGENEPRODUCT	1956
21130517	1421	1425	EGFR	GENEORGENEPRODUCT	1956
21130517	1462	1467	L858R	SEQUENCEVARIANT	RS121434568
21130517	1603	1607	EGFR	GENEORGENEPRODUCT	1956
21130517	1663	1669	tumore	DISEASEORPHENOTYPICFEATURE	D009369
21130517	1712	1716	EGFR	GENEORGENEPRODUCT	1956
21130517	1775	1779	EGFR	GENEORGENEPRODUCT	1956
21130517	1845	1851	tumore	DISEASEORPHENOTYPICFEATURE	D009369
21130517	1982	1986	EGFR	GENEORGENEPRODUCT	1956
21130517	2065	2080	tumore primario	DISEASEORPHENOTYPICFEATURE	D009369
21130517	2120	2128	pazienti	ORGANISMTAXON	9606
21130517	2295	2299	EGFR	GENEORGENEPRODUCT	1956
21130517	2362	2366	EGFR	GENEORGENEPRODUCT	 1956
21130517	2403	2408	L858R	SEQUENCEVARIANT	RS121434568
21130517	2511	2517	tumori	DISEASEORPHENOTYPICFEATURE	D009369
21130517	2634	2640	tumore	DISEASEORPHENOTYPICFEATURE	D009369
21130517	2753	2761	pazienti	ORGANISMTAXON	9606
21130517	2809	2818	erlotinib	CHEMICALENTITY	D000069347
21130517	2911	2915	EGFR	GENEORGENEPRODUCT	1956
21130517	2984	2990	tumore	DISEASEORPHENOTYPICFEATURE	D009369
21130517	3048	3056	pazienti	ORGANISMTAXON	9606
21130517	3208	3212	EGFR	GENEORGENEPRODUCT	1956
21130517	3378	3382	EGFR	GENEORGENEPRODUCT	1956
21130517	3481	3487	tumore	DISEASEORPHENOTYPICFEATURE	D009369
21130517	3519	3523	EGFR	GENEORGENEPRODUCT	1956
21130517	3597	3601	EGFR	GENEORGENEPRODUCT	1956
21130517	3715	3723	pazienti	ORGANISMTAXON	9606
21130517	3772	3778	tumore	DISEASEORPHENOTYPICFEATURE	D009369
21799811	56	63	677 C>T	SEQUENCEVARIANT	RS1801133
21799811	115	120	MTHFR	GENEORGENEPRODUCT	 4524
21799811	173	193	infertilitÃ  maschile	DISEASEORPHENOTYPICFEATURE	D007248
21799811	297	329	Metilentetraidrofolato reduttasi	GENEORGENEPRODUCT	4524
21799811	362	367	MTHFR	GENEORGENEPRODUCT	4524
21799811	427	433	folato	CHEMICALENTITY	D005492
21799811	467	476	metionina	CHEMICALENTITY	D008715
21799811	656	661	MTHFR	GENEORGENEPRODUCT	4524
21799811	701	707	677C>T	SEQUENCEVARIANT	RS1801133
21799811	1387	1393	677C>T	SEQUENCEVARIANT	RS1801133
21799811	1453	1473	infertilitÃ  maschile	DISEASEORPHENOTYPICFEATURE	D007248
21799811	2271	2277	677C>T	SEQUENCEVARIANT	RS1801133
21799811	2338	2358	infertilitÃ  maschile	DISEASEORPHENOTYPICFEATURE	D007248
21799811	2419	2425	677C>T	SEQUENCEVARIANT	RS1801133
21799811	2505	2525	infertilitÃ  maschile	DISEASEORPHENOTYPICFEATURE	D007248
21799811	2687	2707	infertilitÃ  maschile	DISEASEORPHENOTYPICFEATURE	D007248
21903317	85	91	renina	GENEORGENEPRODUCT	5972
21903317	156	162	anemia	DISEASEORPHENOTYPICFEATURE	D000740
21903317	207	219	iperuricemia	DISEASEORPHENOTYPICFEATURE	D033461
21903317	265	268	CKD	DISEASEORPHENOTYPICFEATURE	D051436
21903317	347	353	renina	GENEORGENEPRODUCT	5972
21903317	386	389	REN	GENEORGENEPRODUCT	5972
21903317	443	469	disgenesia tubulare renale	DISEASEORPHENOTYPICFEATURE	C537048
21903317	532	537	morte	DISEASEORPHENOTYPICFEATURE	D003643
21903317	602	622	insufficienza renale	DISEASEORPHENOTYPICFEATURE	D051437
21903317	668	687	ipoplasia polmonare	DISEASEORPHENOTYPICFEATURE	D008171
21903317	757	766	fetopatia	DISEASEORPHENOTYPICFEATURE	C576203
21903317	809	863	inibitore dell'enzima di conversione dell'angiotensina	CHEMICALENTITY	D000806
21903317	898	953	assunzione di bloccanti del recettore dell'angiotensina	CHEMICALENTITY	D057911
21903317	1070	1073	REN	GENEORGENEPRODUCT	5972
21903317	1152	1164	iperuricemia	DISEASEORPHENOTYPICFEATURE	D033461
21903317	1210	1216	anemia	DISEASEORPHENOTYPICFEATURE	D000740
21903317	1262	1285	malattia renale cronica	DISEASEORPHENOTYPICFEATURE	D051436
21903317	1330	1333	CKD	DISEASEORPHENOTYPICFEATURE	D051436
21903317	1434	1437	REN	GENEORGENEPRODUCT	5972
21903317	1516	1519	REN	GENEORGENEPRODUCT	5972
21903317	1582	1594	iperuricemia	DISEASEORPHENOTYPICFEATURE	D033461
21903317	1640	1643	CKD	DISEASEORPHENOTYPICFEATURE	D051436
21903317	1728	1732	UMOD	GENEORGENEPRODUCT	7369
21903317	1766	1777	uromodulina	GENEORGENEPRODUCT	7369
21903317	1812	1817	HNF1B	GENEORGENEPRODUCT	6928
21903317	1850	1879	epatocita nucleare fattore 1b	GENEORGENEPRODUCT	6928
21903317	1971	2016	timidina a citosina mutazione in posizione 28	SEQUENCEVARIANT	C|SUB|T|28|C
21903317	2053	2056	REN	GENEORGENEPRODUCT	 5972
21903317	2134	2193	triptofano in sostituzione dell'arginina all'amminoacido 10	SEQUENCEVARIANT	P|SUB|W|10|R
21903317	2285	2292	c.28T>C	SEQUENCEVARIANT	C|SUB|T|28|C
21903317	2332	2338	p.W10R	SEQUENCEVARIANT	 P|SUB|W|10|R
21903317	2417	2420	REN	GENEORGENEPRODUCT	5972
21903317	2468	2476	pazienti	ORGANISMTAXON	9606
21903317	2524	2527	CKD	DISEASEORPHENOTYPICFEATURE	D051436
21903317	2678	2681	REN	GENEORGENEPRODUCT	5972
21903317	2770	2777	 anemia	DISEASEORPHENOTYPICFEATURE	D000740
21903317	2822	2834	iperuricemia	DISEASEORPHENOTYPICFEATURE	D033461
21903317	2880	2883	CKD	DISEASEORPHENOTYPICFEATURE	D051436
21903317	2929	2937	L'anemia	DISEASEORPHENOTYPICFEATURE	D000740
21903317	3084	3087	REN	GENEORGENEPRODUCT	5972
21903317	3203	3206	REN	GENEORGENEPRODUCT	5972
21903317	3243	3251	pazienti	ORGANISMTAXON	9606
21903317	3299	3302	CKD	DISEASEORPHENOTYPICFEATURE	D051436
21903317	3351	3363	iperuricemia	DISEASEORPHENOTYPICFEATURE	D033461
21903317	3409	3415	anemia	DISEASEORPHENOTYPICFEATURE	D000740
22711886	32	74	Il deficit del fattore 2 associato al TNFR	GENEORGENEPRODUCT	22030
22711886	148	176	leucemia linfocitica cronica	DISEASEORPHENOTYPICFEATURE	D015451
22711886	220	247	linfoma linfocitico piccolo	DISEASEORPHENOTYPICFEATURE	D015451
22711886	279	283	topi	ORGANISMTAXON	10090
22711886	369	373	topi	ORGANISMTAXON	10090
22711886	443	448	BCL-2	GENEORGENEPRODUCT	596
22711886	486	513	fattore 2 associato al TNFR	GENEORGENEPRODUCT	22030
22711886	547	552	TRAF2	GENEORGENEPRODUCT	22030
22711886	689	716	linfoma linfocitico piccolo	DISEASEORPHENOTYPICFEATURE	D015451
22711886	762	791	leucemia linfocitica cronica 	DISEASEORPHENOTYPICFEATURE	D015451
22711886	949	954	TRAF2	GENEORGENEPRODUCT	22030
22711886	957	962	TRAF2	GENEORGENEPRODUCT	22030
22711886	1214	1219	 topi	ORGANISMTAXON	10090
22711886	1314	1324	proteasoma	GENEORGENEPRODUCT	16912
22711886	1351	1356	TRAF2	GENEORGENEPRODUCT	22030
22711886	1493	1498	Traf2	GENEORGENEPRODUCT	22030
22711886	1580	1584	topi	ORGANISMTAXON	10090
22711886	1720	1735	p100 NF-kappaB2	GENEORGENEPRODUCT	18034
22711886	1779	1784	TRAF3	GENEORGENEPRODUCT	22031
22711886	1818	1854	Inibitore dell'apoptosi legato all'X	GENEORGENEPRODUCT	11798
22711886	1889	1897	Bcl-X(L)	GENEORGENEPRODUCT	12048
22711886	1990	2029	inibitori cellulari dell'apoptosi 1 e 2	GENEORGENEPRODUCT	11796,11797
22711886	2237	2242	TRAF2	GENEORGENEPRODUCT	22030
22711886	2308	2311	JNK	GENEORGENEPRODUCT	26419
22711886	2346	2349	ERK	GENEORGENEPRODUCT	26413
22711886	2427	2431	CD40	GENEORGENEPRODUCT	21939
22711886	2475	2480	TRAF2	GENEORGENEPRODUCT	22030
22711886	2560	2563	BCR	GENEORGENEPRODUCT	12518
22711886	2643	2648	TRAF2	GENEORGENEPRODUCT	22030
22711886	2705	2709	CD40	GENEORGENEPRODUCT	21939
22711886	2750	2758	p38 MAPK	GENEORGENEPRODUCT	26416
22711886	2833	2836	BCR	GENEORGENEPRODUCT	12518
22711886	2878	2881	p38	GENEORGENEPRODUCT	26416
22711886	2965	2970	TRAF2	GENEORGENEPRODUCT	22030
22711886	3050	3054	CD40	GENEORGENEPRODUCT	21939
22711886	3152	3190	fattore di attivazione delle cellule B	GENEORGENEPRODUCT	24099
22711886	3313	3318	TRAF2	GENEORGENEPRODUCT	22030
22711886	3361	3366	BCL-2	GENEORGENEPRODUCT	596
22711886	3424	3452	leucemia linfocitica cronica	DISEASEORPHENOTYPICFEATURE	D015451
22711886	3496	3523	linfoma linfocitico piccolo	DISEASEORPHENOTYPICFEATURE	D015451
22711886	3556	3560	topi	ORGANISMTAXON	10090
22711886	3692	3728	Inibitore dell'apoptosi legato all'X	GENEORGENEPRODUCT	11798
22711886	3812	3850	fattore di attivazione delle cellule B	GENEORGENEPRODUCT	24099
23285048	83	95	Delta-like 4	GENEORGENEPRODUCT	54485
23285048	176	188	Delta-like 4	GENEORGENEPRODUCT	54485
23285048	222	226	Dll4	GENEORGENEPRODUCT	54485
23285048	277	282	Notch	GENEORGENEPRODUCT	18128
23285048	391	397	tumore	DISEASEORPHENOTYPICFEATURE	D009369
23285048	540	546	tumore	DISEASEORPHENOTYPICFEATURE	D009369
23285048	604	608	Dll4	GENEORGENEPRODUCT	54485
23285048	769	773	Dll4	GENEORGENEPRODUCT	54485
23285048	806	811	Notch	GENEORGENEPRODUCT	18128
23285048	884	890	tumori	DISEASEORPHENOTYPICFEATURE	D009369
23285048	1003	1007	Dll4	GENEORGENEPRODUCT	54485
23285048	1113	1117	Dll4	GENEORGENEPRODUCT	54485
23285048	1209	1213	topi	ORGANISMTAXON	10090
23285048	1274	1278	CD31	GENEORGENEPRODUCT	18613
23285048	1315	1326	VE-Cadherin	GENEORGENEPRODUCT	12562
23285048	1364	1369	c-kit	GENEORGENEPRODUCT	16590
23285048	1469	1474	CD105	GENEORGENEPRODUCT	13805
23285048	1511	1517	VEGFR3	GENEORGENEPRODUCT	14257
23285048	1554	1557	SMA	GENEORGENEPRODUCT	11475
23285048	1735	1739	Dll4	GENEORGENEPRODUCT	54485
23285048	1817	1823	IGFbp2	GENEORGENEPRODUCT	16008
23285048	1857	1863	IGFbp3	GENEORGENEPRODUCT	16009
23285048	1897	1903	Angpt2	GENEORGENEPRODUCT	11601
23285048	1938	1942	Dll4	GENEORGENEPRODUCT	54485
23285048	1976	1979	DHH	GENEORGENEPRODUCT	13363
23285048	2014	2020	VEGF-A	GENEORGENEPRODUCT	22339
23285048	2080	2084	FGF1	GENEORGENEPRODUCT	14164
23285048	2119	2123	CSF2	GENEORGENEPRODUCT	12981
23285048	2226	2230	Dll4	GENEORGENEPRODUCT	54485
23285048	2271	2274	Akt	GENEORGENEPRODUCT	11651
23285048	2349	2356	Erk 1/2	GENEORGENEPRODUCT	26413,26417
23285048	2475	2479	Dll4	GENEORGENEPRODUCT	54485
23285048	2583	2589	 CD11b	GENEORGENEPRODUCT	16409
23285048	2640	2644	B220	GENEORGENEPRODUCT	19264
23285048	2687	2690	CD3	GENEORGENEPRODUCT	12501
23285048	2751	2755	topi	ORGANISMTAXON	10090
23285048	2883	2887	Dll4	GENEORGENEPRODUCT	54485
23285048	3021	3027	Notch1	GENEORGENEPRODUCT	 18128
23285048	3089	3093	Dll4	GENEORGENEPRODUCT	54485
23285048	3340	3344	Dll4	GENEORGENEPRODUCT	54485
23651211	47	62	T-cell factor-4	GENEORGENEPRODUCT	6934
23651211	148	172	carcinoma epatocellulare	DISEASEORPHENOTYPICFEATURE	D006528
23651211	240	243	Wnt	GENEORGENEPRODUCT	7474
23651211	275	288	beta-catenina	GENEORGENEPRODUCT	1499
23651211	458	513	fattore delle cellule T (TCF)-4 fattore di trascrizione	GENEORGENEPRODUCT	6934
23651211	580	585	TCF-4	GENEORGENEPRODUCT	6934
23651211	675	699	carcinoma epatocellulare	DISEASEORPHENOTYPICFEATURE	D006528
23651211	744	747	HCC	DISEASEORPHENOTYPICFEATURE	D006528
23651211	843	848	TCF-4	GENEORGENEPRODUCT	6934
23651211	881	891	TCF-4J e K	GENEORGENEPRODUCT	6934
23651211	983	1001	oncogenesi epatica	DISEASEORPHENOTYPICFEATURE	D006528
23651211	1047	1053	tumore	DISEASEORPHENOTYPICFEATURE	D009369
23651211	1171	1174	HCC	DISEASEORPHENOTYPICFEATURE	D006528
23651211	1233	1243	TCF-4J e K	GENEORGENEPRODUCT	6934
23651211	1452	1457	TCF-4	GENEORGENEPRODUCT	6934
23651211	1502	1507	umano	ORGANISMTAXON	9606
23651211	1551	1561	tumori HCC	DISEASEORPHENOTYPICFEATURE	D006528
23651211	1740	1746	TCF-4J	GENEORGENEPRODUCT	6934
23651211	1790	1796	TCF-4K	GENEORGENEPRODUCT	6934
23651211	1928	1931	Wnt	GENEORGENEPRODUCT	7474
23651211	1963	1976	beta-catenina	GENEORGENEPRODUCT	1499
23651211	2009	2017	insulina	GENEORGENEPRODUCT	3630
23651211	2049	2054	IGF-1	GENEORGENEPRODUCT	3479
23651211	2087	2091	IRS1	GENEORGENEPRODUCT	3667
23651211	2125	2130	Notch	GENEORGENEPRODUCT	4851
23651211	2194	2200	umani 	ORGANISMTAXON	9606
23651211	2244	2247	HCC	DISEASEORPHENOTYPICFEATURE	D006528
23651211	2353	2358	CLDN2	GENEORGENEPRODUCT	9075
23651211	2391	2397	STK17B	GENEORGENEPRODUCT	9262
23651211	2431	2435	SPP1	GENEORGENEPRODUCT	6696
23651211	2468	2473	AXIN2	GENEORGENEPRODUCT	8313
23651211	2506	2511	WISP2	GENEORGENEPRODUCT	8839
23651211	2544	2548	MMP7	GENEORGENEPRODUCT	4316
23651211	2581	2585	IRS1	GENEORGENEPRODUCT	3667
23651211	2618	2623	ANXA1	GENEORGENEPRODUCT	301
23651211	2657	2664	CAMK2N1	GENEORGENEPRODUCT	55450
23651211	2696	2700	ASPH	GENEORGENEPRODUCT	444
23651211	2733	2738	GPR56	GENEORGENEPRODUCT	9289
23651211	2776	2780	CD24	GENEORGENEPRODUCT	100133941
23651211	2814	2818	JAG1	GENEORGENEPRODUCT	182
23651211	2863	2869	TCF-4J	GENEORGENEPRODUCT	6934
23651211	2926	2937	cellule HCC	DISEASEORPHENOTYPICFEATURE	 D006528
23651211	3012	3022	tumori HCC	DISEASEORPHENOTYPICFEATURE	D006528
23651211	3208	3214	TCF-4J	GENEORGENEPRODUCT	6934
23651211	3261	3267	tumore	DISEASEORPHENOTYPICFEATURE	D009369
23651211	3313	3318	TCF-4	GENEORGENEPRODUCT	6934
23651211	3360	3370	TCF-4J e K	GENEORGENEPRODUCT	6934
23651211	3458	3461	HCC	DISEASEORPHENOTYPICFEATURE	D006528
23651211	3550	3556	TCF-4J	GENEORGENEPRODUCT	6934
23651211	3649	3652	Wnt	GENEORGENEPRODUCT	7474
23651211	3684	3697	beta-catenina	GENEORGENEPRODUCT	1499
23651211	3730	3738	insulina	GENEORGENEPRODUCT	3630
23651211	3771	3776	IGF-1	GENEORGENEPRODUCT	3479
23651211	3808	3812	IRS1	GENEORGENEPRODUCT	3667
23651211	3846	3851	Notch	GENEORGENEPRODUCT	4851
23651211	3981	3984	HCC	DISEASEORPHENOTYPICFEATURE	D006528
23872883	53	83	Estratto di Solidago virgaurea	CHEMICALENTITY	D010936
23872883	143	159	 cardiotossicitÃ 	DISEASEORPHENOTYPICFEATURE	D066126
23872883	204	231	Le malattie cardiovascolari	DISEASEORPHENOTYPICFEATURE	D002318
23872883	276	279	CVD	DISEASEORPHENOTYPICFEATURE	D002318
23872883	483	513	estratto di Solidago virgaurea	CHEMICALENTITY	D010936
23872883	548	562	isoproterenolo	CHEMICALENTITY	D007545
23872883	617	632	cardiotossicitÃ 	DISEASEORPHENOTYPICFEATURE	D066126
23872883	664	669	ratti	ORGANISMTAXON	10116
23872883	730	744	isoproterenolo	CHEMICALENTITY	D007545
23872883	787	792	ratti	ORGANISMTAXON	10116
23872883	938	958	lattato deidrogenasi	GENEORGENEPRODUCT	24533
23872883	992	1012	 creatinfosfochinasi	GENEORGENEPRODUCT	24264
23872883	1046	1066	alanina transaminasi	GENEORGENEPRODUCT	81670
23872883	1100	1122	aspartato transaminasi	GENEORGENEPRODUCT	25721
23872883	1157	1210	attivitÃ  dell'enzima di conversione dell'angiotensina	GENEORGENEPRODUCT	24310
23872883	1250	1261	colesterolo	CHEMICALENTITY	D002784
23872883	1295	1307	trigliceridi	CHEMICALENTITY	D014280
23872883	1353	1365	acido grasso	CHEMICALENTITY	D005227
23872883	1416	1430	malondialdeide	CHEMICALENTITY	D008315
23872883	1463	1466	MDA	CHEMICALENTITY	D008315
23872883	1501	1515	ossido nitrico	CHEMICALENTITY	D009569
23872883	1602	1614	gl utathione	CHEMICALENTITY	D005978
23872883	1649	1670	superossido dismutasi	GENEORGENEPRODUCT	24786
23872883	1793	1817	S. estratto di virgaurea	CHEMICALENTITY	D010936
23872883	1913	1927	isoproterenolo	CHEMICALENTITY	D007545
23872883	2016	2025	Captopril	CHEMICALENTITY	D002216
23872883	2119	2158	enzima di conversione dell'angiotensina	GENEORGENEPRODUCT	24310
23872883	2215	2239	farmaco cardioprotettivo	CHEMICALENTITY	D002316
23872883	2377	2401	S. estratto di virgaurea	CHEMICALENTITY	D010936
23872883	2493	2496	MDA	CHEMICALENTITY	D008315
23872883	2568	2582	isoproterenolo	CHEMICALENTITY	 D007545
23872883	2620	2625	ratti	ORGANISMTAXON	10116
23872883	2700	2724	S. estratto di virgaurea	CHEMICALENTITY	D010936
23872883	2761	2784	agente cardioprotettivo	CHEMICALENTITY	D002316
24014394	59	64	LYRM7	GENEORGENEPRODUCT	90624
24014394	97	102	MZM1L	GENEORGENEPRODUCT	90624
24014394	174	187	encefalopatia	DISEASEORPHENOTYPICFEATURE	D001927
24014394	232	247	acidosi lattica	DISEASEORPHENOTYPICFEATURE	D000140
24014394	300	355	riduzione dell'attivitÃ  del complesso mitocondriale III	DISEASEORPHENOTYPICFEATURE	C565128
24014394	443	513	complesso difettoso III (cIII) della catena respiratoria mitocondriale	DISEASEORPHENOTYPICFEATURE	C565128
24014394	590	594	cIII	GENEORGENEPRODUCT	617
24014394	703	707	cIII	GENEORGENEPRODUCT	617
24014394	771	776	umano	ORGANISMTAXON	9606
24014394	809	814	LYRM7	GENEORGENEPRODUCT	90624
24014394	848	853	MZM1L	GENEORGENEPRODUCT	90624
24014394	896	903	lievito	ORGANISMTAXON	4932
24014394	937	941	MZM1	GENEORGENEPRODUCT	852104
24014394	1036	1040	cIII	GENEORGENEPRODUCT	617
24014394	1083	1091	paziente	ORGANISMTAXON	9606
24014394	1156	1169	encefalopatia	DISEASEORPHENOTYPICFEATURE	D001927
24014394	1215	1230	acidosi lattica	DISEASEORPHENOTYPICFEATURE	D000140
24014394	1276	1291	carenza di cIII	DISEASEORPHENOTYPICFEATURE	C565128
24014394	1420	1427	c.73G>A	SEQUENCEVARIANT	RS587777433
24014394	1464	1469	LYRM7	GENEORGENEPRODUCT	90624
24014394	1503	1508	MZM1L	GENEORGENEPRODUCT	90624
24014394	1631	1641	p.Asp25Asn	SEQUENCEVARIANT	RS587777433
24014394	1689	1694	mzm1D	GENEORGENEPRODUCT	852104
24014394	1722	1729	lievito	ORGANISMTAXON	4932
24014394	1785	1789	mzm1	GENEORGENEPRODUCT	852104
24014394	1826	1830	D25N	SEQUENCEVARIANT	RS587777433
24014394	1914	1946	difetto di crescita respiratoria	DISEASEORPHENOTYPICFEATURE	 D012131
24014394	1991	2010	consumo di ossigeno	CHEMICALENTITY	D010100
24014394	2087	2107	Proteina Rieske Fe-S	GENEORGENEPRODUCT	 856689
24014394	2148	2161	complesso III	GENEORGENEPRODUCT	617
24014394	2215	2220	LYRM7	GENEORGENEPRODUCT	90624
24014394	2253	2258	MZM1L	GENEORGENEPRODUCT	90624
24014394	2345	2359	cIII-difettoso	DISEASEORPHENOTYPICFEATURE	C565128
24014394	2427	2454	encefalopatia mitocondriale	DISEASEORPHENOTYPICFEATURE	C538525
24036311	32	36	CTR9	GENEORGENEPRODUCT	22083
24036311	81	86	PAF1c	GENEORGENEPRODUCT	22083,54624,76246
24036311	164	173	istone H3	GENEORGENEPRODUCT	260423
24036311	615	701	fattore associato alla RNA polimerasi II, complesso omologo (Saccharomyces cerevisiae)	GENEORGENEPRODUCT	22083,54624,76246
24036311	748	762	Complesso PAF1	GENEORGENEPRODUCT	22083,54624,76246
24036311	808	812	Ctr9	GENEORGENEPRODUCT	22083
24036311	847	852	 Rtf1	GENEORGENEPRODUCT	76246
24036311	988	992	Ctr9	GENEORGENEPRODUCT	22083
24036311	1187	1191	Ctr9	GENEORGENEPRODUCT	22083
24036311	1252	1257	Eomes	GENEORGENEPRODUCT	13813
24036311	1291	1295	Elf5	GENEORGENEPRODUCT	13711
24036311	1330	1334	Sox2	GENEORGENEPRODUCT	20674
24036311	1419	1423	Ott4	GENEORGENEPRODUCT	18999
24036311	1457	1462	Nanog	GENEORGENEPRODUCT	71950
24036311	1496	1502	Gata6 	GENEORGENEPRODUCT	14465
24036311	1536	1540	Fgf4	GENEORGENEPRODUCT	14175
24036311	1575	1580	Sox17	GENEORGENEPRODUCT	20671
24036311	1658	1662	Mest	GENEORGENEPRODUCT	17294
24036311	1696	1700	Peg3	GENEORGENEPRODUCT	18616
24036311	1735	1740	Snrpn	GENEORGENEPRODUCT	20646
24036311	1775	1779	Meg3	GENEORGENEPRODUCT	17263
24036311	1943	1952	istone H3	GENEORGENEPRODUCT	260423
24036311	2012	2014	H3	GENEORGENEPRODUCT	260423
24036311	2057	2061	Ctr9	GENEORGENEPRODUCT	22083
24036311	2141	2146	Setd2	GENEORGENEPRODUCT	235626
24036311	2182	2186	Rtf1	GENEORGENEPRODUCT	76246
24036311	2289	2303	complesso PAF1	GENEORGENEPRODUCT	22083,54624,76246
24036311	2424	2427	H3 	GENEORGENEPRODUCT	260423
24036311	2522	2536	complesso PAF1	GENEORGENEPRODUCT	22083,54624,76246
24036311	2568	2575	lievito	ORGANISMTAXON	4932
24288432	70	76	FGFR-4	GENEORGENEPRODUCT	2264
24288432	125	150	displasia broncopolmonare	DISEASEORPHENOTYPICFEATURE	D001997
24288432	196	227	distress respiratorio neonatale	DISEASEORPHENOTYPICFEATURE	D012127
24288432	284	309	Displasia broncopolmonare	DISEASEORPHENOTYPICFEATURE	D001997
24288432	354	357	BPD	DISEASEORPHENOTYPICFEATURE	D001997
24288432	427	445	malattia polmonare	DISEASEORPHENOTYPICFEATURE	D008171
24288432	492	509	nascita prematura	DISEASEORPHENOTYPICFEATURE	D047928
24288432	573	600	sviluppo alveolare alterato	DISEASEORPHENOTYPICFEATURE	 D008171
24288432	646	659	infiammazione	DISEASEORPHENOTYPICFEATURE	D007249
24288432	742	745	BPD	DISEASEORPHENOTYPICFEATURE	D001997
24288432	869	872	BPD	DISEASEORPHENOTYPICFEATURE	D001997
24288432	927	945	malattie polmonari	DISEASEORPHENOTYPICFEATURE	D008171
24288432	1017	1060	sindrome da distress respiratorio neonatale	DISEASEORPHENOTYPICFEATURE	D012127
24288432	1105	1108	RDS	DISEASEORPHENOTYPICFEATURE	D012127
24288432	1306	1334	metalloproteinasi di matrice	GENEORGENEPRODUCT	4312,4313,4318,4321,4325
24288432	1388	1392	MMPs	GENEORGENEPRODUCT	4312,4313,4318,4321,4325
24288432	1447	1482	fattori di crescita dei fibroblasti	GENEORGENEPRODUCT	2247,2248,2249,2252,8817
24288432	1535	1539	FGFs	GENEORGENEPRODUCT	2247,2248,2249,2252,8817
24288432	1595	1600	 FGFR	GENEORGENEPRODUCT	2263,2264
24288432	1761	1764	BPD	DISEASEORPHENOTYPICFEATURE	D001997
24288432	1810	1813	RDS	DISEASEORPHENOTYPICFEATURE	D012127
24288432	2022	2047	MMP-1, -2, -9 e -12, - 16	GENEORGENEPRODUCT	4312,4313,4318,4321,4325
24288432	2085	2104	Recettori FGF 2 e 4	GENEORGENEPRODUCT	2263,2264
24288432	2158	2181	FGF-2, -3, -4, -7 e -18	GENEORGENEPRODUCT	2247,2248,2249, 2252,8817
24288432	2216	2253	Proteina di regolazione del segnale a	GENEORGENEPRODUCT	140885
24288432	2288	2293	SIRPA	GENEORGENEPRODUCT	140885
24288432	2328	2362	Fattore di trascrizione tiroidea-1	GENEORGENEPRODUCT	7080
24288432	2396	2401	TTF-1	GENEORGENEPRODUCT	7080
24288432	2496	2501	MMP-9	GENEORGENEPRODUCT	4318
24288432	2534	2540	MMP-12	GENEORGENEPRODUCT	4321
24288432	2573	2579	FGFR-4	GENEORGENEPRODUCT	2264
24288432	2612	2617	FGF-3	GENEORGENEPRODUCT	2248
24288432	2652	2657	FGF-7	GENEORGENEPRODUCT	2252
24288432	2729	2732	RDS	DISEASEORPHENOTYPICFEATURE	D012127
24288432	2864	2870	FGFR-4	GENEORGENEPRODUCT	2264
24288432	2906	2915	rs1966265	SEQUENCEVARIANT	RS1966265
24288432	2986	2989	RDS	DISEASEORPHENOTYPICFEATURE	D012127
24288432	3047	3050	BPD	DISEASEORPHENOTYPICFEATURE	D001997
24288432	3112	3121	rs1966265	SEQUENCEVARIANT	RS1966265
24288432	3156	3171	recettore FGF 4	GENEORGENEPRODUCT	2264
24288432	3259	3277	malattie alveolari	DISEASEORPHENOTYPICFEATURE	D002282
24333387	79	93	neurotossicitÃ 	DISEASEORPHENOTYPICFEATURE	D020258
24333387	148	163	Streptozotocina	CHEMICALENTITY	D013311
24333387	221	249	compromissione della memoria	DISEASEORPHENOTYPICFEATURE	D008569
24333387	281	286	ratti	ORGANISMTAXON	10116
24333387	401	410	tossicitÃ 	DISEASEORPHENOTYPICFEATURE	D064420
24333387	449	463	Streptozotocin	CHEMICALENTITY	D013311
24333387	496	499	STZ	CHEMICALENTITY	D013311
24333387	552	568	memoria alterata	DISEASEORPHENOTYPICFEATURE	D008569
24333387	598	603	ratti	ORGANISMTAXON	10116
24333387	696	714	Deficit di memoria	DISEASEORPHENOTYPICFEATURE	D008569
24333387	823	827	STZ 	CHEMICALENTITY	D013311
24333387	875	878	STZ	CHEMICALENTITY	D013311
24333387	947	951	GFAP	GENEORGENEPRODUCT	24387
24333387	986	991	CD11b	GENEORGENEPRODUCT	25021
24333387	1026	1031	TNF-a	GENEORGENEPRODUCT	24835
24333387	1109	1127	neuroinfiammazione	DISEASEORPHENOTYPICFEATURE	D007249
24333387	1160	1163	STZ	CHEMICALENTITY	D013311
24333387	1247	1250	ROS	CHEMICALENTITY	D017382
24333387	1284	1291	nitrito	CHEMICALENTITY	D009573
24333387	1324	1330	Ca(2+)	CHEMICALENTITY	D002118
24333387	1495	1510	eccitotossicitÃ 	DISEASEORPHENOTYPICFEATURE	D064420
24333387	1590	1599	Caspase-3	GENEORGENEPRODUCT	25402
24333387	1658	1661	STZ	CHEMICALENTITY	D013311
24333387	1663	1666	rat	ORGANISMTAXON	10116
24333387	1814	1832	Il trattamento STZ	CHEMICALENTITY	D013311
24333387	1939	1946	CaMKIIa	GENEORGENEPRODUCT	25400
24333387	1982	1988	PSD-95	GENEORGENEPRODUCT	29495
24333387	2070	2083	synaptophysin	GENEORGENEPRODUCT	24804
24333387	2119	2126	SNAP-25	GENEORGENEPRODUCT	25012
24333387	2227	2241	neurotossicitÃ 	DISEASEORPHENOTYPICFEATURE	D020258
24333387	2296	2305	Memantina	CHEMICALENTITY	D008559
24333387	2349	2358	Ibuprofen	CHEMICALENTITY	D007052
24333387	2436	2439	STZ	CHEMICALENTITY	D013311
24333387	2555	2569	neurotossicitÃ 	DISEASEORPHENOTYPICFEATURE	D020258
24333387	2601	2604	rat	ORGANISMTAXON	10116
24333387	2776	2779	STZ	CHEMICALENTITY	D013311
24333387	2827	2831	GFAP	GENEORGENEPRODUCT	24387
24333387	2865	2870	CD11b	GENEORGENEPRODUCT	25021
24333387	2905	2910	TNF-a	GENEORGENEPRODUCT	24835
24333387	2943	2946	ROS	CHEMICALENTITY	D017382
24333387	2980	2987	nitrito	CHEMICALENTITY	D009573
24333387	3155	3161	Ca(2+)	CHEMICALENTITY	D002118
24333387	3273	3291	neuroinfiammatorio	DISEASEORPHENOTYPICFEATURE	D007249
24333387	3521	3535	neurotossicitÃ 	DISEASEORPHENOTYPICFEATURE	D020258
24333387	3592	3595	STZ	CHEMICALENTITY	D013311
24333387	3647	3675	compromissione della memoria	DISEASEORPHENOTYPICFEATURE	D008569
24438483	50	61	bupivacaina	CHEMICALENTITY	D002045
24438483	113	140	cardiovascolare depressione	DISEASEORPHENOTYPICFEATURE	D002318
24438483	205	210	lipid	CHEMICALENTITY	D008055
24438483	245	253	propofol	CHEMICALENTITY	D015742
24438483	343	362	emulsioni lipidiche	CHEMICALENTITY	D005217
24438483	420	431	bupivacaina	CHEMICALENTITY	D002045
24438483	481	487	lipidi	CHEMICALENTITY	D008055
24438483	522	530	propofol	CHEMICALENTITY	D015742
24438483	577	588	bupivacaina	CHEMICALENTITY	D002045
24438483	643	658	cardiotossicitÃ 	DISEASEORPHENOTYPICFEATURE	D066126
24438483	746	754	propofol	CHEMICALENTITY	D015742
24438483	789	799	intralipid	CHEMICALENTITY	C545823
24438483	833	843	medialipid	CHEMICALENTITY	D008055
24438483	888	899	bupivacaina	CHEMICALENTITY	D002045
24438483	952	967	cardiotossicitÃ 	DISEASEORPHENOTYPICFEATURE	D066126
24438483	1005	1010	Ratti	ORGANISMTAXON	10116
24438483	1071	1079	ketamina	CHEMICALENTITY	D007649
24438483	1153	1161	propofol	CHEMICALENTITY	D015742
24438483	1196	1206	intralipid	CHEMICALENTITY	C545823
24438483	1251	1259	propofol	CHEMICALENTITY	D015742
24438483	1294	1304	medialipid	CHEMICALENTITY	D008055
24438483	1436	1447	bupivacaina	CHEMICALENTITY	D002045
24438483	1536	1545	disritmia	DISEASEORPHENOTYPICFEATURE	D001145
24438483	1727	1736	asistolia	DISEASEORPHENOTYPICFEATURE	D006323
24438483	1788	1799	bupivacaina	CHEMICALENTITY	D002045
24438483	1906	1915	asistolia	DISEASEORPHENOTYPICFEATURE	D006323
24438483	1991	2000	disritmia	DISEASEORPHENOTYPICFEATURE	D001145
24438483	2113	2122	asistolia	DISEASEORPHENOTYPICFEATURE	D006323
24438483	2234	2245	bupivacaina	CHEMICALENTITY	D002045
24438483	2345	2356	bupivacaina	CHEMICALENTITY	D002045
24438483	2468	2492	I livelli di bupivacaina	CHEMICALENTITY	D002045
24438483	2688	2696	propofol	CHEMICALENTITY	D015742
24438483	2731	2741	intralipid	CHEMICALENTITY	C545823
24438483	2785	2793	propofol	CHEMICALENTITY	D015742
24438483	2828	2838	medialipid	CHEMICALENTITY	D008055
24438483	2919	2930	bupivacaina	CHEMICALENTITY	D002045
24438483	2985	2998	cardiotossici	DISEASEORPHENOTYPICFEATURE	D066126
24438483	3062	3073	bupivacaina	CHEMICALENTITY	D002045
24438483	3169	3180	bupivacaina	CHEMICALENTITY	D002045
24438483	3223	3231	propofol	CHEMICALENTITY	D015742
24438483	3267	3275	propofol	CHEMICALENTITY	D015742
24438483	3306	3316	medialipid	CHEMICALENTITY	D008055
25080425	47	100	trasduttore di segnale e attivatore di trascrizione 3	GENEORGENEPRODUCT	25125
25080425	154	161	betaina	CHEMICALENTITY	D001622
25080425	201	215	isoproterenolo	CHEMICALENTITY	D007545
25080425	273	289	danno miocardico	DISEASEORPHENOTYPICFEATURE	D009202
25080425	321	326	ratti	ORGANISMTAXON	10116
25080425	445	452	betaina	CHEMICALENTITY	D001622
25080425	499	518	ischemia miocardica	DISEASEORPHENOTYPICFEATURE	D017202
25080425	575	580	ratti	ORGANISMTAXON	10116
25080425	646	699	trasduttore di segnale e attivatore di trascrizione 3	GENEORGENEPRODUCT	25125
25080425	733	738	STAT3	GENEORGENEPRODUCT	25125
25080425	878	883	ratti	ORGANISMTAXON	10116
25080425	936	943	betaina	CHEMICALENTITY	D001622
25080425	1039	1065	danno ischemico miocardico	DISEASEORPHENOTYPICFEATURE	D017202
25080425	1113	1118	ratti	ORGANISMTAXON	10116
25080425	1186	1200	isoproterenolo	CHEMICALENTITY	D007545
25080425	1427	1434	betaina	CHEMICALENTITY	D001622
25080425	1701	1715	isoproterenolo	CHEMICALENTITY	D007545
25080425	1774	1779	STAT3	GENEORGENEPRODUCT	25125
25080425	1876	1883	betaina	CHEMICALENTITY	D001622
25080425	1958	1965	betaina	CHEMICALENTITY	D001622
25080425	2059	2064	Bcl-2	GENEORGENEPRODUCT	24224
25080425	2121	2124	Bax	GENEORGENEPRODUCT	24887
25080425	2217	2223	 Bcl-2	GENEORGENEPRODUCT	24224
25080425	2256	2259	Bax	GENEORGENEPRODUCT	24887
25080425	2318	2325	betaina	CHEMICALENTITY	D001622
25080425	2372	2388	danno miocardico	DISEASEORPHENOTYPICFEATURE	D009202
25080425	2531	2538	betaina	CHEMICALENTITY	D001622
25080425	2595	2609	isoproterenolo	CHEMICALENTITY	D007545
25080425	2667	2686	ischemia miocardica	DISEASEORPHENOTYPICFEATURE	D017202
25080425	2748	2753	STAT3	GENEORGENEPRODUCT	25125
25119790	31	43	La curcumina	CHEMICALENTITY	D003474
25119790	84	91	maleate	CHEMICALENTITY	C030272
25119790	143	157	nefrotossicitÃ 	DISEASEORPHENOTYPICFEATURE	D007674
25119790	263	271	ossigeno	CHEMICALENTITY	D010100
25119790	325	349	complesso respiratorio I	CHEMICALENTITY	D042967
25119790	445	454	curcumina	CHEMICALENTITY	D003474
25119790	534	567	 Ã¨ stato valutato il danno renale	DISEASEORPHENOTYPICFEATURE	D007674
25119790	610	617	maleato	CHEMICALENTITY	C030272
25119790	662	673	proteinuria	DISEASEORPHENOTYPICFEATURE	D011507
25119790	772	779	maleate	CHEMICALENTITY	C030272
25119790	824	829	ratti	ORGANISMTAXON	10116
25119790	862	869	Maleato	CHEMICALENTITY	C030272
25119790	921	933	danno renale	DISEASEORPHENOTYPICFEATURE	D007674
25119790	1057	1065	glucosio	CHEMICALENTITY	D005947
25119790	1098	1103	sodio	CHEMICALENTITY	D012964
25119790	1139	1186	lipocalina associata alla gelatinasi neutrofila	GENEORGENEPRODUCT	170496
25119790	1221	1225	NGAL	GENEORGENEPRODUCT	170496
25119790	1376	1409	molecola del danno renale (KIM)-1	GENEORGENEPRODUCT	286934
25119790	1502	1511	claudin-2	GENEORGENEPRODUCT	733684
25119790	1564	1605	necrosi e apoptosi delle cellule tubulari	DISEASEORPHENOTYPICFEATURE	D007673
25119790	1714	1720	lipidi	CHEMICALENTITY	D008055
25119790	1790	1794	Nrf2	GENEORGENEPRODUCT	83619
25119790	1997	2004	Maleate	CHEMICALENTITY	C030272
25119790	2062	2091	specie reattive dell'ossigeno	CHEMICALENTITY	D017382
25119790	2125	2128	ROS	CHEMICALENTITY	D017382
25119790	2239	2246	maleate	CHEMICALENTITY	C030272
25119790	2298	2306	ossigeno	CHEMICALENTITY	D010100
25119790	2350	2353	ADP	CHEMICALENTITY	D000244
25119790	2468	2474	malato	CHEMICALENTITY	C030298
25119790	2507	2517	glutammato	CHEMICALENTITY	D018698
25119790	2605	2614	aconitasi	GENEORGENEPRODUCT	50655
25119790	2727	2736	curcumina	CHEMICALENTITY	D003474
25119790	2785	2794	curcumina	CHEMICALENTITY	D003474
25119790	2858	2865	maleate	CHEMICALENTITY	C030272
25119790	2917	2927	nefropatia	DISEASEORPHENOTYPICFEATURE	D007674
25119790	3118	3126	ossigeno	CHEMICALENTITY	D010100
25119790	3177	3201	respiratorio complesso I	CHEMICALENTITY	D042967
25119790	3314	3317	ROS	CHEMICALENTITY	D017382
25550469	35	60	recettore degli androgeni	GENEORGENEPRODUCT	11835
25550469	212	219	obesitÃ 	DISEASEORPHENOTYPICFEATURE	D009765
25550469	265	277	dislipidemia	DISEASEORPHENOTYPICFEATURE	D050171
25550469	320	324	topi	ORGANISMTAXON	10090
25550469	357	370	Gli androgeni	CHEMICALENTITY	D000728
25550469	552	577	recettore degli androgeni	GENEORGENEPRODUCT	11835
25550469	611	613	AR	GENEORGENEPRODUCT	11835
25550469	650	659	androgeni	CHEMICALENTITY	D000728
25550469	706	717	aterogenesi	DISEASEORPHENOTYPICFEATURE	D050197
25550469	760	765	 topi	ORGANISMTAXON	10090
25550469	824	826	AR	GENEORGENEPRODUCT	11835
25550469	869	871	AR	GENEORGENEPRODUCT	11835
25550469	903	907	topi	ORGANISMTAXON	10090
25550469	957	970	aterosclerosi	DISEASEORPHENOTYPICFEATURE	D050197
25550469	1012	1029	apolipoproteina E	GENEORGENEPRODUCT	11816
25550469	1063	1067	apoE	GENEORGENEPRODUCT	11816
25550469	1217	1230	aterosclerosi	DISEASEORPHENOTYPICFEATURE	D050197
25550469	1292	1294	AR	GENEORGENEPRODUCT	 11835
25550469	1365	1369	apoE	GENEORGENEPRODUCT	11816
25550469	1407	1411	topi	ORGANISMTAXON	10090
25550469	1456	1458	AR	GENEORGENEPRODUCT	11835
25550469	1622	1634	trigliceridi	GENEORGENEPRODUCT	100035834
25550469	1677	1701	sensibilitÃ  all'insulina	GENEORGENEPRODUCT	16334
25550469	1759	1768	aterogena	DISEASEORPHENOTYPICFEATURE	D050197
25550469	1812	1824	dislipidemia	DISEASEORPHENOTYPICFEATURE	D050171
25550469	1863	1874	colesterolo	CHEMICALENTITY	D002784
25550469	1952	1965	aterosclerosi	DISEASEORPHENOTYPICFEATURE	D050197
25550469	2014	2020	lipidi	CHEMICALENTITY	D008055
25550469	2058	2060	AR	GENEORGENEPRODUCT	11835
25550469	2103	2107	topi	ORGANISMTAXON	10090
25550469	2159	2163	topi	ORGANISMTAXON	10090
25550469	2288	2297	androgeni	CHEMICALENTITY	D000728
25550469	2347	2349	AR	GENEORGENEPRODUCT	11835
25550469	2403	2405	AR	GENEORGENEPRODUCT	11835
25550469	2437	2455	diidrotestosterone	CHEMICALENTITY	D013196
25550469	2511	2524	aterosclerosi	DISEASEORPHENOTYPICFEATURE	D050197
25550469	2615	2626	colesterolo	CHEMICALENTITY	D002784
25550469	2674	2678	topi	ORGANISMTAXON	10090
25550469	2762	2768	lipidi	CHEMICALENTITY	D008055
25550469	2815	2822	epatoma	DISEASEORPHENOTYPICFEATURE	D006528
25550469	2938	2943	lipid	CHEMICALENTITY	D008055
25550469	3022	3024	AR	GENEORGENEPRODUCT	11835
25550469	3084	3097	aterosclerosi	DISEASEORPHENOTYPICFEATURE	D050197
25550469	3140	3144	topi	ORGANISMTAXON	10090
25550469	3262	3268	lipidi	CHEMICALENTITY	D008055
25589620	133	142	TossicitÃ 	DISEASEORPHENOTYPICFEATURE	D064420
25589620	190	206	Cancro del retto	DISEASEORPHENOTYPICFEATURE	D012004
25589620	234	242	Pazienti	ORGANISMTAXON	9606
25589620	287	292	5- FU	CHEMICALENTITY	D005472
25589620	392	397	GSTP1	GENEORGENEPRODUCT	2950
25589620	430	434	COX2	GENEORGENEPRODUCT	4513
25589620	468	472	IL10	GENEORGENEPRODUCT	3586
25589620	505	509	EGFR	GENEORGENEPRODUCT	1956
25589620	543	546	EGF	GENEORGENEPRODUCT	1950
25589620	579	584	FGFR4	GENEORGENEPRODUCT	2264
25589620	616	621	CCDN1	GENEORGENEPRODUCT	595
25589620	655	661	VEGFR2	GENEORGENEPRODUCT	3791
25589620	694	698	VEGF	GENEORGENEPRODUCT	7422
25589620	732	737	CXCR2	GENEORGENEPRODUCT	3579
25589620	770	773	IL8	GENEORGENEPRODUCT	3576
25589620	806	810	MMP3	GENEORGENEPRODUCT	4314
25589620	844	849	ICAM1	GENEORGENEPRODUCT	3383
25589620	882	887	ERCC1	GENEORGENEPRODUCT	2067
25589620	921	926	RAD51	GENEORGENEPRODUCT	5888
25589620	960	965	XRCC3	GENEORGENEPRODUCT	7517
25589620	1099	1108	tossicitÃ 	DISEASEORPHENOTYPICFEATURE	D064420
25589620	1233	1248	5-fluorouracile	CHEMICALENTITY	D005472
25589620	1281	1285	5-FU	CHEMICALENTITY	D005472
25589620	1359	1375	tumori del retto	DISEASEORPHENOTYPICFEATURE	D012004
25589620	1460	1464	5-FU	CHEMICALENTITY	D005472
25589620	1507	1511	5-FU	CHEMICALENTITY	D005472
25589620	1640	1644	5-FU	CHEMICALENTITY	D005472
25589620	1742	1747	5- FU	CHEMICALENTITY	D005472
25589620	1821	1829	pazienti	ORGANISMTAXON	9606
25589620	2040	2049	formalina	CHEMICALENTITY	D005557
25589620	2090	2099	paraffina	CHEMICALENTITY	D010232
25589620	2163	2169	tumore	DISEASEORPHENOTYPICFEATURE	D009369
25589620	2420	2425	GSTP1	GENEORGENEPRODUCT	2950
25589620	2457	2466	Ile105Val	SEQUENCEVARIANT	RS1695
25589620	2500	2506	rs1695	SEQUENCEVARIANT	 RS1695
25589620	2758	2766	pazienti	ORGANISMTAXON	9606
25589620	2814	2817	IL8	GENEORGENEPRODUCT	3576
25589620	2848	2855	-251A/A	SEQUENCEVARIANT	RS4073
25589620	2898	2904	rs4073	SEQUENCEVARIANT	RS4073
25589620	2985	2994	tossicitÃ 	DISEASEORPHENOTYPICFEATURE	D064420
25589620	3041	3047	VEGFR2	GENEORGENEPRODUCT	3791
25589620	3082	3087	H472Q	SEQUENCEVARIANT	RS1870377
25589620	3137	3146	rs1870377	SEQUENCEVARIANT	RS1870377
25589620	3300	3308	mucosite	DISEASEORPHENOTYPICFEATURE	D052016
25589620	3461	3469	mucosite	DISEASEORPHENOTYPICFEATURE	D052016
25589620	3528	3534	rs1695	SEQUENCEVARIANT	RS1695
25589620	3588	3596	pazienti	ORGANISMTAXON	9606
25589620	3645	3661	cancro del retto	DISEASEORPHENOTYPICFEATURE	D012004
25589620	3721	3727	rs4073	SEQUENCEVARIANT	RS4073
25589620	3764	3773	rs1870377	SEQUENCEVARIANT	RS1870377
25589620	3860	3869	tossicitÃ 	DISEASEORPHENOTYPICFEATURE	D064420
25589620	3923	3927	5-FU	CHEMICALENTITY	D005472
26684240	50	54	BRAF	GENEORGENEPRODUCT	673
26684240	91	96	V600E	SEQUENCEVARIANT	RS113488022
26684240	153	198	tumori neuroendocrini gastroenteropancreatici	DISEASEORPHENOTYPICFEATURE	C535650
26684240	265	310	tumori neuroendocrini gastroenteropancreatici	DISEASEORPHENOTYPICFEATURE	C535650
26684240	355	363	GEP-NETs	DISEASEORPHENOTYPICFEATURE	C535650
26684240	594	602	GEP-NETs	DISEASEORPHENOTYPICFEATURE	C535650
26684240	633	641	pazienti	ORGANISMTAXON	9606
26684240	758	767	pazopanib	CHEMICALENTITY	C516667
26684240	913	928	NET intestinali	DISEASEORPHENOTYPICFEATURE	D007414
26684240	1077	1085	GEP-NETs	DISEASEORPHENOTYPICFEATURE	C535650
26684240	1175	1199	gene correlato al cancro	DISEASEORPHENOTYPICFEATURE	D009369
26684240	1240	1244	TP53	GENEORGENEPRODUCT	7157
26684240	1280	1285	CNBD1	GENEORGENEPRODUCT	168975
26684240	1318	1321	RB1	GENEORGENEPRODUCT	5925
26684240	1353	1356	APC	GENEORGENEPRODUCT	324
26684240	1391	1395	BCOR	GENEORGENEPRODUCT	54880
26684240	1427	1431	BRAF	GENEORGENEPRODUCT	673
26684240	1465	1471	CTNNB1	GENEORGENEPRODUCT	1499
26684240	1504	1508	EGFR	GENEORGENEPRODUCT	1956
26684240	1541	1546	EP300	GENEORGENEPRODUCT	2033
26684240	1580	1585	ERBB3	GENEORGENEPRODUCT	2065
26684240	1618	1623	KDM6A	GENEORGENEPRODUCT	7403
26684240	1657	1661	KRAS	GENEORGENEPRODUCT	3845
26684240	1695	1698	MGA	GENEORGENEPRODUCT	23269
26684240	1732	1736	MLL3	GENEORGENEPRODUCT	58508
26684240	1770	1774	PTEN	GENEORGENEPRODUCT	5728
26684240	1807	1812	RASA1	GENEORGENEPRODUCT	5921
26684240	1845	1852	SMARCB1	GENEORGENEPRODUCT	6598
26684240	1886	1890	SPEN	GENEORGENEPRODUCT	23013
26684240	1924	1932	 TBC1D12	GENEORGENEPRODUCT	23232
26684240	1966	1969	VHL	GENEORGENEPRODUCT	7428
26684240	2002	2006	TP53	GENEORGENEPRODUCT	7157
26684240	2094	2099	CNBD1	GENEORGENEPRODUCT	168975
26684240	2134	2137	RB1	GENEORGENEPRODUCT	5925
26684240	2232	2239	GEP-NET	DISEASEORPHENOTYPICFEATURE	C535650
26684240	2267	2275	pazienti	ORGANISMTAXON	9606
26684240	2325	2329	TP53	GENEORGENEPRODUCT	 Le mutazioni 7157
26684240	2425	2452	grado intestinale (G) 1 NET	DISEASEORPHENOTYPICFEATURE	D007414
26684240	2481	2489	paziente	ORGANISMTAXON	9606
26684240	2524	2528	BRAF	GENEORGENEPRODUCT	673
26684240	2565	2570	V600E	SEQUENCEVARIANT	RS113488022
26684240	2668	2677	pazopanib	CHEMICALENTITY	C516667
26684240	2725	2729	BRAF	GENEORGENEPRODUCT	673
26684240	2766	2771	V600E	SEQUENCEVARIANT	RS113488022
26684240	2819	2822	NET	DISEASEORPHENOTYPICFEATURE	D018358
26684240	2885	2888	NET	DISEASEORPHENOTYPICFEATURE	D018358
26684240	2936	2940	BRAF	GENEORGENEPRODUCT	673
26684240	3026	3029	NET	DISEASEORPHENOTYPICFEATURE	D018358
26684240	3146	3154	GEP-NETs	DISEASEORPHENOTYPICFEATURE	C535650
26684240	3368	3374	tumore	DISEASEORPHENOTYPICFEATURE	D009369
26684240	3497	3501	BRAF	GENEORGENEPRODUCT	673
26684240	3538	3543	V600E	SEQUENCEVARIANT	RS113488022
26684240	3599	3608	pazopanib	CHEMICALENTITY	C516667
26684240	3713	3721	GEP-NETs	DISEASEORPHENOTYPICFEATURE	C535650
26684240	3750	3758	pazienti	ORGANISMTAXON	9606
27090298	44	67	Sintasi di acidi grassi	GENEORGENEPRODUCT	2194
27090298	98	117	donne in gravidanza	ORGANISMTAXON	9606
27090298	246	250	FASN	GENEORGENEPRODUCT	2194
27090298	284	313	la sintasi degli acidi grassi	GENEORGENEPRODUCT	2194
27090298	387	399	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
27090298	445	467	disfunzione metabolica	DISEASEORPHENOTYPICFEATURE	D008659
27090298	500	504	FASN	GENEORGENEPRODUCT	2194
27090298	557	562	umano	ORGANISMTAXON	9606
27090298	655	659	FASN	GENEORGENEPRODUCT	2194
27090298	785	790	donne	ORGANISMTAXON	 9606
27090298	823	827	FASN	GENEORGENEPRODUCT	2194
27090298	890	923	donne in gravidanza asintomatiche	ORGANISMTAXON	9606
27090298	1001	1010	C-peptide	CHEMICALENTITY	D002096
27090298	1053	1061	glucosio	CHEMICALENTITY	D005947
27090298	1095	1103	insulina	GENEORGENEPRODUCT	3630
27090298	1148	1156	glucosio	CHEMICALENTITY	D005947
27090298	1189	1195	lipidi	CHEMICALENTITY	D008055
27090298	1229	1232	HMW	GENEORGENEPRODUCT	57587
27090298	1264	1276	adiponectina	GENEORGENEPRODUCT	9370
27090298	1449	1467	L'espressione FASN	GENEORGENEPRODUCT	2194
27090298	1538	1542	FASN	GENEORGENEPRODUCT	2194
27090298	1724	1732	glucosio	CHEMICALENTITY	D005947
27090298	1766	1774	insulina	GENEORGENEPRODUCT	3630
27090298	1819	1827	glucosio	CHEMICALENTITY	D005947
27090298	1860	1865	HbAc1	GENEORGENEPRODUCT	3043
27090298	1908	1917	C-peptide	CHEMICALENTITY	D002096
27090298	2054	2058	FASN	GENEORGENEPRODUCT	2194
27090298	2132	2136	FASN	GENEORGENEPRODUCT	2194
27090298	2299	2303	FASN	GENEORGENEPRODUCT	2194
27090298	2348	2353	umana	ORGANISMTAXON	9606
27090298	2428	2432	FASN	GENEORGENEPRODUCT	2194
27103577	58	63	PPARA	GENEORGENEPRODUCT	19013
27103577	137	144	ipossia	DISEASEORPHENOTYPICFEATURE	D000860
27103577	227	234	ipossia	DISEASEORPHENOTYPICFEATURE	D000860
27103577	289	300	recettore a	GENEORGENEPRODUCT	19013
27103577	377	382	PPARa	GENEORGENEPRODUCT	19013
27103577	492	499	ipossia	DISEASEORPHENOTYPICFEATURE	D000860
27103577	562	566	topi	ORGANISMTAXON	10090
27103577	635	642	ipossia	DISEASEORPHENOTYPICFEATURE	D000860
27103577	923	935	acido grasso	CHEMICALENTITY	D005227
27103577	1001	1005	(3)H	CHEMICALENTITY	D014316
27103577	1105	1110	mouse	ORGANISMTAXON	10090
27103577	1161	1168	ipossia	DISEASEORPHENOTYPICFEATURE	D000860
27103577	1211	1228	espressione PPARa	GENEORGENEPRODUCT	19013
27103577	1261	1273	acido grasso	CHEMICALENTITY	D005227
27103577	1321	1365	proteina di disaccoppiamento mitocondriale 3	GENEORGENEPRODUCT	22229
27103577	1399	1403	UCP3	GENEORGENEPRODUCT	22229
27103577	1518	1521	ATP	CHEMICALENTITY	D000255
27103577	1570	1573	ATP	CHEMICALENTITY	D000255
27103577	1699	1704	PPARa	GENEORGENEPRODUCT	19013
27103577	1737	1749	acido grasso	CHEMICALENTITY	D005227
27103577	1797	1801	UCP3	GENEORGENEPRODUCT	22229
27103577	1876	1885	L'ipossia	DISEASEORPHENOTYPICFEATURE	D000860
27103577	1976	1981	PPARA	GENEORGENEPRODUCT	19013
27103577	2109	2112	ATP	CHEMICALENTITY	D000255
27103577	2263	2270	ipossia	DISEASEORPHENOTYPICFEATURE	D000860
27103577	2313	2318	mouse	ORGANISMTAXON	10090
27103577	2400	2405	PPARa	GENEORGENEPRODUCT	19013
27103577	2450	2455	PPARa	GENEORGENEPRODUCT	19013
27103577	2560	2565	PPARa	GENEORGENEPRODUCT	19013
27103577	2667	2674	ipossia	DISEASEORPHENOTYPICFEATURE	D000860
27103577	3066	3071	PPARa	GENEORGENEPRODUCT	19013
27103577	3144	3151	ipossia	DISEASEORPHENOTYPICFEATURE	D000860
27103577	3231	3248	lesioni ipossiche	DISEASEORPHENOTYPICFEATURE	D000860
27491646	34	42	Gartanin	CHEMICALENTITY	C000605798
27491646	165	169	PI3K	GENEORGENEPRODUCT	5291
27491646	200	203	Akt	GENEORGENEPRODUCT	207
27491646	235	239	mTOR	GENEORGENEPRODUCT	2475
27491646	273	277	MAPK	GENEORGENEPRODUCT	5594
27491646	328	333	umano	ORGANISMTAXON	9606
27491646	378	384	glioma	DISEASEORPHENOTYPICFEATURE	D005910
27491646	467	473	glioma	DISEASEORPHENOTYPICFEATURE	D005910
27491646	533	558	tumore cerebrale primario	DISEASEORPHENOTYPICFEATURE	D001932
27491646	699	707	Gartanin	CHEMICALENTITY	C000605798
27491646	743	750	xantone	CHEMICALENTITY	C009689
27491646	784	794	mangostano	ORGANISMTAXON	 58228
27491646	1000	1006	glioma	DISEASEORPHENOTYPICFEATURE	D005910
27491646	1053	1058	mouse	ORGANISMTAXON	10090
27491646	1151	1159	Gartanin	CHEMICALENTITY	C000605798
27491646	1362	1372	ciclina D1	GENEORGENEPRODUCT	595
27491646	1448	1474	chinasi ciclino-dipendente	GENEORGENEPRODUCT	983
27491646	1517	1524	p27Kip1	GENEORGENEPRODUCT	 1027
27491646	1601	1630	matrice metalloproteinasi 2/9	GENEORGENEPRODUCT	4313,4318
27491646	1668	1677	MMP-2/ -9	GENEORGENEPRODUCT	4313,4318
27491646	1812	1820	gartanin	CHEMICALENTITY	C000605798
27491646	1893	1930	protein chinasi attivate dal mitogeno	GENEORGENEPRODUCT	5594
27491646	1963	1967	MAPK	GENEORGENEPRODUCT	5594
27491646	2067	2073	glioma	DISEASEORPHENOTYPICFEATURE	D005910
27491646	2126	2134	gartanin	CHEMICALENTITY	C000605798
27491646	2273	2276	LC3	GENEORGENEPRODUCT	84557
27491646	2385	2393	Beclin 1	GENEORGENEPRODUCT	8678
27491646	2429	2432	LC3	GENEORGENEPRODUCT	84557
27491646	2514	2517	p62	GENEORGENEPRODUCT	8878
27491646	2553	2580	Il trattamento con Gartanin	CHEMICALENTITY	C000605798
27491646	2652	2656	PI3K	GENEORGENEPRODUCT	5291
27491646	2688	2691	Akt	GENEORGENEPRODUCT	207
27491646	2723	2727	mTOR	GENEORGENEPRODUCT	2475
27491646	2871	2879	gartanin	CHEMICALENTITY	C000605798
27491646	2986	3000	3-metiladenina	CHEMICALENTITY	C025946
27491646	3033	3037	3-MA	CHEMICALENTITY	C025946
27491646	3072	3082	clorochina	CHEMICALENTITY	D002738
27491646	3120	3122	CQ	CHEMICALENTITY	D002738
27491646	3233	3241	gartanin	CHEMICALENTITY	C000605798
27491646	3422	3426	PI3K	GENEORGENEPRODUCT	5291
27491646	3457	3460	Akt	GENEORGENEPRODUCT	207
27491646	3492	3496	mTOR	GENEORGENEPRODUCT	2475
27491646	3635	3644	MMP -2/-9	GENEORGENEPRODUCT	4313,4318
27491646	3727	3731	MAPK	GENEORGENEPRODUCT	5594
27509880	59	77	istone deacetilasi	GENEORGENEPRODUCT	3065
27509880	109	121	depsipeptide	CHEMICALENTITY	D047630
27509880	155	170	5-fluorouracile	CHEMICALENTITY	D005472
27509880	214	263	complesso di istocompatibilitÃ  maggiore classe II	GENEORGENEPRODUCT	3119
27509880	297	300	p21	GENEORGENEPRODUCT	1026
27509880	349	360	caspase-3/7	GENEORGENEPRODUCT	836,840
27509880	391	396	umano	ORGANISMTAXON	9606
27509880	440	456	cancro del colon	DISEASEORPHENOTYPICFEATURE	D003110
27509880	592	610	istone deacetilasi	GENEORGENEPRODUCT	3065
27509880	643	647	HDAC	GENEORGENEPRODUCT	3065
27509880	825	837	depsipeptide	CHEMICALENTITY	D047630
27509880	873	877	HDAC	GENEORGENEPRODUCT	3065
27509880	961	976	5-fluorouracile	CHEMICALENTITY	D005472
27509880	1009	1013	5-FU	CHEMICALENTITY	D005472
27509880	1067	1072	umano	ORGANISMTAXON	9606
27509880	1116	1132	cancro del colon	DISEASEORPHENOTYPICFEATURE	D003110
27509880	1414	1418	5-FU	CHEMICALENTITY	D005472
27509880	1467	1479	depsipeptide	CHEMICALENTITY	D047630
27509880	1572	1583	caspase-3/7	GENEORGENEPRODUCT	836,840
27509880	1633	1637	5-FU	CHEMICALENTITY	D005472
27509880	1707	1718	caspase-3/7	GENEORGENEPRODUCT	836,840
27509880	1833	1837	5-FU	CHEMICALENTITY	D005472
27509880	1871	1883	depsipeptide	CHEMICALENTITY	D047630
27509880	1952	1956	5-FU	CHEMICALENTITY	D005472
27509880	1990	2002	depsipeptide	CHEMICALENTITY	D047630
27509880	2185	2196	caspase-3/7	GENEORGENEPRODUCT	836,840
27509880	2356	2369	polisaccaride	CHEMICALENTITY	D011134
27509880	2418	2469	complesso maggiore di istocompatibilitÃ  (MHC) class	GENEORGENEPRODUCT	3123
27509880	2516	2538	Complesso proteico MHC	GENEORGENEPRODUCT	3123
27509880	2662	2666	5-FU	CHEMICALENTITY	D005472
27509880	2700	2712	depsipeptide	CHEMICALENTITY	D047630
27509880	2817	2838	geni MHC di classe II	GENEORGENEPRODUCT	3119
27509880	2882	2902	Geni MHC di classe I	GENEORGENEPRODUCT	3106
27509880	3058	3079	geni MHC di classe II	GENEORGENEPRODUCT	3119
27509880	3161	3165	PCAF	GENEORGENEPRODUCT	8850
27509880	3199	3204	CIITA	GENEORGENEPRODUCT	4261
27509880	3261	3265	5-FU	CHEMICALENTITY	 D005472
27509880	3299	3311	depsipeptide	CHEMICALENTITY	D047630
27509880	3441	3454	MHC classe II	GENEORGENEPRODUCT	3119
27509880	3539	3552	 depsipeptide	CHEMICALENTITY	D047630
27509880	3586	3590	5-FU	CHEMICALENTITY	D005472
27509880	3707	3711	5-FU	CHEMICALENTITY	D005472
27509880	3745	3758	 depsipeptide	CHEMICALENTITY	D047630
27509880	3793	3798	umano	ORGANISMTAXON	9606
27509880	3842	3857	cancro al colon	DISEASEORPHENOTYPICFEATURE	D003110
27509880	3965	3978	MHC classe II	GENEORGENEPRODUCT	3119
27663860	41	79	recettore dell'angiotensina II tipo 1a	GENEORGENEPRODUCT	11607
27663860	126	139	 danno renale	DISEASEORPHENOTYPICFEATURE	D007674
27663860	182	210	deossicorticosterone acetato	CHEMICALENTITY	D064791
27663860	259	271	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
27663860	368	413	recettore dell'angiotensina II tipo 1a (AT1a)	GENEORGENEPRODUCT	11607
27663860	460	473	 danno renale	DISEASEORPHENOTYPICFEATURE	D007674
27663860	535	547	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
27663860	588	592	topi	ORGANISMTAXON	10090
27663860	629	643	recettore AT1a	GENEORGENEPRODUCT	11607
27663860	694	698	topi	ORGANISMTAXON	10090
27663860	740	745	umani	ORGANISMTAXON	9606
27663860	778	827	proteina legante gli acidi grassi di tipo epatico	GENEORGENEPRODUCT	2168
27663860	860	866	L-FABP	GENEORGENEPRODUCT	2168
27663860	930	944	Recettore AT1a	GENEORGENEPRODUCT	11607
27663860	982	988	L-FABP	GENEORGENEPRODUCT	2168
27663860	1027	1031	AT1a	GENEORGENEPRODUCT	11607
27663860	1071	1077	L-FABP	GENEORGENEPRODUCT	2168
27663860	1116	1120	AT1a	GENEORGENEPRODUCT	11607
27663860	1201	1207	L-FABP	GENEORGENEPRODUCT	2168
27663860	1279	1304	danno tubulointerstiziale	DISEASEORPHENOTYPICFEATURE	D007674
27663860	1349	1353	topi	ORGANISMTAXON	10090
27663860	1431	1459	deossicorticosterone acetato	CHEMICALENTITY	D064791
27663860	1493	1497	DOCA	CHEMICALENTITY	D064791
27663860	1643	1649	L-FABP	GENEORGENEPRODUCT	2168
27663860	1687	1691	AT1a	GENEORGENEPRODUCT	11607
27663860	1726	1730	topi	ORGANISMTAXON	10090
27663860	1781	1785	DOCA	CHEMICALENTITY	D064791
27663860	1851	1879	Ã¨ stata indotta ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
27663860	1971	1991	sclerosi glomerulare	DISEASEORPHENOTYPICFEATURE	D007674
27663860	2038	2084	sono stati osservati danni tubulointerstiziali	DISEASEORPHENOTYPICFEATURE	D007674
27663860	2120	2126	L-FABP	GENEORGENEPRODUCT	2168
27663860	2164	2168	AT1a	GENEORGENEPRODUCT	11607
27663860	2203	2207	topi	ORGANISMTAXON	10090
27663860	2258	2262	DOCA	CHEMICALENTITY	D064791
27663860	2328	2340	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
27663860	2429	2446	danno glomerulare	DISEASEORPHENOTYPICFEATURE	D007674
27663860	2527	2533	L-FABP	GENEORGENEPRODUCT	2168
27663860	2571	2575	AT1a	GENEORGENEPRODUCT	11607
27663860	2613	2617	DOCA	CHEMICALENTITY	D064791
27663860	2646	2650	topi	ORGANISMTAXON	10090
27663860	2704	2710	L-FABP	GENEORGENEPRODUCT	2168
27663860	2779	2785	L-FABP	GENEORGENEPRODUCT	2168
27663860	2824	2828	AT1a	GENEORGENEPRODUCT	11607
27663860	2865	2869	DOCA	CHEMICALENTITY	D064791
27663860	2899	2903	topi	ORGANISMTAXON	10090
27663860	2956	2962	L-FABP	GENEORGENEPRODUCT	2168
27663860	3001	3005	AT1a	GENEORGENEPRODUCT	11607
27663860	3042	3046	DOCA	CHEMICALENTITY	D064791
27663860	3075	3080	 topi	ORGANISMTAXON	10090
27663860	3113	3123	Idralazina	CHEMICALENTITY	D006830
27663860	3208	3220	danno renale	DISEASEORPHENOTYPICFEATURE	D007674
27663860	3280	3286	L-FABP	GENEORGENEPRODUCT	2168
27663860	3324	3328	AT1a	GENEORGENEPRODUCT	11607
27663860	3366	3370	DOCA	CHEMICALENTITY	D064791
27663860	3399	3403	topi	ORGANISMTAXON	10090
27663860	3517	3531	recettore AT1a	GENEORGENEPRODUCT	11607
27663860	3650	3675	danno renale ipertensivo 	DISEASEORPHENOTYPICFEATURE	D006973,D007674
27663860	3831	3869	recettore dell'angiotensina II tipo 1a	GENEORGENEPRODUCT	11607
27663860	3916	3928	danno renale	DISEASEORPHENOTYPICFEATURE	D007674
27663860	4015	4044	desossicorticosterone acetato	CHEMICALENTITY	D064791
27663860	4093	4105	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
27707793	130	137	miR-501	GENEORGENEPRODUCT	751560
27707793	198	226	catena pesante della miosina	GENEORGENEPRODUCT	17883
27707793	602	615	cardiotossina	CHEMICALENTITY	D054715
27707793	650	653	CTX	CHEMICALENTITY	D054715
27707793	709	726	lesione muscolare	DISEASEORPHENOTYPICFEATURE	D009135
27707793	769	777	miR- 501	GENEORGENEPRODUCT	751560
27707793	850	857	miR-501	GENEORGENEPRODUCT	751560
27707793	985	1028	canale del cloro, sensibile alla tensione 5	GENEORGENEPRODUCT	12728
27707793	1062	1067	Clcn5	GENEORGENEPRODUCT	12728
27707793	1133	1140	miR-501	GENEORGENEPRODUCT	751560
27707793	1217	1245	catena pesante della miosina	GENEORGENEPRODUCT	17883
27707793	1290	1294	MYH3	GENEORGENEPRODUCT	17883
27707793	1349	1375	isoforme di miosina adulte	GENEORGENEPRODUCT	17879
27707793	1582	1591	gigaxonin	GENEORGENEPRODUCT	209239
27707793	1643	1650	miR-501	GENEORGENEPRODUCT	751560
27707793	1725	1732	miR-501	GENEORGENEPRODUCT	751560
27707793	1768	1772	MYH3	GENEORGENEPRODUCT	17883
27707793	1830	1835	mouse	ORGANISMTAXON	10090
27707793	1929	1936	miR-501	GENEORGENEPRODUCT	751560
27707793	2167	2174	miR-501	GENEORGENEPRODUCT	751560
27729412	57	69	adiponectina	GENEORGENEPRODUCT	11450
27729412	186	193	ALDH1A1	GENEORGENEPRODUCT	11668
27729412	250	280	recettore dell'acido retinoico	GENEORGENEPRODUCT	19401,19411,20181
27729412	347	361	L'adiponectina	GENEORGENEPRODUCT	11450
27729412	400	410	adipochina	GENEORGENEPRODUCT	11450
27729412	515	537	attivitÃ  infiammatoria	DISEASEORPHENOTYPICFEATURE	D007249
27729412	688	697	adipositÃ 	DISEASEORPHENOTYPICFEATURE	D009765
27729412	756	769	infiammatorio	DISEASEORPHENOTYPICFEATURE	D007249
27729412	823	847	malattie cardiovascolari	DISEASEORPHENOTYPICFEATURE	D002318
27729412	904	916	adiponectina	GENEORGENEPRODUCT	11450
27729412	950	960	Vitamina A	CHEMICALENTITY	D014801
27729412	1001	1010	retinoidi	CHEMICALENTITY	D012176
27729412	1203	1215	adiponectina	GENEORGENEPRODUCT	11450
27729412	1292	1302	vitamina A	CHEMICALENTITY	D014801
27729412	1345	1349	topi	ORGANISMTAXON	10090
27729412	1419	1431	adiponectina	GENEORGENEPRODUCT	11450
27729412	1496	1519	aldeide deidrogenasi A1	GENEORGENEPRODUCT	11668
27729412	1553	1560	ALDH1A1	GENEORGENEPRODUCT	11668
27729412	1623	1638	acido retinoico	CHEMICALENTITY	D014212
27729412	1748	1752	topi	ORGANISMTAXON	10090
27729412	1811	1821	vitamina A	CHEMICALENTITY	D014801
27729412	1906	1918	adiponectina	GENEORGENEPRODUCT	11450
27729412	1981	1985	topi	ORGANISMTAXON	10090
27729412	2041	2051	vitamina A	CHEMICALENTITY	D014801
27729412	2144	2181	recettore dell'acido retinoico (RAR)a	GENEORGENEPRODUCT	19401
27729412	2237	2241	RARg	GENEORGENEPRODUCT	19411
27729412	2327	2352	retinoide X del recettore	GENEORGENEPRODUCT	20181
27729412	2408	2420	adiponectina	GENEORGENEPRODUCT	11450
27729412	2473	2480	ALDH1A1	GENEORGENEPRODUCT	11668
27729412	2556	2559	RAR	GENEORGENEPRODUCT	19401,19411,20181
27729412	2644	2656	adiponectina	GENEORGENEPRODUCT	11450
27729412	2756	2763	ALDH1A1	GENEORGENEPRODUCT	11668
27729412	2863	2878	acido retinoico	CHEMICALENTITY	D014212
27729412	2937	2940	RAR	GENEORGENEPRODUCT	19401,19411,20181
27729412	3017	3032	acido retinoico	CHEMICALENTITY	D014212
27729412	3130	3133	RAR	GENEORGENEPRODUCT	19401,19411,20181
27729412	3198	3210	adiponectina	GENEORGENEPRODUCT	11450
27729412	3431	3443	adiponectina	GENEORGENEPRODUCT	11450
27729412	3559	3566	ALDH1A1	GENEORGENEPRODUCT	11668
27729412	3623	3653	recettore dell'acido retinoico	GENEORGENEPRODUCT	19401,19411,20181
27807193	32	38	PTPN22	GENEORGENEPRODUCT	19260
27807193	98	112	Recettore Fcg 	GENEORGENEPRODUCT	14130
27807193	248	265	infezioni fungine	DISEASEORPHENOTYPICFEATURE	D009181
27807193	348	377	acuto e infiammazione cronica	DISEASEORPHENOTYPICFEATURE	D007249
27807193	499	543	proteina tirosina fosfatasi non recettore 22	GENEORGENEPRODUCT	19260
27807193	577	583	PTPN22	GENEORGENEPRODUCT	19260
27807193	684	703	malattia autoimmune	DISEASEORPHENOTYPICFEATURE	D001327
27807193	765	783	artrite reumatoide	DISEASEORPHENOTYPICFEATURE	D001172
27807193	825	831	PTPN22	GENEORGENEPRODUCT	19260
27807193	1083	1112	specie reattive dell'ossigeno	CHEMICALENTITY	D017382
27807193	1230	1236	Ptpn22	GENEORGENEPRODUCT	19260
27807193	1322	1325	Lyn	GENEORGENEPRODUCT	17096
27807193	1360	1363	Syk	GENEORGENEPRODUCT	20963
27807193	1417	1423	Ptpn22	GENEORGENEPRODUCT	19260
27807193	1539	1545	Ptpn22	GENEORGENEPRODUCT	19260
27807193	1665	1671	Ptpn22	GENEORGENEPRODUCT	19260
27807193	1705	1709	topi	ORGANISMTAXON	10090
27807193	1800	1807	artrite	DISEASEORPHENOTYPICFEATURE	D001168
27807193	1956	1968	tioglicolato	CHEMICALENTITY	D013864
27807193	2013	2023	peritonite	DISEASEORPHENOTYPICFEATURE	D010538
27807193	2127	2133	PTPN22	GENEORGENEPRODUCT	19260
27807193	2264	2270	PTPN22	GENEORGENEPRODUCT	19260
27807193	2328	2332	FcgR	GENEORGENEPRODUCT	14130
27840894	59	63	PHEX	GENEORGENEPRODUCT	5251
27840894	116	124	pazienti	ORGANISMTAXON	 9606
27840894	172	197	rachitismo ipofosfatemico	DISEASEORPHENOTYPICFEATURE	D063730
27840894	256	330	gene regolatore del fosfato con omologie all'endopeptidasi sul cromosoma X	GENEORGENEPRODUCT	5251
27840894	363	367	PHEX	GENEORGENEPRODUCT	5251
27840894	450	488	rachitismo ipofosfatemico legato all'X	DISEASEORPHENOTYPICFEATURE	D053098
27840894	533	536	XLH	DISEASEORPHENOTYPICFEATURE	D053098
27840894	581	592	OMIM 307800	DISEASEORPHENOTYPICFEATURE	D053098
27840894	664	672	pazienti	ORGANISMTAXON	9606
27840894	783	808	rachitismo ipofosfatemico	DISEASEORPHENOTYPICFEATURE	D063730
27840894	953	957	PHEX	GENEORGENEPRODUCT	5251
27840894	1047	1085	fattore di crescita dei fibroblasti 23	GENEORGENEPRODUCT	8074
27840894	1118	1123	FGF23	GENEORGENEPRODUCT	8074
27840894	1258	1262	PHEX	GENEORGENEPRODUCT	5251
27840894	1382	1390	c.304G>A	SEQUENCEVARIANT	C |SUB|G|304|A
27840894	1430	1441	p.Gly102Arg	SEQUENCEVARIANT	P|SUB|G|102|R
27840894	1495	1503	c.229T>C	SEQUENCEVARIANT	C|SUB|T|229|C
27840894	1543	1553	p.Cys77Arg	SEQUENCEVARIANT	P|SUB |C|77|R
27840894	1608	1616	c.824T>C	SEQUENCEVARIANT	C|SUB|T|284|C
27840894	1656	1667	p.Leu275Pro	SEQUENCEVARIANT	P|SUB|L|275|P
27840894	1753	1762	c.528delT	SEQUENCEVARIANT	C|DEL|528|T
27840894	1806	1822	p.Glu177LysfsX44	SEQUENCEVARIANT	P|SUB|E|177|K |44
27840894	1876	1886	c.1234delA	SEQUENCEVARIANT	C|DEL|1234|A
27840894	1929	1945	p.Ser412ValfsX12	SEQUENCEVARIANT	P|SUB|S|412|V|12
27840894	2440	2445	FGF23	GENEORGENEPRODUCT	8074
27840894	2500	2508	pazienti	ORGANISMTAXON	9606
27840894	2557	2560	XLH	DISEASEORPHENOTYPICFEATURE	D053098
27840894	2785	2789	PHEX	GENEORGENEPRODUCT	5251
27840894	2877	2881	PHEX	GENEORGENEPRODUCT	5251
27840894	2991	2996	FGF23	GENEORGENEPRODUCT	8074
27840894	3030	3038	pazienti	ORGANISMTAXON	9606
27840894	3086	3089	XLH	DISEASEORPHENOTYPICFEATURE	D053098
27840894	3199	3202	XLH	DISEASEORPHENOTYPICFEATURE	D053098
27860185	34	44	Sildenafil	CHEMICALENTITY	D000068677
27860185	96	129	rimodellamento polmonare ipossico	DISEASEORPHENOTYPICFEATURE	D066253
27860185	323	347	rimodellamento polmonare	DISEASEORPHENOTYPICFEATURE	D066253
27860185	413	435	ipertensione polmonare	DISEASEORPHENOTYPICFEATURE	 D006976
27860185	453	455	PH	DISEASEORPHENOTYPICFEATURE	D006976
27860185	527	537	sildenafil	CHEMICALENTITY	D000068677
27860185	596	598	PH	DISEASEORPHENOTYPICFEATURE	D006976
27860185	772	782	sildenafil	CHEMICALENTITY	D000068677
27860185	918	942	rimodellamento polmonare	DISEASEORPHENOTYPICFEATURE	D066253
27860185	974	979	ratti	ORGANISMTAXON	10116
27860185	1058	1066	 ipossia	DISEASEORPHENOTYPICFEATURE	D000860
27860185	1111	1113	CH	DISEASEORPHENOTYPICFEATURE	D000860
27860185	1150	1158	ossigeno	CHEMICALENTITY	D010100
27860185	1240	1247	I ratti	ORGANISMTAXON	10116
27860185	1335	1345	sildenafil	CHEMICALENTITY	D000068677
27860185	1420	1422	CH	DISEASEORPHENOTYPICFEATURE	D000860
27860185	1462	1467	ratti	ORGANISMTAXON	10116
27860185	1545	1553	ossigeno	CHEMICALENTITY	D010100
27860185	1623	1633	sildenafil	CHEMICALENTITY	D000068677
27860185	1747	1749	CH	DISEASEORPHENOTYPICFEATURE	D000860
27860185	1805	1835	ipertrofia ventricolare destra	DISEASEORPHENOTYPICFEATURE	D017380
27860185	1881	1891	sildenafil	CHEMICALENTITY	D000068677
27860185	1969	1971	CH	DISEASEORPHENOTYPICFEATURE	D000860
27860185	2008	2013	c-kit	GENEORGENEPRODUCT	64030
27860185	2109	2119	sildenafil	CHEMICALENTITY	D000068677
27860185	2184	2189	c-kit	GENEORGENEPRODUCT	64030
27860185	2247	2280	recettore della tirosin-chinasi 2	GENEORGENEPRODUCT	25589
27860185	2314	2321	VEGF-R2	GENEORGENEPRODUCT	25589
27860185	2359	2363	CD68	GENEORGENEPRODUCT	287435
27860185	2488	2495	ipossia	DISEASEORPHENOTYPICFEATURE	D000860
27860185	2595	2608	infiammazione	DISEASEORPHENOTYPICFEATURE	D007249
27860185	2682	2723	fattore inducibile dall'ipossia (HIF)- 1a	GENEORGENEPRODUCT	29560
27860185	2768	2778	sildenafil	CHEMICALENTITY	D000068677
27860185	2843	2848	CXCR4	GENEORGENEPRODUCT	60628
27860185	2981	2991	sildenafil	CHEMICALENTITY	D000068677
27860185	3075	3081	 c-kit	GENEORGENEPRODUCT	64030
27860185	3191	3196	c-kit	GENEORGENEPRODUCT	64030
27860185	3246	3256	sildenafil	CHEMICALENTITY	D000068677
27860185	3361	3385	rimodellamento polmonare	DISEASEORPHENOTYPICFEATURE	D066253
27866394	40	59	bromuro di otilonio	CHEMICALENTITY	C013934
27866394	117	136	 neurotrasmettitore	CHEMICALENTITY	D018377
27866394	194	199	ratti	ORGANISMTAXON	10116
27866394	289	311	Il bromuro di otilonio	CHEMICALENTITY	C013934
27866394	344	346	OB	CHEMICALENTITY	C013934
27866394	463	497	sindrome dell'intestino irritabile	DISEASEORPHENOTYPICFEATURE	D043183
27866394	542	545	IBS	DISEASEORPHENOTYPICFEATURE	D043183
27866394	636	663	canali Ca(2+) di tipo L e T	GENEORGENEPRODUCT	24239,83810
27866394	703	739	recettori muscarinici e tachichinici	GENEORGENEPRODUCT	 1128,6869
27866394	806	811	ratti	ORGANISMTAXON	10116
27866394	853	855	OB	CHEMICALENTITY	C013934
27866394	916	934	neurotrasmettitore	CHEMICALENTITY	D018377
27866394	1097	1099	OB	CHEMICALENTITY	C013934
27866394	1202	1208	ratti 	ORGANISMTAXON	10116
27866394	1390	1393	IBS	DISEASEORPHENOTYPICFEATURE	D043183
27866394	1472	1474	OB	CHEMICALENTITY	C013934
27866394	1507	1512	ratti	ORGANISMTAXON	10116
27866394	1671	1673	OB	CHEMICALENTITY	C013934
27866394	1736	1754	neurotrasmettitori	CHEMICALENTITY	D018377
27866394	1870	1872	SP	GENEORGENEPRODUCT	24806
27866394	1907	1911	NK1r	GENEORGENEPRODUCT	24807
27866394	1947	1951	nNOS	GENEORGENEPRODUCT	24598
27866394	1987	1990	VIP	GENEORGENEPRODUCT	117064
27866394	2027	2032	S100b	GENEORGENEPRODUCT	25742
27866394	2100	2104	CGRP	GENEORGENEPRODUCT	24241
27866394	2142	2147	CRF1r	GENEORGENEPRODUCT	58959
27866394	2197	2199	OB	CHEMICALENTITY	C013934
27866394	2262	2267	CRF2r	GENEORGENEPRODUCT	64680
27866394	2324	2329	ratti	ORGANISMTAXON	10116
27866394	2405	2431	infiammazione della mucosa	DISEASEORPHENOTYPICFEATURE	D052016
27866394	2487	2489	OB	CHEMICALENTITY	C013934
27866394	2554	2557	Mr2	GENEORGENEPRODUCT	81645
27866394	2660	2664	ChAT	GENEORGENEPRODUCT	290567
27866394	2811	2813	OB	CHEMICALENTITY	C013934
27866394	2851	2856	ratti	ORGANISMTAXON	10116
27866394	2904	2906	OB	CHEMICALENTITY	C013934
27866394	2951	2974	canali Ca(2+) di tipo L	GENEORGENEPRODUCT	24239
27866394	3111	3113	OB	CHEMICALENTITY	C013934
28259923	31	68	Il gene dell'adenoma pleomorfo come-2	GENEORGENEPRODUCT	5326
28259923	155	158	Wnt	GENEORGENEPRODUCT	7474
28259923	190	200	b-catenina	GENEORGENEPRODUCT	1499
28259923	251	256	umano	ORGANISMTAXON	9606
28259923	300	326	adenocarcinoma colorettale	DISEASEORPHENOTYPICFEATURE	D015179
28259923	506	512	tumore	DISEASEORPHENOTYPICFEATURE	D009369
28259923	557	585	L'adenocarcinoma colorettale	DISEASEORPHENOTYPICFEATURE	D015179
28259923	630	633	CRC	DISEASEORPHENOTYPICFEATURE	D015179
28259923	691	697	cancro	DISEASEORPHENOTYPICFEATURE	D009369
28259923	746	755	metastasi	DISEASEORPHENOTYPICFEATURE	D009362
28259923	810	818	paziente	ORGANISMTAXON	9606
28259923	892	926	gene dell'adenoma pleomorfo like-2	GENEORGENEPRODUCT	5326
28259923	959	965	PLAGL2	GENEORGENEPRODUCT	5326
28259923	1027	1033	tumore	DISEASEORPHENOTYPICFEATURE	D009369
28259923	1157	1163	cancro	DISEASEORPHENOTYPICFEATURE	D009369
28259923	1248	1254	PLAGL2	GENEORGENEPRODUCT	5326
28259923	1316	1319	CRC	DISEASEORPHENOTYPICFEATURE	D015179
28259923	1347	1355	pazienti	ORGANISMTAXON	9606
28259923	1417	1423	PLAGL2	GENEORGENEPRODUCT	5326
28259923	1484	1487	CRC	DISEASEORPHENOTYPICFEATURE	D015179
28259923	1607	1613	PLAGL2	GENEORGENEPRODUCT	5326
28259923	1669	1678	paraffina	CHEMICALENTITY	D010232
28259923	1735	1738	CRC	DISEASEORPHENOTYPICFEATURE	D015179
28259923	1840	1846	PLAGL2	GENEORGENEPRODUCT	5326
28259923	1912	1918	PLAGL2	GENEORGENEPRODUCT	5326
28259923	2148	2158	N-caderina	GENEORGENEPRODUCT	1000
28259923	2192	2201	vimentina	GENEORGENEPRODUCT	7431
28259923	2291	2301	E-caderina	GENEORGENEPRODUCT	999
28259923	2404	2410	PLAGL2	GENEORGENEPRODUCT	5326
28259923	2461	2464	wnt	GENEORGENEPRODUCT	7474
28259923	2523	2533	b-catenina	GENEORGENEPRODUCT	1499
28259923	2595	2598	CRC	DISEASEORPHENOTYPICFEATURE	D015179
28259923	2650	2659	metastasi	DISEASEORPHENOTYPICFEATURE	D009362
28259923	2750	2756	PLAGL2	GENEORGENEPRODUCT	5326
28259923	2888	2893	ratti	ORGANISMTAXON	10116
28259923	2967	2973	PLAGL2	GENEORGENEPRODUCT	5326
28259923	3060	3066	PLAGL2	GENEORGENEPRODUCT	5326
28259923	3178	3181	Wnt	GENEORGENEPRODUCT	7474
28259923	3213	3223	b-catenina	GENEORGENEPRODUCT	1499
28393239	31	40	Psoriasin	GENEORGENEPRODUCT	6278
28393239	143	163	 cancro del pancreas	DISEASEORPHENOTYPICFEATURE	D010190
28393239	253	263	Psoriasina	GENEORGENEPRODUCT	6278
28393239	296	302	S100A7	GENEORGENEPRODUCT	6278
28393239	358	384	proteina legante il calcio	GENEORGENEPRODUCT	6278
28393239	452	479	lesioni cutanee psoriasiche	DISEASEORPHENOTYPICFEATURE	D011565
28393239	549	553	S100	GENEORGENEPRODUCT	6278
28393239	742	751	Psoriasin	GENEORGENEPRODUCT	6278
28393239	833	839	cancro	DISEASEORPHENOTYPICFEATURE	D009369
28393239	959	969	Psoriasina	GENEORGENEPRODUCT	6278
28393239	1016	1035	cancro del pancreas	DISEASEORPHENOTYPICFEATURE	D010190
28393239	1153	1163	Psoriasina	GENEORGENEPRODUCT	6278
28393239	1280	1298	tumori pancreatici	DISEASEORPHENOTYPICFEATURE	D010190
28393239	1415	1425	Psoriasina	GENEORGENEPRODUCT	6278
28393239	1472	1491	cancro del pancreas	DISEASEORPHENOTYPICFEATURE	D010190
28393239	1646	1656	Psoriasina	GENEORGENEPRODUCT	6278
28393239	1705	1710	umano	ORGANISMTAXON	9606
28393239	1742	1752	Psoriasina	GENEORGENEPRODUCT	6278
28393239	1806	1816	Psoriasina	GENEORGENEPRODUCT	6278
28393239	1996	2006	Psoriasina	GENEORGENEPRODUCT	6278
28393239	2078	2097	cancro del pancreas	DISEASEORPHENOTYPICFEATURE	D010190
28393239	2220	2239	tumori del pancreas	DISEASEORPHENOTYPICFEATURE	D010190
28393239	2350	2360	Psoriasina	GENEORGENEPRODUCT	6278
28393239	2416	2422	cancro	DISEASEORPHENOTYPICFEATURE	D009369
28393239	2489	2503	Tumori primari	DISEASEORPHENOTYPICFEATURE	D009369
28393239	2551	2560	metastasi	DISEASEORPHENOTYPICFEATURE	D009362
28393239	2634	2644	Psoriasina	GENEORGENEPRODUCT	6278
28393239	2677	2729	Le linee cellulari di sovraespressione di psoriasina	GENEORGENEPRODUCT	6278
28393239	2903	2913	Psoriasina	GENEORGENEPRODUCT	6278
28393239	3009	3028	cancro del pancreas	DISEASEORPHENOTYPICFEATURE	D010190
28393239	3103	3130	matrice metalloproteinasi-2	GENEORGENEPRODUCT	4313
28393239	3163	3168	MMP-2	GENEORGENEPRODUCT	4313
28393239	3203	3208	MMP-9	GENEORGENEPRODUCT	4318
28393239	3264	3274	Psoriasina	GENEORGENEPRODUCT	6278
28393239	3384	3403	cancro del pancreas	DISEASEORPHENOTYPICFEATURE	D010190
28393239	3511	3521	Psoriasina	GENEORGENEPRODUCT	6278
28393239	3607	3625	tumori pancreatici	DISEASEORPHENOTYPICFEATURE	D010190
28393239	3658	3685	L'espressione di psoriasina	GENEORGENEPRODUCT	6278
28393239	3743	3762	cancro del pancreas	DISEASEORPHENOTYPICFEATURE	D010190
28393239	3898	3901	MMP	GENEORGENEPRODUCT	4313,4318
28393239	3972	3982	Psoriasina	GENEORGENEPRODUCT	6278
28518143	32	61	Recettore sensibile al calcio	GENEORGENEPRODUCT	24247
28518143	102	110	glucosio	CHEMICALENTITY	D005947
28518143	169	193	disturbo del metabolismo	DISEASEORPHENOTYPICFEATURE	D008659
28518143	242	246	gp78	GENEORGENEPRODUCT	361367
28518143	327	354	La cardiomiopatia diabetica	DISEASEORPHENOTYPICFEATURE	D058065
28518143	399	402	DCM	DISEASEORPHENOTYPICFEATURE	D002311
28518143	485	493	pazienti	ORGANISMTAXON	9606
28518143	541	548	diabete	DISEASEORPHENOTYPICFEATURE	D003920
28518143	585	620	recettore di rilevamento del calcio	GENEORGENEPRODUCT	24247
28518143	654	658	CaSR	GENEORGENEPRODUCT	24247
28518143	698	731	Recettore accoppiato a proteine G	GENEORGENEPRODUCT	24247
28518143	816	822	calcio	CHEMICALENTITY	D002118
28518143	972	976	CaSR	GENEORGENEPRODUCT	24247
28518143	1021	1027	calcio	CHEMICALENTITY	D002118
28518143	1161	1164	DCM	DISEASEORPHENOTYPICFEATURE	D002311
28518143	1193	1198	ratti	ORGANISMTAXON	10116
28518143	1339	1343	CaSR	GENEORGENEPRODUCT	24247
28518143	1390	1436	disturbo del metabolismo energetico miocardico	DISEASEORPHENOTYPICFEATURE	D009202
28518143	1479	1487	glucosio	CHEMICALENTITY	D005947
28518143	1621	1625	CaSR	GENEORGENEPRODUCT	24247
28518143	1695	1699	Mfn1	GENEORGENEPRODUCT	192647
28518143	1733	1737	Mfn2	GENEORGENEPRODUCT	64476
28518143	1825	1829	Cx43	GENEORGENEPRODUCT	24392
28518143	1864	1877	beta-catenina	GENEORGENEPRODUCT	84353
28518143	1911	1921	N-caderina	GENEORGENEPRODUCT	83501
28518143	1972	1993	Concentrazione di ATP	CHEMICALENTITY	D000255
28518143	2092	2095	ATP	CHEMICALENTITY	D000255
28518143	2147	2151	gp78	GENEORGENEPRODUCT	361367
28518143	2222	2226	Fis1	GENEORGENEPRODUCT	288584
28518143	2261	2265	Drp1	GENEORGENEPRODUCT	114114
28518143	2334	2338	Mfn1	GENEORGENEPRODUCT	192647
28518143	2372	2376	Mfn2	GENEORGENEPRODUCT	64476
28518143	2411	2416	 Cx43	GENEORGENEPRODUCT	24392
28518143	2459	2463	CaSR	GENEORGENEPRODUCT	24247
28518143	2508	2512	gp78	GENEORGENEPRODUCT	361367
28518143	2683	2729	disturbo del metabolismo energetico miocardico	DISEASEORPHENOTYPICFEATURE	D009202
28518143	2791	2795	CaSR	GENEORGENEPRODUCT	24247
28518143	2883	2887	gp78	GENEORGENEPRODUCT	361367
28518143	3085	3088	ATP	CHEMICALENTITY	D000255
28518143	3136	3150	Perdita di ATP	CHEMICALENTITY	D000255
28518143	3203	3207	CaSR	GENEORGENEPRODUCT	24247
28518143	3278	3320	metabolismo energetico miocardico anormale	DISEASEORPHENOTYPICFEATURE	D009202
28518143	3365	3369	CaSR	GENEORGENEPRODUCT	24247
28518143	3473	3476	DCM	DISEASEORPHENOTYPICFEATURE	D002311
29049388	42	47	mouse	ORGANISMTAXON	10090
29049388	92	99	podocin	GENEORGENEPRODUCT	170484
29049388	168	186	sindrome nefrosica	DISEASEORPHENOTYPICFEATURE	D009404
29049388	238	243	NPHS2	GENEORGENEPRODUCT	7827
29049388	293	300	podocin	GENEORGENEPRODUCT	7827
29049388	362	380	sindrome nefrosica	DISEASEORPHENOTYPICFEATURE	D009404
29049388	437	444	podocin	GENEORGENEPRODUCT	7827
29049388	481	486	R138Q	SEQUENCEVARIANT	RS74315342
29049388	622	637	malattia renale	DISEASEORPHENOTYPICFEATURE	D007674
29049388	676	680	topi	ORGANISMTAXON	10090
29049388	738	743	R140Q	SEQUENCEVARIANT	P|SUB|R|140|Q
29049388	793	797	topo	ORGANISMTAXON	10090
29049388	828	833	umano	ORGANISMTAXON	9606
29049388	870	875	R138Q	SEQUENCEVARIANT	RS74315342
29049388	967	987	insufficienza renale	DISEASEORPHENOTYPICFEATURE	D051437
29049388	1091	1098	podocin	GENEORGENEPRODUCT	170484
29049388	1143	1148	NPHS2	GENEORGENEPRODUCT	170484
29049388	1188	1193	R140Q	SEQUENCEVARIANT	P|SUB|R|140|Q
29049388	1243	1252	tamoxifen	CHEMICALENTITY	D013629
29049388	1424	1429	R140Q	SEQUENCEVARIANT	P|SUB|R|140|Q
29049388	1527	1538	proteinuria	DISEASEORPHENOTYPICFEATURE	D011507
29049388	1674	1694	insufficienza renale	DISEASEORPHENOTYPICFEATURE	D051437
29049388	2203	2230	fibrosi tubulointerstiziale	DISEASEORPHENOTYPICFEATURE	D007674
29049388	2377	2388	proteinuria	DISEASEORPHENOTYPICFEATURE	D011507
29049388	2467	2472	R140Q	SEQUENCEVARIANT	P|SUB|R|140|Q
29049388	2506	2513	podocin	GENEORGENEPRODUCT	170484
29049388	2693	2700	miRNA21	GENEORGENEPRODUCT	406991
29049388	2796	2806	miRNA-193a	GENEORGENEPRODUCT	406968
29049388	2940	2945	R140Q	SEQUENCEVARIANT	P|SUB|R|140|Q
29049388	2979	2986	podocin	GENEORGENEPRODUCT	170484
29049388	3026	3031	mouse	ORGANISMTAXON	10090
29049388	3124	3129	umano	ORGANISMTAXON	9606
29049388	3173	3191	sindrome nefrosica	DISEASEORPHENOTYPICFEATURE	D009404
29049388	3282	3287	umano	ORGANISMTAXON	9606
29049388	3523	3534	proteinuria	DISEASEORPHENOTYPICFEATURE	D011507
29049388	3580	3597	glomerulosclerosi	DISEASEORPHENOTYPICFEATURE	D005921
29049388	3655	3675	insufficienza renale	DISEASEORPHENOTYPICFEATURE	D051437
29183288	32	62	L'eliminazione dell'arginasi 1	GENEORGENEPRODUCT	11846
29183288	138	161	 risposta infiammatoria	DISEASEORPHENOTYPICFEATURE	D007249
29183288	223	227	asma	DISEASEORPHENOTYPICFEATURE	D001249
29183288	228	229	 	ORGANISMTAXON	10090
29183288	362	370	arginase	GENEORGENEPRODUCT	11846
29183288	455	469	ossido nitrico	CHEMICALENTITY	D009569
29183288	546	555	arginase1	GENEORGENEPRODUCT	11846
29183288	589	593	ARG1	GENEORGENEPRODUCT	11846
29183288	693	716	infiammazione polmonare	DISEASEORPHENOTYPICFEATURE	D011014
29183288	756	760	topi	ORGANISMTAXON	10090
29183288	798	808	ovalbumina	GENEORGENEPRODUCT	66222
29183288	842	845	OVA	GENEORGENEPRODUCT	66222
29183288	908	913	 asma	DISEASEORPHENOTYPICFEATURE	D001249
29183288	955	959	Arg1	GENEORGENEPRODUCT	11846
29183288	1031	1035	Arg1	GENEORGENEPRODUCT	11846
29183288	1085	1089	topi	ORGANISMTAXON	10090
29183288	1123	1182	Sono state condotte la sensibilizzazione e il challenge OVA	GENEORGENEPRODUCT	66222
29183288	1224	1234	metacolina	CHEMICALENTITY	D016210
29183288	1416	1419	IgE	GENEORGENEPRODUCT	629822
29183288	1575	1579	Arg1	GENEORGENEPRODUCT	11846
29183288	1658	1661	OVA	GENEORGENEPRODUCT	66222
29183288	1720	1723	OVA	GENEORGENEPRODUCT	66222
29183288	1792	1796	Arg2	GENEORGENEPRODUCT	11847
29183288	1832	1836	Nos2	GENEORGENEPRODUCT	18126
29183288	1870	1876	Slc7a1	GENEORGENEPRODUCT	11987
29183288	1910	1917	Slc7a2 	GENEORGENEPRODUCT	11988
29183288	1952	1958	Slc7a7	GENEORGENEPRODUCT	20540
29183288	2004	2029	trasportatori di arginina	GENEORGENEPRODUCT	11987,11988,20540
29183288	2064	2067	Il4	GENEORGENEPRODUCT	16189
29183288	2101	2104	Il5	GENEORGENEPRODUCT	16191
29183288	2140	2144	Il13	GENEORGENEPRODUCT	16163
29183288	2190	2211	Citochine di tipo TH2	GENEORGENEPRODUCT	16163,16189,16191
29183288	2247	2251	Ccl2	GENEORGENEPRODUCT	20296
29183288	2286	2291	Ccl11	GENEORGENEPRODUCT	20292
29183288	2331	2341	chemochine	GENEORGENEPRODUCT	20292,20296
29183288	2376	2380	Ifng	GENEORGENEPRODUCT	15978
29183288	2415	2436	Citochina di tipo TH1	GENEORGE NEPRODUCT	15978
29183288	2471	2476	Clca3	GENEORGENEPRODUCT	23844
29183288	2511	2517	Muc5ac	GENEORGENEPRODUCT	17833
29183288	2587	2590	OVA	GENEORGENEPRODUCT	66222
29183288	2634	2637	IgE	GENEORGENEPRODUCT	629822
29183288	2703	2708	IL-10	GENEORGENEPRODUCT	16153
29183288	2757	2761	IL-4	GENEORGENEPRODUCT	16189
29183288	2796	2800	IL-5	GENEORGENEPRODUCT	16191
29183288	2834	2839	IL-13	GENEORGENEPRODUCT	16163
29183288	2874	2882	TNFalpha	GENEORGENEPRODUCT	21926
29183288	2917	2925	IFNgamma	GENEORGENEPRODUCT	15978
29183288	3014	3036	L'eliminazione di Arg1	GENEORGENEPRODUCT	11846
29183288	3196	3208	infiammatori	DISEASEORPHENOTYPICFEATURE	D007249
29183288	3254	3257	OVA	GENEORGENEPRODUCT	66222
29183288	3290	3293	OVA	GENEORGENEPRODUCT	66222
29183288	3337	3341	topi	ORGANISMTAXON	10090
29183288	3375	3378	OVA	GENEORGENEPRODUCT	66222
29183288	3411	3414	OVA	GENEORGENEPRODUCT	66222
29183288	3460	3464	topi	ORGANISMTAXON	 10090
29183288	3514	3517	OVA	GENEORGENEPRODUCT	66222
29183288	3551	3554	IgE	GENEORGENEPRODUCT	629822
29183288	3671	3684	infiammazione	DISEASEORPHENOTYPICFEATURE	D007249
29183288	3732	3736	Arg1	GENEORGENEPRODUCT	11846
29183288	3780	3783	OVA	GENEORGENEPRODUCT	66222
29183288	3841	3844	OVA	GENEORGENEPRODUCT	66222
29183288	4090	4093	IgE	GENEORGENEPRODUCT	629822
29183288	4232	4236	Arg1	GENEORGENEPRODUCT	11846
29183288	4385	4402	geni infiammatori	DISEASEORPHENOTYPICFEATURE	 D007249
29183288	4442	4452	metacolina	CHEMICALENTITY	D016210
29183288	4521	4533	infiammatori	DISEASEORPHENOTYPICFEATURE	D007249
